Processing 00000000.tx.1: The Rockefeller University Press, 0021-9525 $8.00 JCB, Volume 164, Number 1, 123-131 This Article Abstract PDF (Full Text) Alert me when this article is cited Citation Map Services Alert me to new content in the JCB Download to citation manager Cited by other online articles Google Scholar Articles by Lee, J.-T. 

Phrase: "The Rockefeller University Press,"

Phrase: "0021-9525 $8.00 JCB,"

Phrase: "Volume 164,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "Number 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "123-131"

Phrase: "This Article Abstract PDF (Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: ")"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205314:New [Temporal Concept]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "in the JCB Download"

Phrase: "to citation manager"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0335141:manager [Professional or Occupational Group]
   861   C1546507:Manager [Idea or Concept]

Phrase: "Cited by other online articles Google Scholar Articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0684017:scholar [Professional or Occupational Group]
   711   C1706852:Article [Intellectual Product]

Phrase: "by Lee,"

Phrase: "J.-T."
Processing 00000000.tx.2: Articles by Hsu, C. 

Phrase: "Articles by Hsu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.3: Y. 

Phrase: "Y."
Processing 00000000.tx.4: Articles citing this Article PubMed PubMed Citation Articles by Lee, J.-T. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Lee,"

Phrase: "J.-T."
Processing 00000000.tx.5: Articles by Hsu, C. 

Phrase: "Articles by Hsu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.6: Y. 

Phrase: "Y."
Processing 00000000.tx.7: Article Amyloid- peptide induces oligodendrocyte death by activating the neutral sphingomyelinaseceramide pathway Jiunn-Tay Lee3, Jan Xu1, Jin-Moo Lee1, Grace Ku1, Xianlin Han2, Ding-I Yang1, Shawei Chen1 and Chung Y. 

Phrase: "Article Amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "oligodendrocyte death by activating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: "the neutral sphingomyelinaseceramide pathway Jiunn-Tay Lee3,"

Phrase: "Jan Xu1,"

Phrase: "Jin-Moo Lee1,"

Phrase: "Grace Ku1,"

Phrase: "Xianlin Han2,"

Phrase: "Ding-I Yang1,"

Phrase: "Shawei Chen1"

Phrase: "and"

Phrase: "Chung Y."
Processing 00000000.tx.8: Hsu1,4 1 Center for the Study of Nervous System Injury, Department of Neurology 2 Division of Bioorganic Chemistry and Molecular Pharmacology, Department of Internal Medicine, Washington University School of Medicine, St. 

Phrase: "Hsu1,"

Phrase: "4 1 Center for the Study of Nervous System Injury,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205099:Center [Spatial Concept]

Phrase: "Department of Neurology 2 Division of Bioorganic Chemistry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0587475:Neurology department [Health Care Related Organization]
   744   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Molecular Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031330:Pharmacology [Biomedical Occupation or Discipline]
   861   C1524059:pharmacology [Functional Concept]
   789 E C0205464:Pharmacologic [Functional Concept]

Phrase: "Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Washington University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.9: Louis, MO 63110 3 Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan, Republic of China 4 Taipei Medical University, Taipei 110, Taiwan, Republic of China Address correspondence to Chung Y. 

Phrase: "Louis,"

Phrase: "MO 63110 3 Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0587475:Neurology department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "Tri-Service General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0205246:General [Spatial Concept]
   812   C1510665:Hospital [Qualitative Concept]
   812   C1553889:General [Idea or Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "National Defense Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: "Taipei 114,"

Phrase: "Taiwan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "Republic of China 4 Taipei Medical University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0041740:University [Manufactured Object,Organization]
   795   C0205476:Medical [Functional Concept]

Phrase: "Taipei 110,"

Phrase: "Taiwan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "Republic of China"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039260:Republic of China [Geographic Area]
   827   C0008115:China [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "correspondence to Chung Y."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.10: Hsu, Center for the Study of Nervous System Injury, Dept. of Neurology, Washington University School of Medicine, 660 S. 

Phrase: "Hsu,"

Phrase: "Center for the Study of Nervous System Injury,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205099:Center [Spatial Concept]

Phrase: "Dept."

Phrase: "of Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "Washington University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "660 S."
Processing 00000000.tx.11: Euclid Ave., Box 8111, St. 

Phrase: "Euclid Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Box 8111,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.12: Louis, MO 63110. 

Phrase: "Louis,"

Phrase: "MO 63110."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]
Processing 00000000.tx.13: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.14: (314) 362-3304. 

Phrase: "(314"

Phrase: ")"

Phrase: "362-3304."
Processing 00000000.tx.15: Fax: (314) 362-9462. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "(314"

Phrase: ")"

Phrase: "362-9462."
Processing 00000000.tx.16: email: hsuc{at}neuro.wustl.edu  Abstract Top Abstract Introduction Results Discussion Materials and methods References  Amyloid- peptide (A) accumulation in senile plaques, a pathological hallmark of Alzheimer's disease (AD), has been implicated in neuronal degeneration. 

Phrase: "email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "hsuc{at}neuro.wustl.edu  Abstract Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: "A) accumulation in senile plaques,"

Phrase: "a pathological hallmark of Alzheimer's disease"

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "has"

Phrase: "been"

Phrase: "implicated in neuronal degeneration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.17: We have recently demonstrated that A induced oligodendrocyte (OLG) apoptosis, suggesting a role in white matter pathology in AD. 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "that A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "oligodendrocyte (OLG) apoptosis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C3269210:oligodendrocyte apoptosis [Cell Function]
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role in white matter pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in AD."
Processing 00000000.tx.18: Here, we explore the molecular mechanisms involved in A-induced OLG death, examining the potential role of ceramide, a known apoptogenic mediator. 

Phrase: "Here,"

Phrase: "we"

Phrase: "explore"

Phrase: "the molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C1314939:Involved [Functional Concept]

Phrase: "A-induced OLG death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the potential role of ceramide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "a known apoptogenic mediator."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.19: Both A and ceramide induced OLG death. 

Phrase: "Both A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "and"

Phrase: "ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]
Processing 00000000.tx.20: In addition, A activated neutral sphingomyelinase (nSMase), but not acidic sphingomyelinase, resulting in increased ceramide generation. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "neutral sphingomyelinase (nSMase),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "not acidic sphingomyelinase,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0599122:acidic sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   865 E C0037903:Acid Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
           SPHINGOMYELINASE
   865 E C1420259:SPHINGOMYELINASE, ACID [Gene or Genome]

Phrase: "resulting in increased ceramide generation."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0332294:Resulting in [Functional Concept]
   760   C0007745:Ceramide [Biologically Active Substance,Lipid]
   760   C0079411:Generation [Temporal Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   760   C3146294:Generation [Activity]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]
Processing 00000000.tx.21: Blocking ceramide degradation with N-oleoyl-ethanolamine exacerbated A cytotoxicity; 

Phrase: "Blocking ceramide degradation with N-oleoyl-ethanolamine exacerbated A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1157956:ceramide degradation [Molecular Function]
   762   C1156442:ethanolamine degradation [Molecular Function]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: "A cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]

Phrase: ";"
Processing 00000000.tx.22: and addition of bacterial sphingomyelinase (mimicking cellular nSMase activity) induced OLG death. 

Phrase: "and"

Phrase: "addition of bacterial sphingomyelinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "("

Phrase: "mimicking"

Phrase: "cellular nSMase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C2261839:neutral sphingomyelinase activity [Molecular Function]
   861   C1149875:sphingomyelinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: "induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]
Processing 00000000.tx.23: Furthermore, nSMase inhibition by 3-O-methyl-sphingomyelin or by gene knockdown using antisense oligonucleotides attenuated A-induced OLG death. 

Phrase: "Furthermore,"

Phrase: "nSMase inhibition by 3-O-methyl-sphingomyelin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "or by gene knockdown"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C2350567:Gene Knock-Down [Molecular Biology Research Technique]
   770   C0017337:Gene [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antisense oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]
Processing 00000000.tx.24: Glutathione (GSH) precursors inhibited A activation of nSMase and prevented OLG death, whereas GSH depletors increased nSMase activity and A-induced death. 

Phrase: "Glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(GSH) precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709634:Precursor [Idea or Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A activation of nSMase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "prevented OLG death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]

Phrase: "whereas"

Phrase: "GSH depletors"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "nSMase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2261839:neutral sphingomyelinase activity [Molecular Function]
   901   C1149875:sphingomyelinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-induced death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]
Processing 00000000.tx.25: These results suggest that A induces OLG death by activating the nSMaseceramide cascade via an oxidative mechanism. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "OLG death by activating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: "the nSMaseceramide cascade via an oxidative mechanism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.26: Key Words: Alzheimer's disease; 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.27: apoptosis; 

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.28: cell death; 

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.29: oxidative stress; 

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: ";"
Processing 00000000.tx.30: white matter J.-T. 

Phrase: "white matter J.-T."
Processing 00000000.tx.31: Lee and J. 

Phrase: "Lee"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.32: Xu contributed equally to this paper. 

Phrase: "Xu"

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this paper."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030351:Paper [Manufactured Object]
   770   C1547566:Paper [Idea or Concept]
Processing 00000000.tx.33: Abbreviations used in this paper: 3-OMe-SM, 3-O-methyl-sphingomyelin; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1547566:Paper [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "3-OMe-SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036154:SM [Geographic Area]

Phrase: "3-O-methyl-sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: ";"
Processing 00000000.tx.34: A, amyloid- peptide; 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A,"

Phrase: "amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.35: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.36: aSMase, acidic sphingomyelinase; 

Phrase: "aSMase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539725:ASMASE [Gene or Genome]

Phrase: "acidic sphingomyelinase"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599122:acidic sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   964 E C0037903:Acid Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
           SPHINGOMYELINASE
   964 E C1420259:SPHINGOMYELINASE, ACID [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.37: bSMase, bacterial sphingomyelinase; 

Phrase: "bSMase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "bacterial sphingomyelinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.38: BSO, buthionine sulfoximine; 

Phrase: "BSO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054252:Buthionine Sulfoximine [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]
   861   C0054251:buthionine [Amino Acid, Peptide, or Protein]

Phrase: "buthionine sulfoximine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054252:Buthionine Sulfoximine [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]
   861   C0054251:buthionine [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.39: DEM, diethyl maleate; 

Phrase: "DEM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0057931:diethyl maleate [Organic Chemical]
   861   C0220874:Maleate [Organic Chemical]

Phrase: "diethyl maleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0057931:diethyl maleate [Organic Chemical]
   861   C0220874:Maleate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.40: ESI/MS, electrospray ionization/mass spectrometry; 

Phrase: "ESI/MS,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C1516801:Electrospray Ionization [Laboratory Procedure]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C0596801:Ionization [Phenomenon or Process]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "electrospray ionization/mass spectrometry"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C1516801:Electrospray Ionization [Laboratory Procedure]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C0596801:Ionization [Phenomenon or Process]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.41: GSH, glutathione; 

Phrase: "GSH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.42: LDH, lactate dehydrogenase; 

Phrase: "LDH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "lactate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.43: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 

Phrase: "MTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyltetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.44: NAC, N-acetylcysteine; 

Phrase: "NAC,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "N-acetylcysteine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.45: nSMase, neutral sphingomyelinase; 

Phrase: "nSMase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "neutral sphingomyelinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.46: NOE, N-oleoyl-ethanolamine; 

Phrase: "NOE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014983:Ethanolamine [Organic Chemical]
   827   C0059696:ethanolamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "N-oleoyl-ethanolamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014983:Ethanolamine [Organic Chemical]
   827   C0059696:ethanolamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.47: OLG, oligodendrocyte; 

Phrase: "OLG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028944:Oligodendrocyte [Cell]

Phrase: "oligodendrocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028944:Oligodendrocyte [Cell]

Phrase: ";"
Processing 00000000.tx.48: PLP, proteolipid protein.  

Phrase: "PLP,"

Phrase: "proteolipid protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033693:proteolipid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
Processing 00000000.tx.49: Introduction Top Abstract Introduction Results Discussion Materials and methods References  The amyloid- peptide (A), a 3943amino acid cleavage product of amyloid precursor protein (Estus et al., 1992; Haass et al., 1992), has been implicated as the primary neurotoxic factor in Alzheimer's disease (AD) pathogenesis (Yankner et al., 1989). 

Phrase: "Introduction Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: "A"

Phrase: ")"

Phrase: ","

Phrase: "a 3943amino acid cleavage product of amyloid precursor protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0597304:Protein Cleavage [Molecular Function]
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]

Phrase: "(Estus et al.,"

Phrase: "1992"

Phrase: "; Haass et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "has"

Phrase: "been"

Phrase: "implicated as the primary neurotoxic factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]

Phrase: "(Yankner et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.50: In vitro, A is toxic to neurons (Yankner et al., 1989; Behl et al., 1994; Yu et al., 1998), endothelial cells (Thomas et al., 1996; Huang et al., 1998), astrocytes (Brera et al., 2000), vascular smooth muscle cells (Kawai et al., 1993; Davis-Salinas et al., 1995), and oligodendrocytes (OLGs; Xu et al., 2001); 

Phrase: "In vitro, A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0003320:Antigens [Immunologic Factor]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "is"

Phrase: "toxic to neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600688:toxic [Injury or Poisoning]
   790   C1407029:Toxic [Qualitative Concept]

Phrase: "(Yankner et al.,"

Phrase: "1989"

Phrase: "; Behl et al.,"

Phrase: "1994"

Phrase: "; Yu et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Thomas et al.,"

Phrase: "1996"

Phrase: "; Huang et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "(Brera et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "vascular smooth muscle cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "(Kawai et al.,"

Phrase: "1993"

Phrase: "; Davis-Salinas et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "oligodendrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028944:Oligodendrocytes [Cell]

Phrase: "(OLGs"

Phrase: "; Xu et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.51: and A depositions in senile plaques are postulated to cause neuronal and vascular degeneration in AD brains (Masters et al., 1985; Yankner et al., 1989; Thomas et al., 1996). 

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A depositions in senile plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:DEPOSITIONS [Functional Concept]

Phrase: "are"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "vascular degeneration in AD brains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1281300:Vascular degeneration [Disease or Syndrome]
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "(Masters et al.,"

Phrase: "1985"

Phrase: "; Yankner et al.,"

Phrase: "1989"

Phrase: "; Thomas et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.52: Although A-mediated cell death demonstrates morphological, biochemical, and molecular features of apoptosis, the molecular mechanism underlying A cytotoxicity remains largely undefined but may involve oxidative stress (Behl et al., 1994; Schapira, 1996). 

Phrase: "Although"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-mediated cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "demonstrates"

Phrase: "morphological, biochemical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "molecular features of apoptosis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]

Phrase: "the molecular mechanism underlying A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003320:Antigens [Immunologic Factor]
   706 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]

Phrase: "remains"

Phrase: "largely undefined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750600:undefined [Idea or Concept]

Phrase: "but"

Phrase: "may"

Phrase: "involve"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(Behl et al.,"

Phrase: "1994"

Phrase: "; Schapira,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.53: NF-B and AP-1, redox-sensitive transcription factors, are activated in A-treated OLGs, and N-acetylcysteine (NAC), an antioxidant, prevents A-mediated OLG apoptosis (Xu et al., 2001). 

Phrase: "NF-B"

Phrase: "and"

Phrase: "AP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "redox-sensitive transcription factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "activated in A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "A-treated OLGs,"

Phrase: "and"

Phrase: "N-acetylcysteine (NAC),"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "an antioxidant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-mediated OLG apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C3269210:oligodendrocyte apoptosis [Cell Function]
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(Xu et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.54: OLGs are susceptible to oxidative stress because they have low levels of reduced glutathione (GSH) and high concentrations of iron, resulting in a compromised ability to scavenge peroxides (Thorburne and Juurlink, 1996; Back et al., 1998; Juurlink et al., 1998). 

Phrase: "OLGs"

Phrase: "are"

Phrase: "susceptible to oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "because"

Phrase: "they"

Phrase: "have"

Phrase: "low levels of reduced glutathione"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(GSH)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "and"

Phrase: "high concentrations of iron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "resulting in a compromised ability to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0332294:Resulting in [Functional Concept]
   753   C0085732:Ability [Organism Attribute]
   753   C0678226:resulting [Functional Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "scavenge"

Phrase: "peroxides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031180:Peroxides [Inorganic Chemical]

Phrase: "(Thorburne"

Phrase: "and"

Phrase: "Juurlink,"

Phrase: "1996"

Phrase: "; Back et al.,"

Phrase: "1998"

Phrase: "; Juurlink et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.55: Ceramide, a lipid second messenger that increases the cellular oxidative state, has been implicated in several apoptosis paradigms including trophic factor withdrawal and exposure to proinflammatory molecules (Coroneos et al., 1995; Kyriakis and Avruch, 1996; Kolesnick and Kronke, 1998). 

Phrase: "Ceramide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "a lipid second messenger"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   901   C0036522:second messenger [Molecular Function]
   901   C1508748:second messenger [Biologically Active Substance]
   827   C0023779:Lipid [Lipid]
   827   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0205436:Second [Quantitative Concept]
   827   C0335218:Messenger [Professional or Occupational Group]
   827   C0457385:Second [Temporal Concept]
   827   C0565930:/second [Quantitative Concept]
   827   C1561503:second [Idea or Concept]
   827   C1705190:Second [Qualitative Concept]
   755 E C0027627:secondary [Neoplastic Process]
   755 E C0175668:Secondary [Temporal Concept]

Phrase: "that"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the cellular oxidative state,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in several apoptosis paradigms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0162638:Apoptosis [Cell Function]
   760   C0681797:paradigms [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "trophic factor withdrawal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2349954:Withdrawal [Activity]
   827   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "exposure to proinflammatory molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "(Coroneos et al.,"

Phrase: "1995"

Phrase: "; Kyriakis"

Phrase: "and"

Phrase: "Avruch,"

Phrase: "1996"

Phrase: "; Kolesnick"

Phrase: "and"

Phrase: "Kronke,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.56: Cellular ceramide synthesis increases in response to stress or death signals (Haimovitz-Friedman et al., 1994; Tepper et al., 1995; Verheij et al., 1996). 

Phrase: "Cellular ceramide synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1523936:cellular synthesis [Cell Function]
   901   C1157399:ceramide synthesis [Molecular Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "increases in response"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   790   C0442805:Increase [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "to stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038435:Stress [Finding]
   928 E C0231297:Stressful [Functional Concept]

Phrase: "or"

Phrase: "death signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "(Haimovitz-Friedman et al.,"

Phrase: "1994"

Phrase: "; Tepper et al.,"

Phrase: "1995"

Phrase: "; Verheij et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.57: One pathway of ceramide formation involves sphingomyelin hydrolysis by either neutral sphingomyelinase (nSMase) or acidic sphingomyelinase (aSMase; Testi, 1996); 

Phrase: "One pathway of ceramide formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "involves"

Phrase: "sphingomyelin hydrolysis by either neutral sphingomyelinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "(nSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "or"

Phrase: "acidic sphingomyelinase"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599122:acidic sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   964 E C0037903:Acid Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
           SPHINGOMYELINASE
   964 E C1420259:SPHINGOMYELINASE, ACID [Gene or Genome]

Phrase: "(aSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539725:ASMASE [Gene or Genome]

Phrase: "; Testi,"

Phrase: "1996"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.58: both enzymes are involved in several cell death paradigms (Kolesnick and Kronke, 1998; Levade and Jaffrezou, 1999). 

Phrase: "both enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "involved in several cell death paradigms"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C0681797:paradigms [Research Activity]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1314939:Involved [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(Kolesnick"

Phrase: "and"

Phrase: "Kronke,"

Phrase: "1998"

Phrase: "; Levade"

Phrase: "and"

Phrase: "Jaffrezou,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.59: Another pathway involves ceramide synthasecatalyzed de novo ceramide synthesis (Bose et al., 1995; Spiegel and Merrill, 1996; Xu et al., 1998). 

Phrase: "Another pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "involves"

Phrase: "ceramide synthasecatalyzed de novo ceramide synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C1157399:ceramide synthesis [Molecular Function]
   799   C0220781:synthesis [Biologic Function]
   799   C1883254:Synthesis [Activity]

Phrase: "(Bose et al.,"

Phrase: "1995"

Phrase: "; Spiegel"

Phrase: "and"

Phrase: "Merrill,"

Phrase: "1996"

Phrase: "; Xu et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.60: A and ceramide share cell death signaling characteristics. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "and"

Phrase: "ceramide share cell death signaling characteristics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C1320392:Death characteristics [Finding]
   799   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.61: A-induced apoptosis involves TNF-, p75 neurotrophin receptor, and Fas ligand (Blasko et al., 1997; de la Monte et al., 1997; Yaar et al., 1997), which are cell surface receptors that relay death signals through the sphingomyelinceramide pathway (Dobrowsky et al., 1995; Hannun, 1996). 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "involves"

Phrase: "TNF-,"

Phrase: "p75 neurotrophin receptor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0254837:p75 Neurotrophin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0132298:Neurotrophin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1323315:neurotrophin [Molecular Function]
   827   C1332408:neurotrophin [Gene or Genome]

Phrase: "and"

Phrase: "Fas ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023688:Ligand [Chemical]

Phrase: "(Blasko et al.,"

Phrase: "1997"

Phrase: "; de la Monte et al.,"

Phrase: "1997"

Phrase: "; Yaar et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "cell surface receptors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   901   C0699040:Cell surface [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0205148:Surface [Spatial Concept]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "that relay death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "signals through the sphingomyelinceramide pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0037080:Signal Pathway [Molecular Function]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "(Dobrowsky et al.,"

Phrase: "1995"

Phrase: "; Hannun,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.62: Moreover, both A (Kaneko et al., 1995; Askanas et al., 1996; Bruce-Keller et al., 1998; Xu et al., 2001) and ceramide (Garcia-Ruiz et al., 1997; Singh et al., 1998) cause mitochondrial dysfunction and induce oxidative stress. 

Phrase: "Moreover,"

Phrase: "both A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A (Kaneko et al.,"

Phrase: "1995"

Phrase: "; Askanas et al.,"

Phrase: "1996"

Phrase: "; Bruce-Keller et al.,"

Phrase: "1998"

Phrase: "; Xu et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "and"

Phrase: "ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "(Garcia-Ruiz et al.,"

Phrase: "1997"

Phrase: "; Singh et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.63: In vitro, OLG death induced by A (Xu et al., 2001) or ceramide (Larocca et al., 1997; Singh et al., 1998; Scurlock and Dawson, 1999) share similar apoptotic characteristics. 

Phrase: "In vitro, OLG death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "induced by A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C0205263:Induced [Functional Concept]

Phrase: "A (Xu et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "or"

Phrase: "ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "(Larocca et al.,"

Phrase: "1997"

Phrase: "; Singh et al.,"

Phrase: "1998"

Phrase: "; Scurlock"

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "1999"

Phrase: ")"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "similar apoptotic characteristics."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.64: Lower sphingomyelin levels and higher ceramide levels in AD brains have been reported (Soderberg et al., 1992), thereby implying that increased sphingomyelin degradation and ceramide accumulation contribute to AD pathogenesis. 

Phrase: "Lower sphingomyelin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "higher ceramide levels in AD brains"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(Soderberg et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "implying"

Phrase: "that increased sphingomyelin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1157953:sphingomyelin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]
   734   C1291141:Increased sphingomyelin [Finding]

Phrase: "and"

Phrase: "ceramide accumulation"

Phrase: "contribute to AD pathogenesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.65: We have previously shown that A induced OLG death with characteristic features of apoptosis (Xu et al., 2001). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "OLG death with characteristic features of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011065:Death [Organism Function]
   748   C1306577:Death, NOS [Finding]

Phrase: "(Xu et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.66: In this paper, we demonstrate that ceramide mediates A-induced OLG death by activating the nSMaseceramide cascade.  

Phrase: "In this paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-induced OLG death by activating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]

Phrase: "the nSMaseceramide cascade."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.67: Results Top Abstract Introduction Results Discussion Materials and methods References  A and C2-ceramide are cytotoxic to OLGs We have previously shown that A induced apoptosis in primary OLG cultures derived from neonatal rat brains, characterized by nuclear and cytoskeletal disintegration, DNA fragmentation, and mitochondrial dysfunction (Xu et al., 2001). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "and"

Phrase: "C2-ceramide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "are"

Phrase: "cytotoxic to OLGs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   790   C1511636:cytotoxic [Functional Concept]

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "apoptosis in primary OLG cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C3269210:oligodendrocyte apoptosis [Cell Function]
   760   C0162638:Apoptosis [Cell Function]

Phrase: "derived from neonatal rat brains,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1441547:Derived [Qualitative Concept]
   760   C1552240:Neonatal [Professional or Occupational Group]
   760   C1552264:Neonatal [Professional or Occupational Group]
   760   C2939425:Neonatal [Temporal Concept]
   760   C3245521:derived [Idea or Concept]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "characterized by nuclear"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0521447:Nuclear [Spatial Concept]
   790   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "cytoskeletal disintegration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265875:Disintegration [Acquired Abnormality]

Phrase: "DNA fragmentation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "and"

Phrase: "mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(Xu et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.68: In this paper, we used neurosphere-derived differentiated OLGs because of their ease of preparation compared with primary OLG isolation. 

Phrase: "In this paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "neurosphere-"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "differentiated OLGs because of their ease of preparation"

Phrase: "compared with primary OLG isolation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0028944:Oligodendrocyte [Cell]
   760   C0204727:Isolation [Therapeutic or Preventive Procedure]
   760   C0205225:Primary [Qualitative Concept]
   760   C0205409:Isolation [Functional Concept]
   760   C0220862:isolation [Laboratory Procedure]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.69: The neurosphere-derived differentiated OLGs exhibited characteristic OLG morphology, which is composed of large cell bodies with multiple branching processes (Fig. 1, AH). 

Phrase: "The neurosphere-"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "differentiated OLGs"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "characteristic OLG morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "which"

Phrase: "is"

Phrase: "composed of large cell bodies"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   797   C0599444:bodies cell [Cell Component]
   773 E C2752549:cell body [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0242821:bodies [Human]
   760   C0549177:Large [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "with multiple branching processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "AH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1836672:AH [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.70: Immunocytochemical analysis revealed that virtually all cells in culture expressed four OLG-specific surface markers including cyclic nucleotide 3'-phosphodiesterase (Fig. 1 A, CNP), Rip (Fig. 1 C), galactocerebroside (Fig. 1 E, GalC), and PLP (myelin proteolipid protein; Fig. 1 G). 

Phrase: "Immunocytochemical analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that virtually"

Phrase: "all cells in culture"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "four OLG-specific surface markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0005516:Marker [Clinical Attribute]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cyclic nucleotide 3'-phosphodiesterase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1413553:CYCLIC NUCLEOTIDE PHOSPHODIESTERASE [Gene or Genome]
   812   C0031640:Phosphodiesterase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1753334:phosphodiesterase [Molecular Function]

Phrase: "(Fig. 1 A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A,"

Phrase: "CNP"

Phrase: ")"

Phrase: ","

Phrase: "Rip (Fig. 1 C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]
   708   C0297981:RIP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   708   C1825740:RIP-1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "galactocerebroside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0060955:galactocerebroside [Biologically Active Substance,Lipid]

Phrase: "(Fig. 1 E,"

Phrase: "GalC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414946:GALC [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "PLP (myelin proteolipid protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0060617:Myelin Proteolipid Protein [Amino Acid, Peptide, or Protein,Lipid,Neuroreactive Substance or Biogenic Amine]
           myelin proteolipid
   923   C1418654:PROTEOLIPID PROTEIN, MYELIN [Gene or Genome]
   875   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033693:proteolipid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]

Phrase: "; Fig. 1 G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.71: In addition, differentiated OLGs showed similar characteristic electrophysiological membrane potentials (unpublished data) as reported in previous studies (McDonald et al., 1999). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "differentiated OLGs"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar characteristic electrophysiological membrane potentials"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0025251:Membrane Potentials [Cell Function]
   804   C0025255:Membrane [Tissue]
   804   C0596901:Membrane [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   804   C3245505:potentials [Qualitative Concept]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")"

Phrase: "as"

Phrase: "reported in previous studies"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   786   C1317750:Study report [Intellectual Product]
   786   C1831145:Study report [Clinical Attribute]
   770   C0205156:Previous [Temporal Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1552607:previous [Temporal Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(McDonald et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.72: View larger version (82K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(82K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.73: Characterization of OLG cultures. 

Phrase: "Characterization of OLG cultures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]
Processing 00000000.tx.74: Immunofluorescent (A, C, E, and G) and corresponding phase-contrast (B, D, F, and H) photomicrographs of neurosphere-derived differentiated OLGs in culture. 

Phrase: "Immunofluorescent"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
   928 E C0016318:Immunofluorescence [Laboratory Procedure]
   928 E C0079603:Immunofluorescence [Laboratory Procedure]
   907 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "(A"

Phrase: "A,"

Phrase: "C,"

Phrase: "E,"

Phrase: "and"

Phrase: "G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "corresponding phase-contrast"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0444701:Phase contrast [Laboratory Procedure]
   827   C0205390:Phase [Temporal Concept]
   827   C1979874:Contrast [Qualitative Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "H) photomicrographs of neurosphere-"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "differentiated OLGs in culture."
Processing 00000000.tx.75: Cells demonstrate characteristic morphology of OLGs, plump cell body with multiple branching processes. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "demonstrate"

Phrase: "characteristic morphology of OLGs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332437:Morphology [Qualitative Concept]
   770   C0543482:morphology [Spatial Concept]
   770   C0700329:Morphology, NOS [Finding]
   770   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "plump cell body with multiple branching processes."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0599444:Cell body [Cell Component]
   778   C2752549:cell body [Cell Component]
   774   C0230625:cell processes [Cell Component]
   757 E C0007613:Cell Process [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0242821:body [Human]
   748   C0460148:Body [Anatomical Structure]
   748   C1268086:Body [Anatomical Structure]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.76: Virtually all cells in culture immunostained for the OLG-specific antigens, CNP (A), Rip (C), GalC (E), and PLP (G). 

Phrase: "Virtually"

Phrase: "all cells in culture"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "immunostained for the OLG-specific antigens,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0456981:Specific antigens [Immunologic Factor]
   753   C0003320:Antigens [Immunologic Factor]
   753   C0028944:Oligodendrocyte [Cell]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "CNP (A),"

Phrase: "Rip (C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "GalC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414946:GALC [Gene or Genome]

Phrase: "(E"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "PLP (G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0673485:PLP-G [Amino Acid, Peptide, or Protein]
   861   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.77: Bar, 30 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "30 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.78: As demonstrated previously, A 1-40 and A 25-35 peptides have equal potencies for inducing death in primary cultures of OLGs (Xu et al., 2001); 

Phrase: "As"

Phrase: "demonstrated"

Phrase: "previously,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "equal potencies for inducing death"

Phrase: "in primary cultures"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0010453:Cultures [Idea or Concept]
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "of OLGs"

Phrase: "(Xu et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.79: thus, most of our studies were conducted using A 25-35 with key experiments confirmed with A 1-40. 

Phrase: "thus,"

Phrase: "most of our studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205393:Most [Quantitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 with key experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "confirmed with A"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0003320:Antigens [Immunologic Factor]
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "A 1-40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.80: A 25-35 treatment for 48 h caused OLG death in a concentration-dependent manner with an approximate EC50 = 20 M (Fig. 2 A). 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 treatment for 48 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "OLG death in a concentration-dependent manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011065:Death [Organism Function]
   748   C1306577:Death, NOS [Finding]

Phrase: "with an approximate EC50 = 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332232:Approximate [Qualitative Concept]

Phrase: "M ("

Phrase: "Fig. 2 A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.81: C2-ceramide, a cell-permeable ceramide analogue, also induced dose-dependent OLG death with an approximate EC50 = 30 M (Fig. 2 B). 

Phrase: "C2-ceramide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "a cell-permeable ceramide analogue,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0243071:Analog [Chemical Viewed Structurally]

Phrase: "also induced dose-dependent OLG death with an approximate EC50 = 30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0011065:Death [Organism Function]
   738   C1306577:Death, NOS [Finding]

Phrase: "M ("

Phrase: "Fig. 2 B"

Phrase: ")."
Processing 00000000.tx.82: C2-dihydroceramide, a cell-impermeable and inactive form of ceramide, was not cytotoxic at concentrations up to 100 M (unpublished data). 

Phrase: "C2-dihydroceramide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0668446:C2-dihydroceramide [Lipid]
           dihydro-ceramide

Phrase: "a cell-impermeable"

Phrase: "and"

Phrase: "inactive form of ceramide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "not cytotoxic at concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   770   C1511636:cytotoxic [Functional Concept]

Phrase: "up to 100"

Phrase: "M ("

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.83: The toxic effect of ceramide was apparent at an earlier time point than that of A (Fig. 3, A and B), raising the possibility that ceramide may be a mediator of A-induced cell death. 

Phrase: "The toxic effect of ceramide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   760   C1280500:Effect [Qualitative Concept]
   760   C1407029:Toxic [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "apparent at an earlier time point"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750489:apparent [Idea or Concept]

Phrase: "than that"

Phrase: "of A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A (Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "may"

Phrase: "be"

Phrase: "a mediator of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A-induced cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.84: View larger version (20K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.85: A 25-35 and C2-ceramide induced OLG death. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35"

Phrase: "and"

Phrase: "C2-ceramide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]
Processing 00000000.tx.86: (A) OLGs treated with 10100 M A 25-35 for 48 h. 

Phrase: "(A"

Phrase: "A) OLGs"

Phrase: "treated with 10100 M A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   781   C0221134:antigen m [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003320:Antigens [Immunologic Factor]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "A 25-35 for 48 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0062036:H 35-25 [Organic Chemical,Pharmacologic Substance]
   783   C0247683:H 25 [Organic Chemical,Pharmacologic Substance]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.87: (B) OLGs exposed to 10100 M C2-ceramide for 24 h. 

Phrase: "(B) OLGs"

Phrase: "exposed to 10100 M C2-ceramide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0007745:Ceramide [Biologically Active Substance,Lipid]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.88: The assessment of cell survival based on MTT assay or cell death based on LDH assay showed a dose-dependent cytotoxic effect of A 25-35 and C2-ceramide. 

Phrase: "The assessment of cell survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "based on MTT assay"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C2986858:MTT Assay [Research Activity]
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0647210:mtt [Lipid]
   770   C1510438:Assay [Laboratory Procedure]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "or"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "based on LDH assay"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0005507:Assay [Laboratory Procedure]
   760   C0022924:lactate [Organic Chemical]
   760   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0243073:assay [Qualitative Concept]
   760   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   760   C1510438:Assay [Laboratory Procedure]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a dose-dependent cytotoxic effect of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   748   C1280500:Effect [Qualitative Concept]
   748   C1511636:cytotoxic [Functional Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "A 25-35"

Phrase: "and"

Phrase: "C2-ceramide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]
Processing 00000000.tx.89: Data shown are representative of three separate experiments of triplicate samples with similar results; 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three separate experiments of triplicate samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1882932:Representative [Activity]

Phrase: "with similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ";"
Processing 00000000.tx.90: error bars represent SD.  

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SD."
Processing 00000000.tx.91: View larger version (15K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.92: Time-dependent cell death induced by A 25-35 and C2-ceramide. 

Phrase: "Time-dependent cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "induced by A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C0205263:Induced [Functional Concept]

Phrase: "A 25-35"

Phrase: "and"

Phrase: "C2-ceramide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]
Processing 00000000.tx.93: (A) Cell survival as measured by MTT assay. 

Phrase: "(A"

Phrase: "A) Cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007620:Cell Survival [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "measured by MTT assay."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C2986858:MTT Assay [Research Activity]
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C0647210:mtt [Lipid]
   770   C1510438:Assay [Laboratory Procedure]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.94: (B) Cell death as determined by LDH assay. 

Phrase: "(B) Cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007587:Cell Death [Cell Function]
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]
   734   C0004561:B-cell [Cell]

Phrase: "as"

Phrase: "determined by LDH assay."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0005507:Assay [Laboratory Procedure]
   760   C0022924:lactate [Organic Chemical]
   760   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0243073:assay [Qualitative Concept]
   760   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   760   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.95: OLGs were treated with 20 M A 25-35 or 30 M C2-ceramide for the time periods indicated. 

Phrase: "OLGs"

Phrase: "were"

Phrase: "treated with 20 M A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   781   C0221134:antigen m [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003320:Antigens [Immunologic Factor]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "A 25-35"

Phrase: "or"

Phrase: "30 M C2-ceramide for the time periods"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]
   744   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.96: The cells and culture medium were used for the MTT or LDH assay, respectively. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "used for the MTT"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0647210:mtt [Lipid]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "LDH assay,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "respectively."
Processing 00000000.tx.97: Note the faster pace of ceramide in inducing OLG death, 50% OLG death was noted 24 and 48 h after ceramide and A treatment, respectively. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the faster pace of ceramide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0287990:PACE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1552930:Pace [Quantitative Concept]

Phrase: "in inducing OLG death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]

Phrase: "50% OLG death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]

Phrase: "was"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "24"

Phrase: "and"

Phrase: "48 h after ceramide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "respectively."
Processing 00000000.tx.98: Data shown are representative of three separate experiments of triplicate samples with similar results; 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three separate experiments of triplicate samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1882932:Representative [Activity]

Phrase: "with similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ";"
Processing 00000000.tx.99: error bars represent SD.  

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SD."
Processing 00000000.tx.100: Ceramide in A 25-35induced OLG death To support the contention that ceramide is involved in A-induced OLG death, TLC and electrospray ionization/mass spectrometry (ESI/MS) were used to measure ceramide content in OLGs with and without A treatment. 

Phrase: "Ceramide in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "A 25-35induced OLG death To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0011065:Death [Organism Function]
   799   C1306577:Death, NOS [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the contention"

Phrase: "that ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "is"

Phrase: "involved in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C1314939:Involved [Functional Concept]

Phrase: "A-induced OLG death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "TLC"

Phrase: "and"

Phrase: "electrospray ionization/mass spectrometry (ESI/MS)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C1516801:Electrospray Ionization [Laboratory Procedure]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C0596801:Ionization [Phenomenon or Process]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "ceramide content in OLGs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "with"

Phrase: "and without A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C1515981:And [Idea or Concept]

Phrase: "A treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.101: A 25-35 treatment resulted in a fivefold increase in ceramide synthesis as determined by TLC (Fig. 4 A). 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in a fivefold increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442805:Increase [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in ceramide synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157399:ceramide synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "as"

Phrase: "determined by TLC (Fig. 4 A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0003320:Antigens [Immunologic Factor]
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.102: An increase in cellular ceramide content was confirmed by ESI/MS, which demonstrated peak ceramide content 10 h after A treatment (Fig. 4 B). 

Phrase: "An increase in cellular ceramide content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "confirmed by ESI/MS,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   790   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C1516801:Electrospray Ionization [Laboratory Procedure]
   753   C0436196:Spectrometry [Laboratory Procedure]
   753   C0577559:Mass [Finding]
   753   C0596801:Ionization [Phenomenon or Process]
   753   C0750484:Confirmed [Idea or Concept]
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]
   719 E C1456348:Confirm [Qualitative Concept]

Phrase: "which"

Phrase: "demonstrated"

Phrase: "peak ceramide content 10 h after A"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C0062044:H antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0221131:H not otherwise specified Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0595976:antigen h [Immunologic Factor]
   757   C1292143:H antigen [Immunologic Factor]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]

Phrase: "A treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 4 B"

Phrase: ")."
Processing 00000000.tx.103: N-oleoyl-ethanolamine (NOE), a specific ceramidase inhibitor that prevents the degradation of cellular ceramide at subtoxic doses (Sugita et al., 1975; Pahan et al., 1998), augmented A 25-35induced OLG death (Fig. 4 C). 

Phrase: "N-oleoyl-ethanolamine (NOE),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014983:Ethanolamine [Organic Chemical]
   827   C0059696:ethanolamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "a specific ceramidase inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "that"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the degradation of cellular ceramide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1157956:ceramide degradation [Molecular Function]
   797   C1523935:cellular degradation [Cell Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "at subtoxic doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "(Sugita et al.,"

Phrase: "1975"

Phrase: "; Pahan et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "augmented A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35induced OLG death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0011065:Death [Organism Function]
   804   C1306577:Death, NOS [Finding]

Phrase: "(Fig. 4 C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.104: Together, these results suggest a strong correlation between increases in cellular ceramide levels and A-induced OLG death. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a strong correlation between increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "in cellular ceramide levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]
Processing 00000000.tx.105: View larger version (13K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.106: A 25-35induced ceramide production and enhancement of A cytotoxicity by a ceramidase inhibitor. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35induced ceramide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "enhancement of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   790   C2349975:Enhancement [Activity]

Phrase: "A cytotoxicity by a ceramidase inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
Processing 00000000.tx.107: (A) An increase in cellular ceramide synthesis in OLGs prelabeled with [3H]palmitate and treated with 10 M A 25-35 for 24 h. 

Phrase: "(A"

Phrase: "A)"

Phrase: "An increase in cellular ceramide synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in OLGs"

Phrase: "prelabeled with"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "treated with 10 M A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   781   C0221134:antigen m [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003320:Antigens [Immunologic Factor]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "A 25-35 for 24 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0062036:H 35-25 [Organic Chemical,Pharmacologic Substance]
   783   C0247683:H 25 [Organic Chemical,Pharmacologic Substance]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.108: (B) Quantitative determination of endogenous ceramide concentration by ESI/MS at various time points after A 25-35 treatment. 

Phrase: "(B) Quantitative determination of endogenous ceramide concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1148554:determination [Laboratory Procedure]

Phrase: "by ESI/MS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C1516801:Electrospray Ionization [Laboratory Procedure]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C0596801:Ionization [Phenomenon or Process]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "at various time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "after A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.109: Note the elevated ceramide content at 5, 10, and 16 h after A 25-35 exposure. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the elevated ceramide content at 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "10,"

Phrase: "and"

Phrase: "16 h after A"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   802   C0062044:H antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   802   C0221131:H not otherwise specified Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   802   C0595976:antigen h [Immunologic Factor]
   802   C1292143:H antigen [Immunologic Factor]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "A 25-35 exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0274281:Exposure, NOS [Injury or Poisoning]
   812   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.110: (C) Effect of NOE, a ceramidase inhibitor, on A-induced OLG death. 

Phrase: "(C"

Phrase: ")"

Phrase: "Effect of NOE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "a ceramidase inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "on A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]
Processing 00000000.tx.111: OLGs were treated with 10 M A 25-35 plus 1 M NOE for 24 h. 

Phrase: "OLGs"

Phrase: "were"

Phrase: "treated with 10 M A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   781   C0221134:antigen m [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003320:Antigens [Immunologic Factor]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "A 25-35 plus 1 M NOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0014983:Ethanolamine [Organic Chemical]
   791   C0059696:ethanolamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.112: The culture medium was collected for the LDH assay. 

Phrase: "The culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected for the LDH assay."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0022924:lactate [Organic Chemical]
   753   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0243073:assay [Qualitative Concept]
   753   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
Processing 00000000.tx.113: Data shown are mean  SD of three separate experiments in triplicate. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "mean  SD of three separate experiments"

Phrase: "in triplicate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]
Processing 00000000.tx.114: *, Significant difference from control; 

Phrase: "*,"

Phrase: "Significant difference from control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.115: **, significant difference from A treatment; 

Phrase: "*"

Phrase: "*,"

Phrase: "significant difference from A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "A treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: ";"
Processing 00000000.tx.116: P < 0.05.  

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.117: nSMase activation in A 25-35induced OLG death Ceramide is derived from sphingomyelin hydrolysis catalyzed by nSMase or aSMase (Hannun, 1996). 

Phrase: "nSMase activation in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "A 25-35induced OLG death Ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "is"

Phrase: "derived from sphingomyelin hydrolysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]
   770   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "catalyzed by nSMase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1882074:Neutral [Qualitative Concept]
   770   C2825492:Neutral [Phenomenon or Process]

Phrase: "or"

Phrase: "aSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539725:ASMASE [Gene or Genome]

Phrase: "(Hannun,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.118: A 25-35 treatment increased nSMase activity in OLGs as early as 2.5 min after exposure and reached maximal levels at 16 h (Fig. 5 A). 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "nSMase activity in OLGs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C2261839:neutral sphingomyelinase activity [Molecular Function]
   806   C1149875:sphingomyelinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "as early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "as 2.5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0702093:/min [Temporal Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "and"

Phrase: "reached maximal levels at 16 h (Fig. 5 A"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   745   C0430420:antigen levels [Laboratory Procedure]
   745   C0456951:Level 5 [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.119: A 1-40 treatment also increased OLG nSMase activity in a similar manner (unpublished data). 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 1-40 treatment also increased OLG nSMase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   835   C0474395:increased activity [Finding]
   821   C2261839:neutral sphingomyelinase activity [Molecular Function]
   804   C1149875:sphingomyelinase activity [Molecular Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "in a similar manner"

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.120: In contrast, A 25-35 treatment did not alter aSMase activity (Fig. 5 A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "aSMase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 5 A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.121: The addition of recombinant bacterial sphingomyelinase (bSMase), an exogenous source of sphingomylinase that mimics nSMase action by degrading membrane sphingomyelin to increase cellular ceramide levels (Okazaki et al., 1989; Jarvis et al., 1994; Zhang et al., 1997; Tonnetti et al., 1999), caused OLG death (Fig. 5 B). 

Phrase: "The addition of recombinant bacterial sphingomyelinase (bSMase),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "an exogenous source of sphingomylinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "that"

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "nSMase action by degrading membrane sphingomyelin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441472:Action [Functional Concept]
   744   C3266814:Action [Activity]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cellular ceramide levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Okazaki et al.,"

Phrase: "1989"

Phrase: "; Jarvis et al.,"

Phrase: "1994"

Phrase: "; Zhang et al.,"

Phrase: "1997"

Phrase: "; Tonnetti et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "caused OLG death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]

Phrase: "(Fig. 5 B"

Phrase: ")."
Processing 00000000.tx.122: Furthermore, the nSMase inhibitors, 3-O-methyl-sphingomyelin (3-OMe-SM; Lister et al., 1995) and NAC (Liu et al., 1998a; Yoshimura et al., 1999), were effective in protecting OLGs against A cytotoxicity (Fig. 5, C and D). 

Phrase: "Furthermore,"

Phrase: "the nSMase inhibitors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]
   734   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "3-O-methyl-sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: "(3-OMe-SM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036154:SM [Geographic Area]

Phrase: "; Lister et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "and"

Phrase: "NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Liu et al.,"

Phrase: "1998a"

Phrase: "; Yoshimura et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "effective in protecting OLGs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "against A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.123: Confirming the effects of the nSMase inhibitors, a marked reduction in nSMase enzymatic activity was observed in OLGs treated with 3-OMe-SM or NAC (Fig. 6 A). 

Phrase: "Confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the effects of the nSMase inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "a marked reduction in nSMase enzymatic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C2267000:Reduction Activity [Molecular Function]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed in OLGs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "treated with 3-OMe-SM"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0036154:SM [Geographic Area]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Fig. 6 A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.124: Moreover, significant decreases in endogenous ceramide content and increases in sphingomyelin levels were detected in OLGs treated with the inhibitors (Fig. 6, B and C). 

Phrase: "Moreover,"

Phrase: "significant decreases in endogenous ceramide content"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0547047:decreases [Quantitative Concept]
   719 E C0392756:Decrease [Qualitative Concept]

Phrase: "and"

Phrase: "increases in sphingomyelin levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   777   C1291141:Increased sphingomyelin [Finding]
   770   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]
   770   C0441889:Levels [Qualitative Concept]
   770   C0442805:Increase [Functional Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "were"

Phrase: "detected in OLGs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "treated with the inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C"

Phrase: ")."
Processing 00000000.tx.125: To further confirm the contribution of nSMase in A-mediated cell death, sense and antisense oligonucleotides specific for nSMase were generated. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the contribution of nSMase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "in A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-mediated cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "antisense oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "specific for nSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "were"

Phrase: "generated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]
Processing 00000000.tx.126: Antisense oligonucleotides reduced nSMase activity (Fig. 7 A), reduced ceramide content in cell lysates (Fig. 7 B), and attenuated A-induced cell death (Fig. 7 C), but sense oligonucleotides had no effect on nSMase activity, ceramide content, or cell survival. 

Phrase: "Antisense oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "nSMase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2261839:neutral sphingomyelinase activity [Molecular Function]
   901   C1149875:sphingomyelinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 7 A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: ")"

Phrase: ","

Phrase: "reduced ceramide content in cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   810   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(Fig. 7 B"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "attenuated A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 7 C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "sense oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "had"

Phrase: "no effect on nSMase activity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "ceramide content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "or"

Phrase: "cell survival."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.127: View larger version (28K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.128: Sphingomyelinase in A-induced OLG death. 

Phrase: "Sphingomyelinase in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "A-induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]
Processing 00000000.tx.129: (A) nSMase and aSMase activity in OLGs treated with 10 M A 25-35 for various time periods (from 2.5 min to 36 h). 

Phrase: "(A"

Phrase: "A) nSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "aSMase activity in OLGs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "treated with 10 M A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   781   C0221134:antigen m [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003320:Antigens [Immunologic Factor]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "A 25-35 for various time periods"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0439582:Time periods [Temporal Concept]
   751 E C0585019:Temporal periods [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C3541383:Time [Temporal Concept]
   714   C0439531:/period [Temporal Concept]
   714   C1948053:Period [Temporal Concept]

Phrase: "("

Phrase: "from 2.5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0702093:/min [Temporal Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "to 36 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.130: (B) A or bSMase induced OLG death as determined by LDH assay. 

Phrase: "(B) A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0368721:B antigen [Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "or"

Phrase: "bSMase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "OLG death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "as"

Phrase: "determined by LDH assay."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0005507:Assay [Laboratory Procedure]
   760   C0022924:lactate [Organic Chemical]
   760   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0243073:assay [Qualitative Concept]
   760   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   760   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.131: OLGs were exposed to 10 M A 25-35 or bSMase (1 U/ml) for 24 h. 

Phrase: "OLGs"

Phrase: "were"

Phrase: "exposed to 10 M A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   781   C0221134:antigen m [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003320:Antigens [Immunologic Factor]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "A 25-35"

Phrase: "or"

Phrase: "bSMase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1 U/ml) for 24 h."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C2736788:1 U/mL [Quantitative Concept]
   820   C0439446:mL/24.h [Quantitative Concept]
   790   C0439340:U/ml [Quantitative Concept]
   790   C1880521:U/mL [Quantitative Concept]
   790   C2945590:U/mL [Quantitative Concept]
   783   C0439391:mL/h [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.132: (C) LDH and (D) trypan blue assays on the effects of nSMase inhibitors on A-mediated OLG death. 

Phrase: "(C"

Phrase: ")"

Phrase: "LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "and ("

Phrase: "D)"

Phrase: "trypan blue assays on the effects of nSMase inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0005507:Assay [Laboratory Procedure]
   706   C0243073:assay [Qualitative Concept]
   706   C1510438:Assay [Laboratory Procedure]

Phrase: "on A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-mediated OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]
Processing 00000000.tx.133: OLGs were treated with 25 mM NAC or 1 M 3-OMe-SM for 2 h before 10 M A 25-35 treatment for 24 h. 

Phrase: "OLGs"

Phrase: "were"

Phrase: "treated with 25 mM NAC"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C0001047:acetylcysteine n [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "1 M 3-OMe-SM for 2 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0292015:SM 1 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0036154:SM [Geographic Area]

Phrase: "before 10 M A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0221134:M antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003320:Antigens [Immunologic Factor]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 treatment for 24 h."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.134: Data shown are representative of three separate experiments of triplicate samples with similar results; 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three separate experiments of triplicate samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1882932:Representative [Activity]

Phrase: "with similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ";"
Processing 00000000.tx.135: error bars represent SD. 

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SD."
Processing 00000000.tx.136: *, Significant difference from control; 

Phrase: "*,"

Phrase: "Significant difference from control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.137: **, significant difference from A treatment; 

Phrase: "*"

Phrase: "*,"

Phrase: "significant difference from A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "A treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: ";"
Processing 00000000.tx.138: P < 0.05.  

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.139: View larger version (14K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.140: Effect of nSMase inhibitors on sphingomyelinase activity and ceramide/sphingomyelin content in A 25-35treated OLGs. 

Phrase: "Effect of nSMase inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on sphingomyelinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149875:sphingomyelinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "ceramide/sphingomyelin content in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "A 25-35treated OLGs."
Processing 00000000.tx.141: nSMase and aSMase activity (A) and cellular ceramide (B) and sphingomyelin (C) content in OLGs treated with NAC or 3-OMe-SM nSMase inhibitors. 

Phrase: "nSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "aSMase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(A"

Phrase: "A)"

Phrase: "and"

Phrase: "cellular ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: "(C"

Phrase: ")"

Phrase: "content in OLGs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0423896:Content [Mental Process]
   790   C0456205:Content [Conceptual Entity]

Phrase: "treated with NAC"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   819   C0001047:acetylcysteine n [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]
   715 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "3-OMe-SM nSMase inhibitors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0243077:inhibitors [Chemical Viewed Functionally]
   766 E C1999216:Inhibitor [Qualitative Concept]
   719   C1822791:SPHINGOMYELINASE, NEUTRAL, 3 [Gene or Genome]
Processing 00000000.tx.142: OLGs were treated with 1 M 3-OMe-SM or 25 mM NAC for 2 h before 10 M A 25-35 exposure for 16 h. 

Phrase: "OLGs"

Phrase: "were"

Phrase: "treated with 1 M 3-OMe-SM"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   774   C0292015:SM 1 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0036154:SM [Geographic Area]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "25 mM NAC for 2 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0001047:acetylcysteine n [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine

Phrase: "before 10 M A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0221134:M antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003320:Antigens [Immunologic Factor]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 exposure for 16 h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.143: Representative TLC data are shown from one of three experiments in the top panels in B and C. 

Phrase: "Representative TLC data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown from one of three experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0205447:One [Quantitative Concept]
   753   C0205449:Three [Quantitative Concept]
   753   C0681814:Experiments [Research Activity]
   719   C1547282:Show [Intellectual Product]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "in the top panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "in B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.144: A and the bottom panels in B and C show composite results from three separate experiments; 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "and"

Phrase: "the bottom panels in B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441833:Panel [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "C"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "composite results from three separate experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.145: error bars represent SD. 

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SD."
Processing 00000000.tx.146: *, Significant difference from control; 

Phrase: "*,"

Phrase: "Significant difference from control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.147: **, significant difference from A treatment; 

Phrase: "*"

Phrase: "*,"

Phrase: "significant difference from A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "A treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: ";"
Processing 00000000.tx.148: P < 0.05.  

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.149: View larger version (16K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.150: Treatment of OLGs with nSMase antisense oligonucleotides. 

Phrase: "Treatment of OLGs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with nSMase antisense oligonucleotides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.151: OLGs were treated with sense or antisense oligonucleotides specific for nSMase 4 h before 20 M A addition. 

Phrase: "OLGs"

Phrase: "were"

Phrase: "treated with sense"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0036658:sense [Organ or Tissue Function]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "antisense oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "specific for nSMase 4 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "before 20 M A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0221134:M antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003320:Antigens [Immunologic Factor]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.152: After 24 h, the cells were harvested and assayed for nSMase activity (A), ceramide content (B), and MTT (C). 

Phrase: "After 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "assayed for nSMase activity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C2261839:neutral sphingomyelinase activity [Molecular Function]
   806   C1149875:sphingomyelinase activity [Molecular Function]
   806   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   760   C1882074:Neutral [Qualitative Concept]
   760   C2825492:Neutral [Phenomenon or Process]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "(A"

Phrase: "A"

Phrase: ")"

Phrase: ","

Phrase: "ceramide content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "MTT (C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.153: The graph depicts a representative of three separate experiments with similar results; 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "depicts"

Phrase: "a representative of three separate experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882932:Representative [Activity]

Phrase: "with similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ";"
Processing 00000000.tx.154: error bars represent SD. 

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SD."
Processing 00000000.tx.155: *, Significant differences compared with A treatment alone; 

Phrase: "*,"

Phrase: "Significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C1707455:Compared [Activity]

Phrase: "A treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ";"
Processing 00000000.tx.156: P < 0.05.  

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.157: It has been shown that A depletes GSH in cortical neurons in vitro (Muller et al., 1997), which correlates well with the ability of A to heighten cellular oxidative stress (Cafe et al., 1996). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "depletes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "GSH in cortical neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1260386:GSH [Disease or Syndrome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Muller et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "correlates"

Phrase: "well with the ability of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003320:Antigens [Immunologic Factor]
   753   C0085732:Ability [Organism Attribute]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "A to"

Phrase: "heighten"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442803:heighten [Qualitative Concept]

Phrase: "cellular oxidative stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C1516373:Cellular Stress [Cell or Molecular Dysfunction]
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "(Cafe et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.158: GSH depletion has been shown to activate nSMase activity (Liu and Hannun, 1997; Liu et al., 1998a, b). 

Phrase: "GSH depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "nSMase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2261839:neutral sphingomyelinase activity [Molecular Function]
   901   C1149875:sphingomyelinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Liu"

Phrase: "and"

Phrase: "Hannun,"

Phrase: "1997"

Phrase: "; Liu et al.,"

Phrase: "1998a,"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.159: The fact that NAC, a GSH precursor, inhibited A 25-35 activation of nSMase and prevented A-mediated OLG death suggests that A 25-35 depletion of cellular GSH is involved in the AnSMaseceramide OLG death signaling cascade. 

Phrase: "The fact"

Phrase: "that NAC,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "a GSH precursor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709634:Precursor [Idea or Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 activation of nSMase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "prevented A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-mediated OLG death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 depletion of cellular GSH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333668:Depletion [Functional Concept]

Phrase: "is"

Phrase: "involved in the AnSMaseceramide OLG death signaling cascade."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C2611812:signaling cascade [Cell Function]
   744   C0011065:Death [Organism Function]
   744   C0028944:Oligodendrocyte [Cell]
   744   C0037083:Signaling [Cell Function]
   744   C1306577:Death, NOS [Finding]
   744   C1314939:Involved [Functional Concept]
   744   C1707310:Cascade [Manufactured Object]
   744   C3537152:signaling [Biologic Function]
   711 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.160: Buthionine sulfoximine (BSO) and diethyl maleate (DEM) have been shown to deplete GSH in various cell types (Anderson and Meister, 1983; Masukawa et al., 1983; Szekely and Lobreau, 1987). 

Phrase: "Buthionine sulfoximine (BSO)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054252:Buthionine Sulfoximine [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]
   861   C0054251:buthionine [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "diethyl maleate (DEM)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0057931:diethyl maleate [Organic Chemical]
   861   C0220874:Maleate [Organic Chemical]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "GSH in various cell types"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1260386:GSH [Disease or Syndrome]

Phrase: "(Anderson"

Phrase: "and"

Phrase: "Meister,"

Phrase: "1983"

Phrase: "; Masukawa et al.,"

Phrase: "1983"

Phrase: "; Szekely"

Phrase: "and"

Phrase: "Lobreau,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.161: Both BSO and DEM selectively increased nSMase activity (Fig. 8 A), increased ceramide levels (Fig. 8 B), decreased cellular GSH levels (Fig. 8 C), and were cytotoxic to OLGs (Fig. 8 D). 

Phrase: "Both BSO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054252:Buthionine Sulfoximine [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]
   861   C0054251:buthionine [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "DEM selectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0057931:diethyl maleate [Organic Chemical]
   827   C0220874:Maleate [Organic Chemical]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "nSMase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2261839:neutral sphingomyelinase activity [Molecular Function]
   901   C1149875:sphingomyelinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 8 A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: ")"

Phrase: ","

Phrase: "increased ceramide levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 8 B"

Phrase: ")"

Phrase: ","

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "cellular GSH levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1260386:GSH [Disease or Syndrome]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 8 C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "were"

Phrase: "cytotoxic to OLGs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   790   C1511636:cytotoxic [Functional Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D)."
Processing 00000000.tx.162: View larger version (14K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.163: Effects of GSH depleting agents compared with A 25-35 on sphingomyelinase activity, cellular GSH content, and cell survival. 

Phrase: "Effects of GSH depleting agents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "compared with A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C1707455:Compared [Activity]

Phrase: "A 25-35 on sphingomyelinase activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1149875:sphingomyelinase activity [Molecular Function]
   753   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "cellular GSH content,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1260386:GSH [Disease or Syndrome]

Phrase: "and"

Phrase: "cell survival."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.164: OLGs were treated with 10 M A 25-35, 100 M BSO, or 500 M DEM for 16 h before measurement of sphingomyelinase activity (A), ceramide synthesis (B), or GSH content (C), or 24 h before MTT assay (D). 

Phrase: "OLGs"

Phrase: "were"

Phrase: "treated with 10 M A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   781   C0221134:antigen m [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003320:Antigens [Immunologic Factor]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "A 25-35,"

Phrase: "100 M BSO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054252:Buthionine Sulfoximine [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]
   812   C0054251:buthionine [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "500 M DEM for 16 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0057931:diethyl maleate [Organic Chemical]
   748   C0220874:Maleate [Organic Chemical]

Phrase: "before measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of sphingomyelinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149875:sphingomyelinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(A"

Phrase: "A"

Phrase: ")"

Phrase: ","

Phrase: "ceramide synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157399:ceramide synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "GSH content (C),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1260386:GSH [Disease or Syndrome]

Phrase: "or"

Phrase: "24 h before MTT assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.165: Data shown in A, C, and D are representative of three separate experiments of triplicate samples and, in B, of two separate experiments with similar findings; 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   756   C1547282:Show [Intellectual Product]

Phrase: "A,"

Phrase: "C,"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "are"

Phrase: "representative of three separate experiments of triplicate samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1882932:Representative [Activity]

Phrase: "and"

Phrase: ","

Phrase: "in B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "of two separate experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "with similar findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: ";"
Processing 00000000.tx.166: error bars represent SD. 

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SD."
Processing 00000000.tx.167: *, Significant difference from control; 

Phrase: "*,"

Phrase: "Significant difference from control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.168: P < 0.05.  

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.169: Because A 25-35 did not activate aSMase, it is unlikely that aSMase is involved in A 25-35induced OLG death. 

Phrase: "Because"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "aSMase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539725:ASMASE [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that aSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539725:ASMASE [Gene or Genome]

Phrase: "is"

Phrase: "involved in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C1314939:Involved [Functional Concept]

Phrase: "A 25-35induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0011065:Death [Organism Function]
   804   C1306577:Death, NOS [Finding]
Processing 00000000.tx.170: Selective aSMase inhibitors such as desipramine and chlorpromazine (Albouz et al., 1986) were ineffective in protecting OLGs from A 25-35induced death (unpublished data). 

Phrase: "Selective aSMase inhibitors such as desipramine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "chlorpromazine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008286:Chlorpromazine [Organic Chemical,Pharmacologic Substance]

Phrase: "(Albouz et al.,"

Phrase: "1986"

Phrase: ")"

Phrase: "were"

Phrase: "ineffective in protecting OLGs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3242229:ineffective [Idea or Concept]

Phrase: "from A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35induced death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.171: Furthermore, fumonisin B2, a ceramide synthase inhibitor, did not block A 25-35 cytotoxicity in this cell death paradigm (unpublished data). 

Phrase: "Furthermore,"

Phrase: "fumonisin B2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0060837:fumonisin B2 [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0507114:B2 [Body Part, Organ, or Organ Component]
   861   C1416271:B2 [Gene or Genome]

Phrase: "a ceramide synthase inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0665744:ceramide synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 cytotoxicity in this cell death paradigm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   726   C0022686:Cytotoxic cell [Cell]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.172: Together, these results suggest that ceramide generation catalyzed by nSMase, but not aSMase or ceramide synthase, mediates the A 25-35 death pathway in OLGs.  

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ceramide generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "catalyzed by nSMase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1882074:Neutral [Qualitative Concept]
   770   C2825492:Neutral [Phenomenon or Process]

Phrase: "but"

Phrase: "not aSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539725:ASMASE [Gene or Genome]

Phrase: "or"

Phrase: "ceramide synthase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0665744:ceramide synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 death pathway in OLGs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.173: Discussion Top Abstract Introduction Results Discussion Materials and methods References  Several lines of evidence support the contention that ceramide mediates, at least in part, A-induced OLG death. 

Phrase: "Discussion Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the contention"

Phrase: "that ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]
Processing 00000000.tx.174: Both A and C2-ceramide (but not the biologically inactive dihydroceramide) caused OLG death in a time-dependent manner. 

Phrase: "Both A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "and"

Phrase: "C2-ceramide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "("

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the biologically inactive dihydroceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0668446:dihydro-ceramide [Lipid]

Phrase: ")"

Phrase: "caused OLG death in a time-dependent manner."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1301931:death time [Clinical Attribute]
   750   C0007465:Death Cause [Finding]
   744   C0011065:Death [Organism Function]
   744   C1306577:Death, NOS [Finding]
Processing 00000000.tx.175: A treatment increased ceramide formation in OLGs. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "ceramide formation in OLGs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1157399:ceramide formation [Molecular Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.176: In addition, increasing cellular ceramide release from sphingomyelin by exogenous bSMase, which mimics cellular nSMase action, also induced OLG death. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cellular ceramide release from sphingomyelin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by exogenous bSMase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "cellular nSMase action,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441472:Action [Functional Concept]
   812   C3266814:Action [Activity]

Phrase: "also induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]
Processing 00000000.tx.177: Inhibition of ceramide degradation by NOE, a ceramidase inhibitor, enhanced A cytotoxicity in OLGs. 

Phrase: "Inhibition of ceramide degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by NOE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014983:Ethanolamine [Organic Chemical]
   827   C0059696:ethanolamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "a ceramidase inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "enhanced A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A cytotoxicity in OLGs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
Processing 00000000.tx.178: Results from this study also support the contention that A cytotoxicity is mediated via activation of nSMase leading to increased cellular ceramide generation. 

Phrase: "Results from this study also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the contention"

Phrase: "that A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]

Phrase: "is"

Phrase: "mediated via activation of nSMase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C1879547:Activation [Activity]
   753   C1882074:Neutral [Qualitative Concept]
   753   C2825492:Neutral [Phenomenon or Process]

Phrase: "leading to increased cellular ceramide generation."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   767   C0861064:increased lead [Finding]
   753   C0007634:Cellular [Cell]
   753   C0007745:Ceramide [Biologically Active Substance,Lipid]
   753   C0079411:Generation [Temporal Concept]
   753   C0178539:Cellular [Functional Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332152:Leading [Temporal Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1522538:Leading [Functional Concept]
   753   C3146294:Generation [Activity]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.179: A 25-35 and A 1-40 activated nSMase, but not aSMase, in OLGs. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35"

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 1-40 activated nSMase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "not aSMase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539725:ASMASE [Gene or Genome]

Phrase: "in OLGs."
Processing 00000000.tx.180: Additionally, nSMase inhibitors such as 3-OMe-SM and NAC (also an antioxidant) prevented A 25-35induced nSMase activity, which resulted in decreased ceramide synthesis from sphingomyelin and protected OLGs from A 25-35 cytotoxicity. 

Phrase: "Additionally,"

Phrase: "nSMase inhibitors such as 3-OMe-SM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(also"

Phrase: "an antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: ")"

Phrase: "prevented A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35induced nSMase activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C2261839:neutral sphingomyelinase activity [Molecular Function]
   827   C1149875:sphingomyelinase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "resulted in decreased ceramide synthesis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C1157399:ceramide synthesis [Molecular Function]
   760   C0007745:Ceramide [Biologically Active Substance,Lipid]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0220781:synthesis [Biologic Function]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1883254:Synthesis [Activity]
   726 E C0547047:Decrease [Quantitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "from sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "protected OLGs from A"

Phrase: "A 25-35 cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   741 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   741 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.181: Antisense oligonucleotides specific for nSMase also attenuated A-induced OLG cell death, further implicating nSMase as a mediator. 

Phrase: "Antisense oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "specific for nSMase also attenuated A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0456981:Specific antigens [Immunologic Factor]
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: "A-induced OLG cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "implicating"

Phrase: "nSMase as a mediator."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.182: Chemical agents such as BSO and DEM that deplete cellular GSH content also activated nSMase in OLGs and caused cell death. 

Phrase: "Chemical agents such as BSO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1516446:Chemical Agents [Functional Concept]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1254351:Agent [Pharmacologic Substance]
   719   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "DEM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0057931:diethyl maleate [Organic Chemical]
   861   C0220874:Maleate [Organic Chemical]

Phrase: "that"

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "cellular GSH content also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]
   812   C1260386:GSH [Disease or Syndrome]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "nSMase in OLGs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caused cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.183: The specific role of nSMase in A-induced OLG death is supported by the finding that pharmacological inhibition of nSMase, but not aSMase or ceramide synthase, prevented A 25-35induced OLG death. 

Phrase: "The specific role of nSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-induced OLG death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "is"

Phrase: "supported by the finding"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C1521721:Supported [Conceptual Entity]
   770   C2825141:Finding [Finding]
   737 E C0183683:Support [Medical Device]

Phrase: "that pharmacological inhibition of nSMase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "but"

Phrase: "not aSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539725:ASMASE [Gene or Genome]

Phrase: "or"

Phrase: "ceramide synthase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0665744:ceramide synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "prevented A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0011065:Death [Organism Function]
   804   C1306577:Death, NOS [Finding]
Processing 00000000.tx.184: The exact mechanism underlying A-mediated nSMase activation remains to be elucidated but may involve changes in the cellular redox state and/or GSH metabolism (Sawai and Hannun, 1999); 

Phrase: "The exact mechanism underlying A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003320:Antigens [Immunologic Factor]
   706 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-mediated nSMase activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated"

Phrase: "but"

Phrase: "may"

Phrase: "involve"

Phrase: "changes in the cellular redox state"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0443172:State changes [Quantitative Concept]
           changes
   753   C0392747:changes [Functional Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and/or"

Phrase: "GSH metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "(Sawai"

Phrase: "and"

Phrase: "Hannun,"

Phrase: "1999"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.185: GSH is the most abundant thiol-containing compound in living cells. 

Phrase: "GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "is"

Phrase: "the most abundant thiol-containing compound in living cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205198:Compound [Qualitative Concept]
   742   C1706082:Compound [Chemical]
Processing 00000000.tx.186: nSMase enzymatic activity is directly regulated by cellular GSH content (Liu and Hannun, 1997; Liu et al., 1998a,b). 

Phrase: "nSMase enzymatic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C2261839:neutral sphingomyelinase activity [Molecular Function]
   875   C1149875:sphingomyelinase activity [Molecular Function]
   861   C2267219:Enzymatic Activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "regulated by cellular GSH content"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007634:Cellular [Cell]
   760   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0178539:Cellular [Functional Concept]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1260386:GSH [Disease or Syndrome]

Phrase: "(Liu"

Phrase: "and"

Phrase: "Hannun,"

Phrase: "1997"

Phrase: "; Liu et al.,"

Phrase: "1998a,"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.187: A has been shown to deplete GSH in cultured cortical neurons (Muller et al., 1997), and depletion of cellular GSH stores by oxidative stress has been proposed as a prime mechanism underlying the A cytotoxic action (Muller et al., 1997; Pereira et al., 1999). 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "GSH in cultured cortical neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1260386:GSH [Disease or Syndrome]

Phrase: "(Muller et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "depletion of cellular GSH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333668:Depletion [Functional Concept]

Phrase: "stores by oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1698986:Store [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "proposed as a prime mechanism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441712:Mechanism [Functional Concept]
   760   C0871133:prime [Functional Concept]
   760   C1441414:PROPOSED [Idea or Concept]
   760   C1553874:Proposed [Qualitative Concept]
   760   C1578820:Proposed [Idea or Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A cytotoxic action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441472:Action [Functional Concept]
   827   C3266814:Action [Activity]

Phrase: "(Muller et al.,"

Phrase: "1997"

Phrase: "; Pereira et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.188: Thus, it is plausible that a decrease in GSH level subsequent to A exposure may activate nSMase in OLGs. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "plausible"

Phrase: "that"

Phrase: "a decrease in GSH level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "subsequent to A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "may"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "nSMase in OLGs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.189: NAC, a GSH precursor, inhibited A 25-35 activation of nSMase and protected OLGs against A-induced death, whereas depletion of cellular GSH stores by BSO or DEM resulted in selective activation of nSMase and OLG death. 

Phrase: "NAC,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "a GSH precursor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709634:Precursor [Idea or Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 25-35 activation of nSMase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "protected OLGs against A"

Phrase: "A-induced death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]

Phrase: "whereas"

Phrase: "depletion of cellular GSH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333668:Depletion [Functional Concept]

Phrase: "stores by BSO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0054252:Buthionine Sulfoximine [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]
   770   C0054251:buthionine [Amino Acid, Peptide, or Protein]
   770   C1698986:Store [Functional Concept]

Phrase: "or"

Phrase: "DEM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0057931:diethyl maleate [Organic Chemical]
   861   C0220874:Maleate [Organic Chemical]

Phrase: "resulted in selective activation of nSMase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1879547:Activation [Activity]
   748   C1882074:Neutral [Qualitative Concept]
   748   C2825492:Neutral [Phenomenon or Process]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]
Processing 00000000.tx.190: Although the agents used to manipulate GSH levels may be relatively nonspecific, these findings raise the possibility that the activation of nSMase by A may involve the depletion of cellular GSH content. 

Phrase: "Although"

Phrase: "the agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "manipulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0947647:Manipulate [Therapeutic or Preventive Procedure]

Phrase: "GSH levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1260386:GSH [Disease or Syndrome]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "relatively nonspecific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0750540:Nonspecific [Idea or Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that"

Phrase: "the activation of nSMase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "may"

Phrase: "involve"

Phrase: "the depletion of cellular GSH content."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333668:Depletion [Functional Concept]
Processing 00000000.tx.191: Oxidative stress plays a prominent role in A-mediated neuronal and OLG death (Behl et al., 1994; Behl, 1999; Markesbery, 1999; Xu et al., 2001). 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a prominent role in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "A-mediated neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0521390:Neuronal [Immunologic Factor]
   755 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "OLG death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "(Behl et al.,"

Phrase: "1994"

Phrase: "; Behl,"

Phrase: "1999"

Phrase: "; Markesbery,"

Phrase: "1999"

Phrase: "; Xu et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.192: Brain tissue is especially sensitive to oxidative injury because of its higher metabolic rate driven by glucose, lower concentrations of protective antioxidants, and higher levels of polyunsaturated fatty acids that are susceptible to lipid peroxidation (Behl and Sagara, 1997; Behl, 1999; Markesbery, 1999). 

Phrase: "Brain tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "especially sensitive to oxidative injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "because of its higher metabolic rate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0870882:Metabolic rate [Physiologic Function]
   827   C0311400:Metabolic [Functional Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1524026:Metabolic [Cell Function]
   827   C2707259:Metabolic [Clinical Attribute]

Phrase: "driven by glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   756   C0013126:Drive [Mental Process]

Phrase: "lower concentrations of protective antioxidants,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "higher levels of polyunsaturated fatty acids"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   787   C1281901:Fatty acid level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "susceptible to lipid peroxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "(Behl"

Phrase: "and"

Phrase: "Sagara,"

Phrase: "1997"

Phrase: "; Behl,"

Phrase: "1999"

Phrase: "; Markesbery,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.193: Although A-mediated oxidative stress induces mtDNA damage (Bozner et al., 1997; Xu et al., 2001) and activates selected transcription factors including NF-B and AP-1 (Abate et al., 1990; Schreck et al., 1991; Pinkus et al., 1996; Xu et al., 2001), the mechanism by which A induces oxidative stress in the AD brain remains unknown. 

Phrase: "Although"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A-mediated oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   812   C0038435:Stress [Finding]
   812   C0311404:Oxidative [Functional Concept]
   741 E C0231297:Stressful [Functional Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "mtDNA damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "(Bozner et al.,"

Phrase: "1997"

Phrase: "; Xu et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "and"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "selected transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "NF-B"

Phrase: "and"

Phrase: "AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "Abate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "et al.,"

Phrase: "1990"

Phrase: "; Schreck et al.,"

Phrase: "1991"

Phrase: "; Pinkus et al.,"

Phrase: "1996"

Phrase: "; Xu et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "the mechanism by which A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "A"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "oxidative stress in the AD brain remains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0038435:Stress [Finding]
   748   C0311404:Oxidative [Functional Concept]

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.194: Ceramide has emerged as a potent second messenger in oxidative stress-induced apoptosis (Hannun and Luberto, 2000). 

Phrase: "Ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "has"

Phrase: "emerged as a potent second messenger"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0036522:second messenger [Molecular Function]
   790   C1508748:second messenger [Biologically Active Substance]
   753   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0205436:Second [Quantitative Concept]
   753   C0335218:Messenger [Professional or Occupational Group]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]

Phrase: "in oxidative stress-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(Hannun"

Phrase: "and"

Phrase: "Luberto,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.195: Hydrogen peroxide (Goldkorn et al., 1998), 1--D-arabinofuranosylcytosine (Bradshaw et al., 1996), daunorubicin (Jaffrezou et al., 1996), TNF- (Bezombes et al., 1998), -rays (Bruno et al., 1998), hypoxia (Yoshimura et al., 1998), CD40 activation (Segui et al., 1999), and sindbis virus infection (Jan et al., 2000) are among the agents that can mediate cell death via nSMase activation, thus emphasizing the central role of the nSMaseceramide cascade. 

Phrase: "Hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(Goldkorn et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "1--D-arabinofuranosylcytosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0010711:Arabinofuranosylcytosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(Bradshaw et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: ","

Phrase: "daunorubicin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011015:Daunorubicin [Antibiotic,Organic Chemical]

Phrase: "(Jaffrezou et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: ","

Phrase: "TNF- (Bezombes et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ", -"

Phrase: "rays"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086894:RAYS [Fish]
  1000   C0851346:Rays [Natural Phenomenon or Process]
   966 E C2314876:ray [Fish]

Phrase: "(Bruno et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "hypoxia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242184:Hypoxia [Pathologic Function]
  1000   C1963140:HYPOXIA [Finding]

Phrase: "(Yoshimura et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "CD40 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "(Segui et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "sindbis virus infection"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2062416:Sindbis virus infection [Disease or Syndrome]
   901   C0042769:virus infection [Disease or Syndrome]
   827   C0009450:Infection, NOS [Disease or Syndrome]
   755 E C0439663:Infected [Functional Concept]
   734   C0037170:Sindbis Virus [Virus]
   716 E C0030657:infectivity [Qualitative Concept]

Phrase: "(Jan et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "are among the agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1551058:Are [Quantitative Concept]
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "can"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell death via nSMase activation,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007587:Cell Death [Cell Function]
   783   C1326120:cell activation [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "thus"

Phrase: "emphasizing"

Phrase: "the central role of the nSMaseceramide cascade."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.196: Results shown here provide a unique signaling pathway from cell surface A engagement, induction of oxidative stress, and activation of the nSMaseceramide cascade culminating in OLG death. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a unique signaling pathway from cell surface A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037083:signaling pathway [Cell Function]
   770   C0086982:Signaling Pathway [Molecular Function]
   767 E C0037080:pathway signaling [Molecular Function]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]

Phrase: "A engagement,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0425152:engagement [Finding]
   861   C2937292:engagement [Finding]

Phrase: "induction of oxidative stress,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1518761:Oxidative Stress Induction [Cell or Molecular Dysfunction]
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activation of the nSMaseceramide cascade culminating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "in OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]
Processing 00000000.tx.197: In summary, this work demonstrates a novel mechanism for A-induced OLG death. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "demonstrates"

Phrase: "a novel mechanism for A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "A-induced OLG death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]
Processing 00000000.tx.198: These results reveal a causal relationship between A exposure and the activation of the nSMaseceramide pathway, which is likely to involve heightened oxidative stress after depletion of cellular GSH stores. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a causal relationship between A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "A exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "and"

Phrase: "the activation of the nSMaseceramide pathway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "which"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "involve"

Phrase: "heightened oxidative stress after depletion of cellular GSH stores."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   762   C1516373:Cellular Stress [Cell or Molecular Dysfunction]
   742   C0038435:Stress [Finding]
   742   C0311404:Oxidative [Functional Concept]
Processing 00000000.tx.199: In addition, we have evidence that activation of the nSMaseceramide cascade may also contribute to A-induced death of cortical neurons and cerebral endothelial cells (unpublished data), thereby suggesting that this cascade may be operating in many cell types other than OLGs. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that activation of the nSMaseceramide cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "also"

Phrase: "contribute to A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C1880177:Contribute [Activity]

Phrase: "A-induced death of cortical neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C2754100:neuron death [Cell Function]
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]

Phrase: "and"

Phrase: "cerebral endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0225336:Endothelial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "operating in many cell types"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0449475:Cell types [Intellectual Product]
   773 E C0007634:Cell Type [Cell]
           Cell
   760   C0332307:Types [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1547052:*Type [Quantitative Concept]
   726   C3242339:operate [Functional Concept]

Phrase: "other than OLGs."
Processing 00000000.tx.200: AnSMaseceramide cascade represents a novel signaling pathway that contributes at least in part to A cytotoxicity to various types of brain cells. 

Phrase: "AnSMaseceramide cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707310:Cascade [Manufactured Object]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a novel signaling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "contributes at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880177:Contribute [Activity]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "to A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A cytotoxicity to various types of brain cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   714   C0022686:Cytotoxic cell [Cell]
Processing 00000000.tx.201: Identification of this pathway may lead to the development of more effective therapeutic strategies aimed at preventing A-induced cell death. 

Phrase: "Identification of this pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "may"

Phrase: "lead to the development of more effective therapeutic strategies"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   742   C0243107:development [Physiologic Function]
   742   C0302350:Therapeutic [Functional Concept]
   742   C0678723:Development [Organism Function]
   742   C0679199:strategies [Mental Process]
   742   C1280519:effective [Qualitative Concept]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C1527148:Development [Functional Concept]
   742   C1704419:Effective [Qualitative Concept]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "aimed at preventing A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   786   C0108800:AIM antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003320:Antigens [Immunologic Factor]
   737   C0309872:PREVENT [Pharmacologic Substance]
   737   C1947946:Aim [Idea or Concept]
   737   C2948600:Aim [Pharmacologic Substance]
   737   C3540471:AIM [Gene or Genome]
   737   C3540472:AIM [Functional Concept]

Phrase: "A-induced cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.202: For instance, blockade of the A-activated death signaling process can be achieved by pharmacological modulation of nSMase activity as demonstrated in this work.  

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "blockade of the A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332206:Blockade [Functional Concept]
   770   C3540676:Blockade [Pharmacologic Substance]

Phrase: "A-activated death signaling process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C3537152:signaling process [Biologic Function]
   804   C1184743:Process [Body Part, Organ, or Organ Component]
   804   C1522240:Process [Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "achieved by pharmacological modulation of nSMase activity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C2261839:neutral sphingomyelinase activity [Molecular Function]
   770   C1149875:sphingomyelinase activity [Molecular Function]
   770   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   744   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0205464:pharmacological [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0443264:Modulation [Spatial Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C1882074:Neutral [Qualitative Concept]
   744   C2825492:Neutral [Phenomenon or Process]

Phrase: "as"

Phrase: "demonstrated in this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.203: Materials and methods Top Abstract Introduction Results Discussion Materials and methods References  Reagents and cell culture All chemicals were purchased from Sigma-Aldrich, and all cell culture reagents were purchased from Invitrogen unless otherwise specified. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "All chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Sigma-Aldrich,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0869011:purchased [Activity]
   770   C1719918:Sigma [Intellectual Product]

Phrase: "and"

Phrase: "all cell culture reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "purchased from Invitrogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "specified."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205369:Specified [Qualitative Concept]
   966 E C1521902:Specify [Qualitative Concept]
Processing 00000000.tx.204: B104 cells (a gift from David Schubert, Salk Institute for Biological Studies, La Jolla, CA) were cultured in DME supplemented with 10% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin. 

Phrase: "B104 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "a gift from David Schubert,"

Phrase: "Salk Institute for Biological Studies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)"

Phrase: "were"

Phrase: "cultured in DME"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 10% FBS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "100 U/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100 g/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.205: OLG culture Neurospheres were cultured using the methods of Zhang et al. 

Phrase: "OLG culture Neurospheres"

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the methods of Zhang et al."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.206: (1999) with modifications. 

Phrase: "(1999"

Phrase: ")"

Phrase: "with modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392747:Modification [Functional Concept]
   966   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.207: In brief, embryonic rat brains (E1416 d) were dissected, homogenized gently in DME/Ham's F12, and centrifuged at 350 g for 5 min. 

Phrase: "In brief, embryonic rat brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   812   C0006104:Brains [Body Part, Organ, or Organ Component]
   779 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(E1416"

Phrase: "d)"

Phrase: "were"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: ","

Phrase: "homogenized"

Phrase: "gently in DME/Ham's F12,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   760   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1414499:F12 [Gene or Genome]
   760   C1638411:Gently [Qualitative Concept]

Phrase: "and"

Phrase: "centrifuged at 350 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439267:g% [Quantitative Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.208: The pellet was digested with 0.05% trypsin in 1.5 ml of 0.53 M EDTA for 30 min at 37C, followed by the addition of 1.5 ml DME/Ham's F12 with 20% FBS, and filtered through 10-m nylon mesh. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "digested with 0.05% trypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0868946:digested [Physiologic Function]

Phrase: "in 1.5 ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439526:/mL [Quantitative Concept]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "of 0.53 M EDTA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1831960:M-EDTA [Organic Chemical,Pharmacologic Substance]
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C,"

Phrase: "followed by the addition of 1.5 ml DME/Ham's F12"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   756   C0332283:Followed by [Temporal Concept]
           followed
   738   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   738   C0439526:/mL [Quantitative Concept]
   738   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   738   C1414499:F12 [Gene or Genome]
   738   C1883712:Addition [Functional Concept]
   704 E C1719822:Follow [Intellectual Product]

Phrase: "with 20% FBS,"

Phrase: "and"

Phrase: "filtered through 10-m nylon mesh."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0441210:Nylon mesh [Medical Device]
   753   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   753   C0181805:Mesh [Medical Device]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0740034:Nylon [Biomedical or Dental Material]
   753   C1135584:MeSH [Intellectual Product]
   753   C1552983:Mesh [Quantitative Concept]
   719   C0180860:Filter [Manufactured Object]
   719   C0581406:Filter [Medical Device]
   719   C1522664:Filter [Intellectual Product]
   719   C1704449:Filter [Conceptual Entity]
   719   C1704684:Filter [Medical Device]
   719   C1875155:FILTER [Medical Device]
Processing 00000000.tx.209: The filtrate was centrifuged at 350 g for 5 min, and the pellet was washed twice with DME/Ham's F12. 

Phrase: "The filtrate"

Phrase: "was"

Phrase: "centrifuged at 350 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439267:g% [Quantitative Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "for 5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with DME/Ham's F12."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   760   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1414499:F12 [Gene or Genome]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.210: Dissociated cells were layered on a preequilibrated Percoll gradient (formed by centrifuging 50% Percoll and 50% DME/Ham's F12 at 23,500 g for 1 h at 4C) and centrifuged at 3,500 g for 15 min. 

Phrase: "Dissociated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "layered on a preequilibrated Percoll gradient"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C0934502:Layered [Body Part, Organ, or Organ Component]
   719 E C1522408:Layer [Qualitative Concept]
   719 E C1561599:Layer [Intellectual Product]

Phrase: "("

Phrase: "formed by centrifuging 50% Percoll"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0205431:Formed [Functional Concept]
   726   C0179834:centrifuge [Medical Device]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "50% DME/Ham's F12 at 23,500 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1414499:F12 [Gene or Genome]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "centrifuged at 3,500 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.211: The fraction containing glial progenitors banding between myelin and blood cell layers was recovered and washed twice with DME/Ham's F12 followed by another wash with neurosphere culture medium (DME/Ham's F12/Hepes, N1 supplement, 25 g/ml insulin, 130 ng/ml progesterone, 20 ng/ml of basic FGF, and 20 ng/ml EGF). 

Phrase: "The fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "glial progenitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870134:Progenitor [Family Group]

Phrase: "banding between myelin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0026969:Myelin [Tissue]
   790   C0026973:Myelin [Cell Component]
   790   C0185014:Banding [Therapeutic or Preventive Procedure]
   756 E C0175723:Band [Medical Device]
   756 E C0439645:Band [Spatial Concept]
   756 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "blood cell layers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0934502:layers [Body Part, Organ, or Organ Component]
   793 E C1522408:Layer [Qualitative Concept]
   793 E C1561599:Layer [Intellectual Product]
   734   C0005773:Blood cell [Cell]
   706 E C2328697:Hemal cell [Cell]

Phrase: "was"

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with DME/Ham's F12"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   760   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1414499:F12 [Gene or Genome]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "followed by another wash"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0441648:Wash [Activity]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with neurosphere culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C2242979:Culture [Laboratory Procedure]
   827   C3244283:medium [Intellectual Product]

Phrase: "(DME/Ham's F12/Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "N1 supplement,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242295:Supplement [Food]
   861   C1947943:Supplement [Intellectual Product]
   861   C2348609:Supplement [Functional Concept]

Phrase: "25 g/ml insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "130 ng/ml progesterone,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   812   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   812   C2757070:Progesterone [Pharmacologic Substance]
   756 E C0010094:Corpus luteum hormone [Hormone]
   756 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   756 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   756 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "20 ng/ml of basic FGF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "20 ng/ml EGF"

Phrase: ")."
Processing 00000000.tx.212: The cell pellet was resuspended in 20 ml of neurosphere culture medium and seeded in 75-mm culture flasks. 

Phrase: "The cell pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in 20 ml of neurosphere culture medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   744   C0009458:Medium [Intellectual Product]
   744   C0010453:Culture [Idea or Concept]
   744   C0220814:culture [Functional Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C0439526:/mL [Quantitative Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C2242979:Culture [Laboratory Procedure]
   744   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "seeded in 75-mm culture flasks."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0872171:flasks [Medical Device]
   753   C2242979:Culture [Laboratory Procedure]
   719   C0036563:Seed [Plant]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]
Processing 00000000.tx.213: After 24 h, when neurospheres had formed, 5 ml of fresh medium was added to each culture every other day for 7 d, and then the neurosphere cultures were split (1:2). 

Phrase: "After 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "when"

Phrase: "neurospheres"

Phrase: "had"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ","

Phrase: "5 ml of fresh medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added to each culture"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C1524062:Added [Functional Concept]
   770   C2242979:Culture [Laboratory Procedure]
   737 E C1883712:Add [Functional Concept]

Phrase: "every other day for 7 d,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0332173:Every day [Temporal Concept]
           /day
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the neurosphere"

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "split"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1534709:Split [Functional Concept]
  1000   C1881714:SPLIT [Phenomenon or Process]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.214: The neurospheres were dissociated gently 10 times with a syringe and a 25-gauge needle and centrifuged at 350 g. 

Phrase: "The neurospheres"

Phrase: "were"

Phrase: "dissociated"

Phrase: "gently 10 times with a syringe"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "a 25-gauge needle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027551:Needle [Medical Device]
   827   C1704318:Needle [Medical Device]
   827   C1882041:Needle [Spatial Concept]
   734   C0456638:25 gauge [Quantitative Concept]

Phrase: "and"

Phrase: "centrifuged at 350 g."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439267:g% [Quantitative Concept]
   737   C0179834:centrifuge [Medical Device]
Processing 00000000.tx.215: The resulting cell pellets were treated with 0.05% trypsin/0.53 mM EDTA and centrifuged at 350 g for 10 min. 

Phrase: "The resulting cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0993610:pellets [Biomedical or Dental Material]
   793 E C0441436:Pellet [Manufactured Object]
   793 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "treated with 0.05% trypsin/0.53 mM EDTA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   764   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   742   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   742   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C1522326:Treated [Functional Concept]
   708 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "centrifuged at 350 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439267:g% [Quantitative Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.216: The cells were resuspended in progenitor medium (69% DME/Ham's F12/Hepes containing N1 supplement, 10 g/ml insulin, 20 nM progesterone, 30% conditioned medium from B104 cells, and 1% FBS) and plated on 100-mm culture dishes precoated with poly-L-ornithine. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in progenitor medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C0870134:Progenitor [Family Group]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "(69% DME/Ham's F12/Hepes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "N1 supplement,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242295:Supplement [Food]
   861   C1947943:Supplement [Intellectual Product]
   861   C2348609:Supplement [Functional Concept]

Phrase: "10 g/ml insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "20 nM progesterone,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   827   C2757070:Progesterone [Pharmacologic Substance]
   771 E C0010094:Corpus luteum hormone [Hormone]
   771 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   771 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   771 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "30% conditioned medium from B104 cells,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "1% FBS)"

Phrase: "and"

Phrase: "plated on 100-mm culture dishes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0180454:Culture plate [Medical Device]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C2242979:Culture [Laboratory Procedure]
   719   C0005971:Plate [Medical Device]
   719   C0020498:DISH [Disease or Syndrome]
   719   C1139930:plate [Medical Device]
   719   C3537155:Plate [Manufactured Object]

Phrase: "precoated with poly-L-ornithine."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0071632:poly-L-ornithine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0029277:Ornithine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0747726:POLY [Conceptual Entity]
Processing 00000000.tx.217: For differentiated OLG cultures, progenitor cells were detached with trypsin/EDTA and cultured on poly-L-ornithinecoated plates or coverslips in mature OLG medium (DME/Ham's F12; N1 supplement, 20 g/ml biotin; 20 g/ml triiodo-L-thyronine, T3, and 1% FBS). 

Phrase: "For differentiated OLG cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "progenitor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0038250:Progenitor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "detached with trypsin/EDTA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   770   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0687118:Detached [Functional Concept]
   770   C1561504:detached [Idea or Concept]

Phrase: "and"

Phrase: "cultured on poly-L-ornithinecoated plates"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   767   C0180454:culture plates [Medical Device]
   753   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0747726:POLY [Conceptual Entity]
   753   C1139930:plates [Medical Device]
   719 E C0005971:Plate [Medical Device]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]
   719 E C3537155:Plate [Manufactured Object]

Phrase: "or"

Phrase: "coverslips in mature OLG medium"

Phrase: "(DME/Ham's F12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1414499:F12 [Gene or Genome]

Phrase: "; N1 supplement,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242295:Supplement [Food]
   861   C1947943:Supplement [Intellectual Product]
   861   C2348609:Supplement [Functional Concept]

Phrase: "20 g/ml biotin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C2700256:Biotin [Laboratory Procedure]

Phrase: "; 20 g/ml triiodo-L-thyronine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0282364:Thyronine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "T3,"

Phrase: "and"

Phrase: "1% FBS"

Phrase: ")."
Processing 00000000.tx.218: Immunocytochemistry Differentiated OLG cultures were fixed in 4% PFA, washed in PBS, and blocked with 5% goat serum. 

Phrase: "Immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "Differentiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]

Phrase: "OLG cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "fixed in 4% PFA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "washed in PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "blocked with 5% goat serum."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0018019:goat [Mammal]
   760   C0028778:Blocked [Pathologic Function]
   760   C0229671:Serum [Body Substance]
   760   C0332206:Blocked [Functional Concept]
   760   C1265549:goat [Mammal]
   760   C1510458:Goat [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.219: Fixed cells were incubated with the primary antibody overnight at 4C. 

Phrase: "Fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with the primary antibody overnight"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439583:Overnight [Temporal Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.220: The following primary antibodies were used: antimouse CNP, antimouse Rip, antimouse PLP (Chemicon), and antimouse GalC (Cedarlane Laboratories) at a concentration of 1:100. 

Phrase: "The following primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "antimouse CNP,"

Phrase: "antimouse Rip,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539807:RIP [Gene or Genome]

Phrase: "antimouse PLP (Chemicon"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "antimouse GalC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1414946:GALC [Gene or Genome]

Phrase: "(Cedarlane Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100."
Processing 00000000.tx.221: The secondary antibody, antimouse IgG conjugated to FITC (Vector Laboratories), was added for 1 h at RT. 

Phrase: "The secondary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "antimouse IgG"

Phrase: "conjugated to FITC (Vector Laboratories"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C0522529:Conjugated [Spatial Concept]
   760   C1619828:Laboratories [Intellectual Product]
   760   C1705099:Vector [Idea or Concept]
   726 E C0301869:Conjugate [Immunologic Factor]
   726 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "added for 1 h at RT."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0700308:h 1 [Element, Ion, or Isotope]
   767   C0945818:Add 1 [Quantitative Concept]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1524062:Added [Functional Concept]
   719 E C1883712:Add [Functional Concept]
Processing 00000000.tx.222: The cells were washed in PBS and visualized using a confocal microscope (model LSM 5 Pascal; Carl Zeiss MicroImaging, Inc.) equipped with a CCD camera (model Axiocam HR; Carl Zeiss MicroImaging, Inc.). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed in PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a confocal microscope"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1626420:Confocal microscope [Medical Device]
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "(model LSM 5 Pascal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439473:pascal [Quantitative Concept]

Phrase: "; Carl Zeiss MicroImaging,"

Phrase: "Inc.)"

Phrase: "equipped with a CCD camera"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0598124:CCD camera [Manufactured Object]
   760   C0179533:Camera [Medical Device]
   760   C1654607:Camera [Eukaryote]
   760   C1706254:CAMERA [Medical Device]

Phrase: "(model Axiocam HR"

Phrase: "; Carl Zeiss MicroImaging,"

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.223: Images were collected and processed using Adobe Photoshop software. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Adobe Photoshop software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.224: Sphingomyelinase assay The cells were washed twice with PBS, pH 7.4, and lysed in 0.2% Triton X-100 for 10 min at 4C. 

Phrase: "Sphingomyelinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "lysed in 0.2% Triton X-100"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0024348:lysed [Pathologic Function]
   748   C0242759:Triton [Geographic Area]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.225: The lysates were sonicated for 30 s in ice-cold bath, and protein concentrations were determined by Lowry assay (Lowry et al., 1951). 

Phrase: "The lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "sonicated for 30 s"

Phrase: "in ice-cold bath,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0150141:Bath [Therapeutic or Preventive Procedure]
   734   C0456963:Ice cold [Qualitative Concept]

Phrase: "and"

Phrase: "protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by Lowry assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "(Lowry et al.,"

Phrase: "1951"

Phrase: ")."
Processing 00000000.tx.226: A sphingomyelinase substrate, [methyl-14C]sphingomyelin (55 mCi/mmol; Amersham Biosciences), was evaporated to dryness and resuspended in either 25 l of nSMase assay buffer (40 mM Hepes, 5 mM MgCl2, and 0.2% Triton X-100, pH 7.4) or aSMase assay buffer (250 mM sodium acetate and 0.2% Triton X-100, pH 5.2) and sonicated to form micelles on ice until use. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A sphingomyelinase substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "[methyl-14C"

Phrase: "]sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: "(55 mCi/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "; Amersham Biosciences"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "evaporated"

Phrase: "to dryness"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1512080:Dryness [Qualitative Concept]
   789 E C0011682:Dry [Natural Phenomenon or Process]
   789 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "resuspended in either 25 l of nSMase assay buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0005507:Assay [Laboratory Procedure]
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0243073:assay [Qualitative Concept]
   739   C1510438:Assay [Laboratory Procedure]
   739   C1882074:Neutral [Qualitative Concept]
   739   C2825492:Neutral [Phenomenon or Process]

Phrase: "(40 mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.2% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "or"

Phrase: "aSMase assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(250 mM sodium acetate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.2% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "pH 5.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "sonicated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "micelles on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0025938:Micelles [Lipid]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.227: Each reaction containing 25 l of cell lysate protein (1 mg/ml) and 25 l [methyl-14C]sphingomyelin (0.23 nmol) in nSMase or aSMase assay buffer was incubated for 2 h at 37C. 

Phrase: "Each reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "25 l of cell lysate protein (1 mg/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0022827:cell l [Cell]
   767   C0439268:mg/L [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "25 l [methyl-14C"

Phrase: "]sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: "(0.23 nmol) in nSMase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439191:NMOLE [Quantitative Concept]

Phrase: "or"

Phrase: "aSMase assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.228: The reaction was terminated with 200 l CHCl3/methanol (1:1) and 90 l H2O followed by vigorous agitation. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated with 200 l CHCl3/methanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C1553404:terminated [Idea or Concept]
   753   C2348570:Terminated [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "90 l H2O"

Phrase: "followed by vigorous agitation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0085631:Agitation [Sign or Symptom]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.229: The samples were centrifuged at 6,000 g for 5 min. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged at 6,000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.230: [14C]Phosphocholine in the aqueous phase (120 l) was collected for liquid scintillation counting. 

Phrase: "[14C"

Phrase: "]Phosphocholine in the aqueous phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031716:Phosphocholine [Organic Chemical,Pharmacologic Substance]

Phrase: "(120 l)"

Phrase: "was"

Phrase: "collected for liquid scintillation counting."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.231: Phosphocholine is the degraded moiety of sphingomyelin after ceramide is released by nSMase or aSMase. 

Phrase: "Phosphocholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031716:Phosphocholine [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "the degraded moiety of sphingomyelin"

Phrase: "after ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "is"

Phrase: "released by nSMase"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1882074:Neutral [Qualitative Concept]
   770   C2825492:Neutral [Phenomenon or Process]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "aSMase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539725:ASMASE [Gene or Genome]
Processing 00000000.tx.232: The aSMase or nSMase activity was calculated as picomoles of sphingomyelin hydrolyzed by 1 mg of total proteins per hour and expressed as a percentage of control values. 

Phrase: "The aSMase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037903:aSMase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539725:ASMASE [Gene or Genome]

Phrase: "or"

Phrase: "nSMase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2261839:neutral sphingomyelinase activity [Molecular Function]
   901   C1149875:sphingomyelinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "calculated as picomoles of sphingomyelin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   726   C0439192:picomole [Quantitative Concept]

Phrase: "hydrolyzed by 1 mg of total proteins"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   757   C0439177:Protein.total [Quantitative Concept]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439269:mg% [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   745 E C0555903:Total protein [Laboratory Procedure]
   745 E C1261360:total protein [Laboratory or Test Result]

Phrase: "per hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439227:Hour [Temporal Concept]
  1000   C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "expressed as a percentage of control values."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0042295:Values [Qualitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.233: TLC OLGs with or without A 25-35 treatment were cultured with 10 Ci [3H]palmitate (1 mCi/ml; Amersham Biosciences; Kaneko et al., 1995). 

Phrase: "TLC OLGs with"

Phrase: "or without A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003320:Antigens [Immunologic Factor]

Phrase: "A 25-35 treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "cultured with 10 Ci [3H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1442460:3H [Temporal Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "]palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(1 mCi/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2348021:mCi/ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; Amersham Biosciences"

Phrase: "; Kaneko et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.234: The labeled cells were collected and washed twice with PBS, pH 7.4, to remove free isotope before lipid extraction (Xu et al., 1998). 

Phrase: "The labeled cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "free isotope before lipid extraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0022262:Isotope [Element, Ion, or Isotope]

Phrase: "(Xu et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.235: The cell pellet was resuspended in 400 l methanol/1 N HCl (100:6, vol/vol) followed by 800 l chloroform and 240 l H2O. 

Phrase: "The cell pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in 400 l methanol/1 N HCl (100"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "6,"

Phrase: "vol/vol)"

Phrase: "followed by 800 l chloroform"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "240 l H2O."
Processing 00000000.tx.236: The sample was mixed and centrifuged at 6,000 g for 5 min. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "centrifuged at 6,000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.237: The lipid fraction was reextracted with 1 ml chloroform/methanol (2:1, vol/vol) and applied to a TLC plate. 

Phrase: "The lipid fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "reextracted with 1 ml chloroform/methanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "vol/vol)"

Phrase: "and"

Phrase: "applied to a TLC plate."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0005971:Plate [Medical Device]
   760   C0185125:Applied [Health Care Activity]
   760   C1139930:plate [Medical Device]
   760   C3537155:Plate [Manufactured Object]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.238: The solvent was chloroform/methanol/acetic acid/H2O (85:4.5:5:0.5, vol/vol) for ceramide and chloroform/methanol/acetic acid/water (65:25:8.8:4.5, vol/vol) for sphingomyelin. 

Phrase: "The solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "chloroform/methanol/acetic acid/H2O"

Phrase: "(85"

Phrase: ":"

Phrase: "4.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450367:4 5 [Quantitative Concept]

Phrase: ":"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "vol/vol) for ceramide"

Phrase: "and"

Phrase: "chloroform/methanol/acetic acid/water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   804   C0599638:WATER [Substance]
   804   C1550678:Water [Inorganic Chemical]
   733 E C0443350:Watery [Qualitative Concept]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "25"

Phrase: ":"

Phrase: "8.8"

Phrase: ":"

Phrase: "4.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450367:4 5 [Quantitative Concept]

Phrase: "vol/vol) for sphingomyelin."
Processing 00000000.tx.239: Plates were air dried and sprayed with 1 M sodium salicylate for autoradiography. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "air dried"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0001861:Air [Substance]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "sprayed with 1 M sodium salicylate"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0037549:Sodium Salicylate [Organic Chemical,Pharmacologic Substance]
   783   C0597484:Sodium 1+ [Element, Ion, or Isotope,Pharmacologic Substance]
           Sodium+
   753   C0036075:salicylate [Organic Chemical,Pharmacologic Substance]
   753   C0036077:Salicylate, NOS [Organic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0233601:sprayed [Mental or Behavioral Dysfunction]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   719 E C1704413:{Spray} [Quantitative Concept]
   719 E C2003858:Spray [Functional Concept]

Phrase: "for autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.240: Standard lipids were stained by rhodamine 6G (Sigma-Aldrich) and visualized by UV light. 

Phrase: "Standard lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "stained by rhodamine 6G"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0073193:rhodamine 6G [Organic Chemical,Pharmacologic Substance]
   802   C0600322:Rhodamine stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Rhodamine
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Sigma-Aldrich"

Phrase: ")"

Phrase: "and"

Phrase: "visualized by UV light."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0041625:UV Light [Natural Phenomenon or Process]
           UV
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]
   770   C1961129:uV [Quantitative Concept]
Processing 00000000.tx.241: Quantitative ceramide analysis by ESI/MS After three washes with PBS, pH 7.4, OLGs harvested from 100-mm culture plates with or without A 25-35 treatment were homogenized in 0.5 ml PBS, pH 7.4, with a glass tissue grinder. 

Phrase: "Quantitative ceramide analysis by ESI/MS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "After three washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "with PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "OLGs"

Phrase: "harvested from 100-mm culture plates"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0180454:culture plates [Medical Device]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1139930:plates [Medical Device]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C0005971:Plate [Medical Device]
   719   C1512335:Harvest [Health Care Activity]
   719 E C3537155:Plate [Manufactured Object]

Phrase: "with"

Phrase: "or without A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003320:Antigens [Immunologic Factor]

Phrase: "A 25-35 treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0199452:CNP treatment [Therapeutic or Preventive Procedure]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "homogenized in 0.5 ml PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with a glass tissue grinder."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0493160:GRINDER, TISSUE [Medical Device]
Processing 00000000.tx.242: A bicinchomic protein assay kit was used to determine the protein concentration before lipid extraction (Pierce Chemical Co.). 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A bicinchomic protein assay kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0812225:KIT [Medical Device]
   804   C1150635:KIT [Molecular Function]
   804   C1705212:Kit [Medical Device]
   804   C1705213:KIT [Medical Device]
   804   C3273202:Kit [Manufactured Object]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the protein concentration before lipid extraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0427716:Protein concentration [Laboratory Procedure]
   790   C1304757:Protein concentration [Laboratory or Test Result]
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "(Pierce Chemical Co."

Phrase: ")."
Processing 00000000.tx.243: Lipids from the homogenates were extracted as described previously with modifications (Bligh and Dyer, 1959) using 50 mM LiOH in the aqueous layer and C17:0 ceramide (2 nmol/mg protein) as an internal standard for quantitation of ceramide content. 

Phrase: "Lipids from the homogenates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously with modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0392747:Modification [Functional Concept]
   756   C1554963:modification [Qualitative Concept]

Phrase: "(Bligh"

Phrase: "and"

Phrase: "Dyer,"

Phrase: "1959"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "50 mM LiOH in the aqueous layer"

Phrase: "and"

Phrase: "C17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539216:C17 [Gene or Genome]

Phrase: ":"

Phrase: "0 ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "(2 nmol/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1881965:nmol/mg{protein} [Quantitative Concept]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "as an internal standard"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205102:Internal [Spatial Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]
   861   C2828392:Standard [Intellectual Product]

Phrase: "for quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantitation [Quantitative Concept]

Phrase: "of ceramide content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.244: These molecular species represent <1% of the endogenous cellular lipid mass. 

Phrase: "These molecular species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "<1% of the endogenous cellular lipid mass."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0007634:Cellular [Cell]
   748   C0023779:Lipid [Lipid]
   748   C0178539:Cellular [Functional Concept]
   748   C0205227:Endogenous [Functional Concept]
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C2827734:1+ [Quantitative Concept]
   748   C2981698:1+ [Classification]
   748   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.245: The lipid extracts were dried under a nitrogen stream, dissolved in chloroform, desalted with Sep-Pak columns, and filtered with 0.2 m PTFE syringe filters (Fisher Scientific). 

Phrase: "The lipid extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "dried under a nitrogen stream,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0028158:Nitrogen [Element, Ion, or Isotope]
   760   C0442540:Stream [Natural Phenomenon or Process]
   760   C1512080:Dried [Qualitative Concept]
   760   C1550581:nitrogen [Human-caused Phenomenon or Process]
   760   C2827485:Dried [Body Substance]
   726 E C0011682:Dry [Natural Phenomenon or Process]
   726 E C0205222:Dry [Qualitative Concept]

Phrase: "dissolved in chloroform,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756   C1549535:Dissolve [Functional Concept]

Phrase: "desalted with Sep-Pak columns,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030211:PAK [Geographic Area]
   760   C1418664:SEP [Gene or Genome]
   760   C1419968:SeP [Gene or Genome]
   760   C1826261:SEP [Gene or Genome]
   726   C1185738:Column [Body Part, Organ, or Organ Component]
   726   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "filtered with 0.2 m PTFE syringe filters"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0032611:PTFE [Biomedical or Dental Material,Organic Chemical]
   744   C0039142:Syringe [Medical Device]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1706072:Syringe [Manufactured Object]
   711   C0180860:Filter [Manufactured Object]
   711   C0581406:Filter [Medical Device]
   711   C1522664:Filter [Intellectual Product]
   711   C1704449:Filter [Conceptual Entity]
   711   C1704684:Filter [Medical Device]
   711   C1875155:FILTER [Medical Device]

Phrase: "(Fisher"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.246: Lipids were reextracted with 20 mM LiOH in the aqueous layer, dried under a nitrogen stream, and resuspended in 0.5 ml of chloroform/methanol (1:1, vol/vol) for ESI/MS analysis. 

Phrase: "Lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "reextracted with 20 mM LiOH"

Phrase: "in the aqueous layer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "dried under a nitrogen stream,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0028158:Nitrogen [Element, Ion, or Isotope]
   760   C0442540:Stream [Natural Phenomenon or Process]
   760   C1512080:Dried [Qualitative Concept]
   760   C1550581:nitrogen [Human-caused Phenomenon or Process]
   760   C2827485:Dried [Body Substance]
   726 E C0011682:Dry [Natural Phenomenon or Process]
   726 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "resuspended in 0.5 ml of chloroform/methanol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444499:0/5 [Quantitative Concept]
   744   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   744   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0439526:/mL [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "vol/vol) for ESI/MS analysis."
Processing 00000000.tx.247: ESI/MS analysis was performed using a spectrometer (model TSQ-7000; Finnigan) equipped with an electrospray ion source as described previously (Han et al., 1996, 2001). 

Phrase: "ESI/MS analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a spectrometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183395:Spectrometer [Medical Device]
  1000   C1710143:Spectrometer [Manufactured Object]

Phrase: "(model TSQ-7000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "; Finnigan"

Phrase: ")"

Phrase: "equipped with an electrospray ion source"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1708574:Ion Source [Research Device]
   753   C0022023:Ion [Element, Ion, or Isotope]
   753   C0449416:Source [Finding]
   753   C1700702:ION [Functional Concept]
   753   C1705919:Source [Idea or Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Han et al.,"

Phrase: "1996,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.248: A 5-min period of signal averaging in the profile mode was used for each spectrum of a lipid extract. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A 5-min period of signal averaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439531:/period [Temporal Concept]
   748   C1948053:Period [Temporal Concept]

Phrase: "in the profile mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513371:Mode [Functional Concept]
   861   C1705738:Mode [Quantitative Concept]
   861   C2347637:Mode [Quantitative Concept]
   861   C2348146:Mode [Quantitative Concept]

Phrase: "was"

Phrase: "used for each spectrum of a lipid extract."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   767   C0023767:Lipid A [Immunologic Factor,Lipid]
   750   C1524063:Use of [Functional Concept]
   744   C0023779:Lipid [Lipid]
   744   C1273517:used [Finding]
   744   C1883073:Spectrum [Quantitative Concept]
   744   C2827424:Spectrum [Conceptual Entity]
   744   C2828366:Extract [Substance]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.249: All extracts were directly infused into the ESI chamber using a syringe pump at 1 l/min flow rate. 

Phrase: "All extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "infused into the ESI chamber"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   760   C1418549:ESI [Gene or Genome]
   760   C1516801:ESI [Laboratory Procedure]
   760   C1579194:ESI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C3537449:ESI [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a syringe pump at 1 l/min flow rate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C2826285:Flow Rate [Quantitative Concept]
   793   C0806140:Flow [Natural Phenomenon or Process]
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.250: Ceramide in the lipid extracts was quantitated directly as deprotenated ions ([M-H]-) in comparison with an internal standard (C17:0 ceramide) after correction for 13C isotope effects in the negative-ion mode. 

Phrase: "Ceramide in the lipid extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "was"

Phrase: "quantitated"

Phrase: "directly as deprotenated ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0022023:Ions [Element, Ion, or Isotope]
   770   C1947931:Directly [Qualitative Concept]
   737 E C1700702:ION [Functional Concept]

Phrase: "("

Phrase: "["

Phrase: "M-"

Phrase: "H]-) in comparison"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0033727:H+ [Element, Ion, or Isotope]
   790   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441932:H+ [Classification]
   790   C0564385:/h [Quantitative Concept]

Phrase: "with an internal standard"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205102:Internal [Spatial Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]
   861   C2828392:Standard [Intellectual Product]

Phrase: "(C17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539216:C17 [Gene or Genome]

Phrase: ":"

Phrase: "0 ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: ")"

Phrase: "after"

Phrase: "correction for 13C isotope effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705565:CORRECTION [Intellectual Product]
   760   C1947976:Correction [Functional Concept]

Phrase: "in the negative-ion mode."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0022023:Ion [Element, Ion, or Isotope]
   827   C0205160:Negative [Qualitative Concept]
   827   C1513371:Mode [Functional Concept]
   827   C1513916:Negative [Finding]
   827   C1700702:ION [Functional Concept]
   827   C1705738:Mode [Quantitative Concept]
   827   C2347637:Mode [Quantitative Concept]
   827   C2348146:Mode [Quantitative Concept]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.251: Ion peaks were identified using tandem mass spectroscopic analyses as described previously (Han and Gross, 1995). 

Phrase: "Ion peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "tandem mass spectroscopic analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Han"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "and"

Phrase: "Gross, 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439806:Gross [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.252: Cell death assays OLG viability was quantitated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and trypan blue exclusion method. 

Phrase: "Cell death assays OLG viability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C0007620:Cell Viability [Cell Function]
   804   C0443348:viability [Qualitative Concept]

Phrase: "was"

Phrase: "quantitated by 3-"

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyltetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: "(MTT) assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "trypan blue exclusion method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.253: Cell death was also assessed by the amount of lactate dehydrogenase (LDH) release into the culture medium after A or C2-ceramide treatment (Koh and Choi, 1987; Shaikh et al., 1997; Xu et al., 1998). 

Phrase: "Cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "also"

Phrase: "assessed by the amount of lactate dehydrogenase (LDH) release"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0022924:lactate [Organic Chemical]
   744   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030685:Release [Health Care Activity]
   744   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1265611:Amount [Quantitative Concept]
   744   C1283071:Release [Functional Concept]
   744   C1516048:Assessed [Activity]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "into the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "after A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "or"

Phrase: "C2-ceramide treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]

Phrase: "(Koh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "Choi,"

Phrase: "1987"

Phrase: "; Shaikh et al.,"

Phrase: "1997"

Phrase: "; Xu et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.254: The amount of LDH released by cells killed with Triton X-100 was considered maximal cell death or "full kill" (Xu et al., 1998). 

Phrase: "The amount of LDH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "released by cells"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "killed with Triton X-100"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   862   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   806   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   760   C0162388:killed [Social Behavior]
   760   C0242759:Triton [Geographic Area]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1550555:kill [Functional Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "maximal cell death or ""full kill"""
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0599733:cell kill [Cell Function]
   799   C0162388:kill [Social Behavior]
   799   C0681205:Kill [Idea or Concept]
   799   C1550555:kill [Functional Concept]

Phrase: "(Xu et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.255: Assay for cellular GSH content Cellular GSH levels were determined using a GSH-400 colorimetric assay kit (Calbiochem-Novabiochem). 

Phrase: "Assay for cellular GSH content Cellular GSH levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1516365:Cellular Assay [Research Activity]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a GSH-400 colorimetric assay kit (Calbiochem-Novabiochem"

Phrase: ")."
Processing 00000000.tx.256: Triplicate samples (3 x 106 cells) were collected by centrifugation and washed twice with PBS, pH 7.4. 

Phrase: "Triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "(3 x 106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.257: The cell pellets were treated with 5% metaphosphoric acid (Sigma-Aldrich). 

Phrase: "The cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "treated with 5% metaphosphoric acid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0066055:metaphosphoric acid [Inorganic Chemical]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(Sigma-Aldrich"

Phrase: ")."
Processing 00000000.tx.258: A Teflon pestle was used to homogenize the cells. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A Teflon pestle"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "homogenize"

Phrase: "the cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.259: Protein concentrations were determined by Lowry assay (Lowry et al., 1951). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by Lowry assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "(Lowry et al.,"

Phrase: "1951"

Phrase: ")."
Processing 00000000.tx.260: The homogenates were centrifuged at 3,000 g for 10 min at 4C. 

Phrase: "The homogenates"

Phrase: "were"

Phrase: "centrifuged at 3,000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.261: Supernatants were assayed for GSH according to the instructions provided with the kit. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "assayed for GSH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1260386:GSH [Disease or Syndrome]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "according to the instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302828:instructions [Intellectual Product]
  1000   C1442085:Instructions [Idea or Concept]
  1000   C3263700:Instructions [Clinical Attribute]
   966 E C0039401:Instruction [Educational Activity]

Phrase: "provided with the kit."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0812225:KIT [Medical Device]
   770   C1150635:KIT [Molecular Function]
   770   C1705212:Kit [Medical Device]
   770   C1705213:KIT [Medical Device]
   770   C1999230:Provided [Activity]
   770   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.262: A standard curve was generated with graded concentrations of GSH (540 M). 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A standard curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]

Phrase: "was"

Phrase: "generated with graded concentrations of GSH (540"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086045:Concentrations [Mental Process]
   748   C1260386:GSH [Disease or Syndrome]
   748   C3146294:Generated [Activity]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "M)."
Processing 00000000.tx.263: GSH concentration was measured by absorbance at 400 nm with a spectrophotometer. 

Phrase: "GSH concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "measured by absorbance"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0444706:Measured [Qualitative Concept]
   790   C1268822:Absorbance [Clinical Attribute]
   790   C2825050:Absorbance [Phenomenon or Process]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "at 400 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "with a spectrophotometer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183400:Spectrophotometer [Medical Device]
Processing 00000000.tx.264: nSMase antisense oligonucleotides Morpholino sense (GCCGCAGAGAAAAGTTGTGCTTCAT) and antisense (CCTCTTACCTCAGTTACAATTTATA) oligonucleotides were generated for nSMase (Gene Tools, LLC). 

Phrase: "nSMase antisense oligonucleotides Morpholino sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0036658:sense [Organ or Tissue Function]

Phrase: "(GCCGCAGAGAAAAGTTGTGCTTCAT"

Phrase: ")"

Phrase: "and"

Phrase: "antisense"

Phrase: "(CCTCTTACCTCAGTTACAATTTATA"

Phrase: ")"

Phrase: "oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "generated for nSMase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1882074:Neutral [Qualitative Concept]
   770   C2825492:Neutral [Phenomenon or Process]
   770   C3146294:Generated [Activity]

Phrase: "(Gene Tools,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0336791:Tool [Manufactured Object]
   827   C2827396:Tool [Manufactured Object]

Phrase: "LLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3271738:LLC [Cell Component]

Phrase: ")."
Processing 00000000.tx.265: OLGs in serum-free medium were treated with 1.4 M oligonucleotides in EPEI delivery solution (per manufacturer's instructions; Gene Tools) for 4 h. 

Phrase: "OLGs in serum-free medium"

Phrase: "were"

Phrase: "treated with 1.4 M oligonucleotides"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "in EPEI delivery solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "("

Phrase: "per manufacturer's instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "; Gene Tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0336791:Tool [Manufactured Object]
   827   C2827396:Tool [Manufactured Object]

Phrase: ")"

Phrase: "for 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.266: The medium was exchanged and A was added for 24 h, after which cells were harvested for nSMase activity or cell death determination. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "exchanged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0678640:exchange [Social Behavior]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A"

Phrase: "was"

Phrase: "added for 24 h,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "after"

Phrase: "which cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested for nSMase activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C2261839:neutral sphingomyelinase activity [Molecular Function]
   806   C1149875:sphingomyelinase activity [Molecular Function]
   806   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   760   C1882074:Neutral [Qualitative Concept]
   760   C2825492:Neutral [Phenomenon or Process]
   726   C1512335:Harvest [Health Care Activity]

Phrase: "or"

Phrase: "cell death determination."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0079221:death determination [Diagnostic Procedure]
   827   C1148554:determination [Laboratory Procedure]
   734   C0007587:Cell Death [Cell Function]
Processing 00000000.tx.267: Statistical analysis Results are expressed as mean  SD. 

Phrase: "Statistical analysis Results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "are"

Phrase: "expressed as mean  SD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.268: Differences among groups were analyzed by one-way ANOVA followed by Bonferroni's post-hoc t test to determine statistical significance. 

Phrase: "Differences among groups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed by one-way ANOVA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C1709320:One-way ANOVA [Quantitative Concept]
   760   C0205447:One [Quantitative Concept]
   760   C0936012:Analyzed [Research Activity]

Phrase: "followed by Bonferroni's post-hoc t test to"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C0687676:Post [Temporal Concept]
   744   C1704687:Post [Manufactured Object]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "determine"

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.269: Comparison between two experimental groups was based on two-tailed t test. 

Phrase: "Comparison between two experimental groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "was"

Phrase: "based on two-tailed t test."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039259:tailed [Body Part, Organ, or Organ Component]
   753   C0039593:Test [Functional Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0392366:test [Intellectual Product]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.270: P < 0.05 was considered statistically significant.  

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.271: Acknowledgments  We would like to thank Dr. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "would like to"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.272: Yannan Ouyang for his technical expertise in confocal microscopy. 

Phrase: "Yannan Ouyang for his technical expertise"

Phrase: "in confocal microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.273: This work was supported by National Institutes of Heath grants NS37230 and NS40525. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Heath grants NS37230"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0018173:Grants [Quantitative Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "NS40525."
Processing 00000000.tx.274: Submitted: 2 July 2003 Accepted: 19 November 2003  References Top Abstract Introduction Results Discussion Materials and methods References  Abate, C., L. 

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ":"

Phrase: "2 July 2003"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "19 November 2003"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Abate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: ","

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.275: Patel, F.J. 

Phrase: "Patel,"

Phrase: "F.J."
Processing 00000000.tx.276: Rauscher, III, and T. 

Phrase: "Rauscher,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.277: Curran. 

Phrase: "Curran."
Processing 00000000.tx.278: 1990. 

Phrase: "1990."
Processing 00000000.tx.279: Redox regulation of fos and jun DNA-binding activity in vitro. 

Phrase: "Redox regulation of fos"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "jun DNA-binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C2266866:Binding Activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.280: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.281: 249:11571161.[Medline] Albouz, S., F. 

Phrase: "249"

Phrase: ":"

Phrase: "11571161."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Albouz,"

Phrase: "S."

Phrase: ","

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.282: Le Saux, D. 

Phrase: "Le Saux,"

Phrase: "D."
Processing 00000000.tx.283: Wenger, J.J. 

Phrase: "Wenger,"

Phrase: "J.J."
Processing 00000000.tx.284: Hauw, and N. 

Phrase: "Hauw,"

Phrase: "and"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.285: Baumann. 

Phrase: "Baumann."
Processing 00000000.tx.286: 1986. 

Phrase: "1986."
Processing 00000000.tx.287: Modifications of sphingomyelin and phosphatidylcholine metabolism by tricyclic antidepressants and phenothiazines. 

Phrase: "Modifications of sphingomyelin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0392747:Modification [Functional Concept]
   756   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "phosphatidylcholine metabolism by tricyclic antidepressants"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C1158423:phosphatidylcholine metabolism [Molecular Function]
   778 E C1158424:lecithin metabolism [Molecular Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "phenothiazines."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0031434:phenothiazines [Organic Chemical,Pharmacologic Substance]
  1000   C0031436:Phenothiazines [Organic Chemical,Pharmacologic Substance]
  1000   C0304370:Phenothiazines [Organic Chemical,Pharmacologic Substance]
   966 E C3536886:Phenothiazine [Pharmacologic Substance]
Processing 00000000.tx.288: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.289: 38:357363.[CrossRef][Medline] Anderson, M.E., and A. 

Phrase: "38"

Phrase: ":"

Phrase: "357363."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Anderson,"

Phrase: "M."

Phrase: "E.,"

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.290: Meister. 

Phrase: "Meister."
Processing 00000000.tx.291: 1983. 

Phrase: "1983."
Processing 00000000.tx.292: Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis. 

Phrase: "Transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "direct utilization of gamma-glutamylcyst"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0042153:utilization [Functional Concept]

Phrase: "(e)ine for glutathione synthesis."
Processing 00000000.tx.293: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.294: Natl. 

Phrase: "Natl."
Processing 00000000.tx.295: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.296: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.297: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.298: 80:707711.[Abstract] Askanas, V., J. 

Phrase: "80"

Phrase: ":"

Phrase: "707711."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Askanas,"

Phrase: "V.,"

Phrase: "J."
Processing 00000000.tx.299: McFerrin, S. 

Phrase: "McFerrin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.300: Baque, R.B. 

Phrase: "Baque,"

Phrase: "R.B."
Processing 00000000.tx.301: Alvarez, E. 

Phrase: "Alvarez,"

Phrase: "E."
Processing 00000000.tx.302: Sarkozi, and W.K. 

Phrase: "Sarkozi,"

Phrase: "and"

Phrase: "W.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.303: Engel. 

Phrase: "Engel."
Processing 00000000.tx.304: 1996. 

Phrase: "1996."
Processing 00000000.tx.305: Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. 

Phrase: "Transfer of beta-amyloid precursor protein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1517499:Gene Transfer [Molecular Biology Research Technique]
   748   C0040671:Transfer [Mental Process]
   748   C1705822:Transfer [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "adenovirus vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1510800:Adenovirus Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "mitochondrial abnormalities in cultured normal human muscle."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0000768:Abnormalities [Congenital Abnormality]
   748   C0000769:abnormalities [Functional Concept]
   714 E C1704258:Abnormality [Finding]
Processing 00000000.tx.306: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.307: Natl. 

Phrase: "Natl."
Processing 00000000.tx.308: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.309: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.310: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.311: 93:13141319.[Abstract/Free FullText] Back, S.A., X. 

Phrase: "93"

Phrase: ":"

Phrase: "13141319."

Phrase: "[Abstract/Free FullText"

Phrase: "] Back, S.A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0221135:S antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   867   C0312963:s antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   867   C1419805:S-ANTIGEN [Gene or Genome]
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.,"

Phrase: "X."
Processing 00000000.tx.312: Gan, Y. 

Phrase: "Gan,"

Phrase: "Y."
Processing 00000000.tx.313: Li, P.A. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "P.A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C0221133:P not otherwise specified Antigen [Immunologic Factor]
   983   C0599990:p antigen [Finding]
   983   C2607880:p Antigen [Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.314: Rosenberg, and J.J. 

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "and"

Phrase: "J.J."
Processing 00000000.tx.315: Volpe. 

Phrase: "Volpe."
Processing 00000000.tx.316: 1998. 

Phrase: "1998."
Processing 00000000.tx.317: Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. 

Phrase: "Maturation-dependent vulnerability of oligodendrocytes"

Phrase: "to oxidative stress-induced death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "caused by glutathione depletion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0333668:Depletion [Functional Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.318: J. 

Phrase: "J."
Processing 00000000.tx.319: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.320: 18:62416253.[Abstract/Free FullText] Behl, C. 

Phrase: "18"

Phrase: ":"

Phrase: "62416253."

Phrase: "[Abstract/Free FullText"

Phrase: "] Behl,"

Phrase: "C."
Processing 00000000.tx.321: 1999. 

Phrase: "1999."
Processing 00000000.tx.322: Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. 

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: ":"

Phrase: "implications for novel therapeutic approaches."
Processing 00000000.tx.323: Prog. 

Phrase: "Prog."
Processing 00000000.tx.324: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.325: 57:301323.[CrossRef][Medline] Behl, C., and Y. 

Phrase: "57"

Phrase: ":"

Phrase: "301323."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Behl,"

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.326: Sagara. 

Phrase: "Sagara."
Processing 00000000.tx.327: 1997. 

Phrase: "1997."
Processing 00000000.tx.328: Mechanism of amyloid beta protein induced neuronal cell death: current concepts and future perspectives. 

Phrase: "Mechanism of amyloid beta protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "neuronal cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2754100:neuronal cell death [Cell Function]
           neuron death
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "current concepts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178566:concepts [Idea or Concept]

Phrase: "and"

Phrase: "future perspectives."
Processing 00000000.tx.329: J. 

Phrase: "J."
Processing 00000000.tx.330: Neural Transm. 

Phrase: "Neural Transm."
Processing 00000000.tx.331: Suppl. 

Phrase: "Suppl."
Processing 00000000.tx.332: 49:125134.[Medline] Behl, C., J.B. 

Phrase: "49"

Phrase: ":"

Phrase: "125134."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Behl,"

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "J.B."
Processing 00000000.tx.333: Davis, R. 

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.334: Lesley, and D. 

Phrase: "Lesley,"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.335: Schubert. 

Phrase: "Schubert."
Processing 00000000.tx.336: 1994. 

Phrase: "1994."
Processing 00000000.tx.337: Hydrogen peroxide mediates amyloid beta protein toxicity. 

Phrase: "Hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "amyloid beta protein toxicity."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   812   C0040539:toxicity [Qualitative Concept]
   812   C0600688:Toxicity [Injury or Poisoning]
   756   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   741 E C1407029:Toxic [Qualitative Concept]
   719 E C0032346:Poison [Hazardous or Poisonous Substance]
   719 E C1548769:Poison [Intellectual Product]
   719 E C1550590:poison [Idea or Concept]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.338: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.339: 77:817827.[Medline] Bezombes, C., N. 

Phrase: "77"

Phrase: ":"

Phrase: "817827."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bezombes,"

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.340: Maestre, G. 

Phrase: "Maestre,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.341: Laurent, T. 

Phrase: "Laurent,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.342: Levade, A. 

Phrase: "Levade,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.343: Bettaieb, and J.P. 

Phrase: "Bettaieb,"

Phrase: "and"

Phrase: "J.P."
Processing 00000000.tx.344: Jaffrezou. 

Phrase: "Jaffrezou."
Processing 00000000.tx.345: 1998. 

Phrase: "1998."
Processing 00000000.tx.346: Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. 

Phrase: "Restoration of TNF-alpha-induced ceramide generation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449982:Restoration [Intellectual Product]

Phrase: "and"

Phrase: "apoptosis in resistant human leukemia KG1a cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162638:Apoptosis [Cell Function]

Phrase: "by the P-glycoprotein blocker PSC833."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0139121:PSC833 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.347: FASEB J. 

Phrase: "FASEB J."
Processing 00000000.tx.348: 12:101109.[Abstract/Free FullText] Blasko, I., T.L. 

Phrase: "12"

Phrase: ":"

Phrase: "101109."

Phrase: "[Abstract/Free FullText"

Phrase: "] Blasko,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "T.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.349: Schmitt, E. 

Phrase: "Schmitt,"

Phrase: "E."
Processing 00000000.tx.350: Steiner, K. 

Phrase: "Steiner,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.351: Trieb, and B. 

Phrase: "Trieb,"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.352: Grubeck-Loebenstein. 

Phrase: "Grubeck-Loebenstein."
Processing 00000000.tx.353: 1997. 

Phrase: "1997."
Processing 00000000.tx.354: Tumor necrosis factor alpha augments amyloid beta protein (25-35) induced apoptosis in human cells. 

Phrase: "Tumor necrosis factor alpha"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           tumor necrosis factor
  1000   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
  1000   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumour necrosis factor
   923   C1323304:tumor necrosis factor [Molecular Function]
   861   C0333516:Tumor necrosis [Neoplastic Process]
   812   C0027540:Necrosis [Organ or Tissue Function]
   812   C0027651:Tumor [Neoplastic Process]
   812   C0439095:Alpha [Intellectual Product]
   812   C1334928:Necrosis [Finding]
   812   C1521761:Factor [Functional Concept]
   812   C1578706:Tumor [Intellectual Product]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3273930:Tumor [Finding]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "amyloid beta protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "(25-35"

Phrase: ")"

Phrase: "induced apoptosis in human cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.355: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.356: Lett. 

Phrase: "Lett."
Processing 00000000.tx.357: 238:1720.[CrossRef][Medline] Bligh, E.G., and W.J. 

Phrase: "238"

Phrase: ":"

Phrase: "1720."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bligh,"

Phrase: "E.G."

Phrase: ","

Phrase: "and"

Phrase: "W.J."
Processing 00000000.tx.358: Dyer. 

Phrase: "Dyer."
Processing 00000000.tx.359: 1959. 

Phrase: "1959."
Processing 00000000.tx.360: A rapid method of total lipid extraction and purification. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A rapid method of total lipid extraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0449341:Method of extraction [Intellectual Product]
           extraction method
   778   C0872257:rapid method [Diagnostic Procedure]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "purification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]
Processing 00000000.tx.361: Can. 

Phrase: "Can."
Processing 00000000.tx.362: J. 

Phrase: "J."
Processing 00000000.tx.363: Med. 

Phrase: "Med."
Processing 00000000.tx.364: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.365: 37:911917.[Medline] Bose, R., M. 

Phrase: "37"

Phrase: ":"

Phrase: "911917."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bose,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.366: Verheij, A. 

Phrase: "Verheij,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.367: Haimovitz-Friedman, K. 

Phrase: "Haimovitz-Friedman,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.368: Scotto, Z. 

Phrase: "Scotto,"

Phrase: "Z."
Processing 00000000.tx.369: Fuks, and R. 

Phrase: "Fuks,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.370: Kolesnick. 

Phrase: "Kolesnick."
Processing 00000000.tx.371: 1995. 

Phrase: "1995."
Processing 00000000.tx.372: Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. 

Phrase: "Ceramide synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0665744:ceramide synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "daunorubicin-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "an alternative mechanism for generating death signals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.373: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.374: 82:405414.[Medline] Bozner, P., V. 

Phrase: "82"

Phrase: ":"

Phrase: "405414."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bozner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "V."
Processing 00000000.tx.375: Grishko, S.P. 

Phrase: "Grishko,"

Phrase: "S.P."
Processing 00000000.tx.376: LeDoux, G.L. 

Phrase: "LeDoux,"

Phrase: "G.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439294:g l [Quantitative Concept]
Processing 00000000.tx.377: Wilson, Y.C. 

Phrase: "Wilson,"

Phrase: "Y.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.378: Chyan, and M.A. 

Phrase: "Chyan,"

Phrase: "and"

Phrase: "M.A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0221134:M antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.379: Pappolla. 

Phrase: "Pappolla."
Processing 00000000.tx.380: 1997. 

Phrase: "1997."
Processing 00000000.tx.381: The amyloid beta protein induces oxidative damage of mitochondrial DNA. 

Phrase: "The amyloid beta protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "oxidative damage of mitochondrial DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   797   C1096176:Mitochondrial Damage [Pathologic Function]
   760   C0010957:Damage [Injury or Poisoning]
   760   C1883709:Damage [Functional Concept]
Processing 00000000.tx.382: J. 

Phrase: "J."
Processing 00000000.tx.383: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.384: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.385: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.386: 56:13561362.[Medline] Bradshaw, C.D., K.M. 

Phrase: "56"

Phrase: ":"

Phrase: "13561362."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bradshaw,"

Phrase: "C."

Phrase: "D."

Phrase: ","

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.387: Ella, A.L. 

Phrase: "Ella,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2927379:Ella [Pharmacologic Substance]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.L."
Processing 00000000.tx.388: Thomas, C. 

Phrase: "Thomas,"

Phrase: "C."
Processing 00000000.tx.389: Qi, and K.E. 

Phrase: "Qi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376586:Qi [Idea or Concept]

Phrase: "and"

Phrase: "K.E."
Processing 00000000.tx.390: Meier. 

Phrase: "Meier."
Processing 00000000.tx.391: 1996. 

Phrase: "1996."
Processing 00000000.tx.392: Effects of Ara-C on neutral sphingomyelinase and mitogen- and stress-activated protein kinases in T-lymphocyte cell lines. 

Phrase: "Effects of Ara-C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on neutral sphingomyelinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539580:Neutral Sphingomyelinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "mitogen-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0026249:Mitogen [Pharmacologic Substance]

Phrase: "and"

Phrase: "stress-activated protein kinases in T-lymphocyte cell lines."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   801   C0872280:stress activated protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0018850:stress protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1515879:Activated Lymphocyte [Cell]
   742   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0038435:Stress [Finding]
   742   C1879547:Activated [Activity]
   708 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.393: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.394: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.395: Biol. 

Phrase: "Biol."
Processing 00000000.tx.396: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.397: 40:709719.[Medline] Brera, B., A. 

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "709719."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brera,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.398: Serrano, and M.L. de Ceballos. 

Phrase: "Serrano,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1551580:Serrano [Population Group]
  1000   C1551977:Serrano [Language]

Phrase: "and"

Phrase: "M.L. de Ceballos."
Processing 00000000.tx.399: 2000. 

Phrase: "2000."
Processing 00000000.tx.400: beta-amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress. 

Phrase: "beta-amyloid peptides"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C2825879:Amyloid, Beta [Laboratory Procedure]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "are"

Phrase: "cytotoxic to astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   790   C1511636:cytotoxic [Functional Concept]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: ":"

Phrase: "a role for oxidative stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.401: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.402: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.403: 7:395405.[CrossRef][Medline] Bruce-Keller, A.J., J.G. 

Phrase: "7"

Phrase: ":"

Phrase: "395405."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bruce-Keller,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.J.,"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.404: Begley, W. 

Phrase: "Begley,"

Phrase: "W."
Processing 00000000.tx.405: Fu, D.A. 

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "D."

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.406: Butterfield, D.E. 

Phrase: "Butterfield,"

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.407: Bredesen, J.B. 

Phrase: "Bredesen,"

Phrase: "J.B."
Processing 00000000.tx.408: Hutchins, K. 

Phrase: "Hutchins,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.409: Hensley, and M.P. 

Phrase: "Hensley,"

Phrase: "and"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.410: Mattson. 

Phrase: "Mattson."
Processing 00000000.tx.411: 1998. 

Phrase: "1998."
Processing 00000000.tx.412: Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. 

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "protects"

Phrase: "isolated plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "mitochondrial membranes against lipid peroxidation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0596952:Mitochondrial Membranes [Cell Component]
   781   C0025249:Membrane lipid [Cell Component,Lipid]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "induced by hydrogen peroxide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0020275:Hydrogen [Element, Ion, or Isotope]
   770   C0031180:Peroxide [Inorganic Chemical]
   770   C0205263:Induced [Functional Concept]
   770   C0523702:HYDROGEN [Laboratory Procedure]
   770   C0885426:hydrogen [Inorganic Chemical]

Phrase: "and"

Phrase: "amyloid beta-peptide."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
  1000   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.413: J. 

Phrase: "J."
Processing 00000000.tx.414: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.415: 70:3139.[Medline] Bruno, A.P., G. 

Phrase: "70"

Phrase: ":"

Phrase: "3139."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bruno,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.P.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.416: Laurent, D. 

Phrase: "Laurent,"

Phrase: "D."
Processing 00000000.tx.417: Averbeck, C. 

Phrase: "Averbeck,"

Phrase: "C."
Processing 00000000.tx.418: Demur, J. 

Phrase: "Demur"

Phrase: ","

Phrase: "J."
Processing 00000000.tx.419: Bonnet, A. 

Phrase: "Bonnet,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.420: Bettaieb, T. 

Phrase: "Bettaieb,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.421: Levade, and J.P. 

Phrase: "Levade,"

Phrase: "and"

Phrase: "J.P."
Processing 00000000.tx.422: Jaffrezou. 

Phrase: "Jaffrezou."
Processing 00000000.tx.423: 1998. 

Phrase: "1998."
Processing 00000000.tx.424: Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. 

Phrase: "Lack of ceramide generation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "in TF-1 human myeloid leukemic cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   858   C0427861:Human cells [Laboratory or Test Result]
   839   C0887899:Myeloid Cells [Cell]
   822 E C0596993:Myeloid cell [Cell]
   810   C1517806:Leukemic Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "resistant to ionizing radiation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.425: Cell Death Differ. 

Phrase: "Cell Death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Differ."
Processing 00000000.tx.426: 5:172182.[CrossRef][Medline] Cafe, C., C. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "172182."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cafe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442599:Cafe [Manufactured Object]

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "C."
Processing 00000000.tx.427: Torri, L. 

Phrase: "Torri,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.428: Bertorelli, N. 

Phrase: "Bertorelli,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.429: Angeretti, E. 

Phrase: "Angeretti,"

Phrase: "E."
Processing 00000000.tx.430: Lucca, G. 

Phrase: "Lucca,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.431: Forloni, and F. 

Phrase: "Forloni,"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.432: Marzatico. 

Phrase: "Marzatico."
Processing 00000000.tx.433: 1996. 

Phrase: "1996."
Processing 00000000.tx.434: Oxidative stress after acute and chronic application of beta-amyloid fragment 25-35 in cortical cultures. 

Phrase: "Oxidative stress after acute"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   819   C0848237:acute stress [Sign or Symptom]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]

Phrase: "and"

Phrase: "chronic application of beta-amyloid fragment 25-35"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0185125:Application [Health Care Activity]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C3539080:APPLICATION [Quantitative Concept]

Phrase: "in cortical cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.435: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.436: Lett. 

Phrase: "Lett."
Processing 00000000.tx.437: 203:6165.[CrossRef][Medline] Coroneos, E., M. 

Phrase: "203"

Phrase: ":"

Phrase: "6165."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Coroneos,"

Phrase: "E.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.438: Martinez, S. 

Phrase: "Martinez,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.439: McKenna, and M. 

Phrase: "McKenna,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: Kester. 

Phrase: "Kester."
Processing 00000000.tx.441: 1995. 

Phrase: "1995."
Processing 00000000.tx.442: Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. 

Phrase: "Differential regulation of sphingomyelinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "ceramidase activities by growth factors"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   811   C1149472:growth factor activity [Molecular Function]
   790   C1149756:ceramidase activity [Molecular Function]
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cytokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.443: Implications for cellular proliferation and differentiation. 

Phrase: "Implications for cellular proliferation"

Phrase: "and"

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.444: J. 

Phrase: "J."
Processing 00000000.tx.445: Biol. 

Phrase: "Biol."
Processing 00000000.tx.446: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.447: 270:2330523309.[Abstract/Free FullText] Davis-Salinas, J., S.M. 

Phrase: "270"

Phrase: ":"

Phrase: "2330523309."

Phrase: "[Abstract/Free FullText"

Phrase: "] Davis-Salinas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1004422:salinas [Eukaryote]

Phrase: "J.,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.448: Saporito-Irwin, C.W. 

Phrase: "Saporito-Irwin,"

Phrase: "C.W."
Processing 00000000.tx.449: Cotman, and W.E. 

Phrase: "Cotman,"

Phrase: "and"

Phrase: "W.E."
Processing 00000000.tx.450: Van Nostrand. 

Phrase: "Van Nostrand."
Processing 00000000.tx.451: 1995. 

Phrase: "1995."
Processing 00000000.tx.452: Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. 

Phrase: "Amyloid beta-protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "its own production in cultured degenerating cerebrovascular smooth muscle cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0033268:production [Occupational Activity]
Processing 00000000.tx.453: J. 

Phrase: "J."
Processing 00000000.tx.454: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.455: 65:931934.[Medline] de la Monte, S.M., Y.K. 

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "931934."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] de la Monte,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Y.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.456: Sohn, and J.R. 

Phrase: "Sohn,"

Phrase: "and"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.457: Wands. 

Phrase: "Wands."
Processing 00000000.tx.458: 1997. 

Phrase: "1997."
Processing 00000000.tx.459: Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. 

Phrase: "Correlates of p53-"

Phrase: "and"

Phrase: "Fas (CD95"

Phrase: ")-"

Phrase: "mediated apoptosis in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.460: J. 

Phrase: "J."
Processing 00000000.tx.461: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.462: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.463: 152:7383.[CrossRef][Medline] Dobrowsky, R.T., G.M. 

Phrase: "152"

Phrase: ":"

Phrase: "7383."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dobrowsky,"

Phrase: "R.T.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.464: Jenkins, and Y.A. 

Phrase: "Jenkins,"

Phrase: "and"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.465: Hannun. 

Phrase: "Hannun."
Processing 00000000.tx.466: 1995. 

Phrase: "1995."
Processing 00000000.tx.467: Neurotrophins induce sphingomyelin hydrolysis. 

Phrase: "Neurotrophins"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0027754:Neurotrophins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0132298:Neurotrophin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   966 E C1323315:neurotrophin [Molecular Function]
   966 E C1332408:neurotrophin [Gene or Genome]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "sphingomyelin hydrolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]
Processing 00000000.tx.468: Modulation by co-expression of p75NTR with Trk receptors. 

Phrase: "Modulation by co-expression of p75NTR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "with Trk receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.469: J. 

Phrase: "J."
Processing 00000000.tx.470: Biol. 

Phrase: "Biol."
Processing 00000000.tx.471: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.472: 270:2213522142.[Abstract/Free FullText] Estus, S., T.E. 

Phrase: "270"

Phrase: ":"

Phrase: "2213522142."

Phrase: "[Abstract/Free FullText"

Phrase: "] Estus,"

Phrase: "S."

Phrase: ","

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.473: Golde, T. 

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.474: Kunishita, D. 

Phrase: "Kunishita,"

Phrase: "D."
Processing 00000000.tx.475: Blades, D. 

Phrase: "Blades,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0179323:blades [Medical Device]
   966 E C2700402:Blade [Plant]
   966 E C2948008:Blade [Pharmacologic Substance]

Phrase: "D."
Processing 00000000.tx.476: Lowery, M. 

Phrase: "Lowery,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.477: Eisen, M. 

Phrase: "Eisen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: Usiak, X.M. 

Phrase: "Usiak,"

Phrase: "X.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.479: Qu, T. 

Phrase: "Qu,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.480: Tabira, B.D. 

Phrase: "Tabira,"

Phrase: "B.D."
Processing 00000000.tx.481: Greenberg, et al. 

Phrase: "Greenberg,"

Phrase: "et al."
Processing 00000000.tx.482: 1992. 

Phrase: "1992."
Processing 00000000.tx.483: Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. 

Phrase: "Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0243072:derivatives [Chemical Viewed Structurally]
   706 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.484: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.485: 255:726728.[Medline] Garcia-Ruiz, C., A. 

Phrase: "255"

Phrase: ":"

Phrase: "726728."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Garcia-Ruiz,"

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.486: Colell, M. 

Phrase: "Colell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.487: Mari, A. 

Phrase: "Mari,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.488: Morales, and J.C. 

Phrase: "Morales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026530:Morales [Individual Behavior]

Phrase: "and"

Phrase: "J.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.489: Fernandez-Checa. 

Phrase: "Fernandez-Checa."
Processing 00000000.tx.490: 1997. 

Phrase: "1997."
Processing 00000000.tx.491: Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. 

Phrase: "Direct effect of ceramide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the mitochondrial electron transport chain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1325653:Mitochondrial electron transport chain [Cell Component]
   923   C2244392:electron transport chain [Molecular Function]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   756   C1752477:mitochondrial electron transport [Molecular Function]
   708   C0678851:mitochondrial transport [Cell Function]

Phrase: "leads to generation of reactive oxygen species."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0079411:Generation [Temporal Concept]
   748   C0181586:leads [Medical Device]
   748   C0205332:Reactive [Qualitative Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3146294:Generation [Activity]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.492: Role of mitochondrial glutathione. 

Phrase: "Role of mitochondrial glutathione."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.493: J. 

Phrase: "J."
Processing 00000000.tx.494: Biol. 

Phrase: "Biol."
Processing 00000000.tx.495: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.496: 272:1136911377.[Abstract/Free FullText] Goldkorn, T., N. 

Phrase: "272"

Phrase: ":"

Phrase: "1136911377."

Phrase: "[Abstract/Free FullText"

Phrase: "] Goldkorn,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.497: Balaban, M. 

Phrase: "Balaban,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.498: Shannon, V. 

Phrase: "Shannon,"

Phrase: "V."
Processing 00000000.tx.499: Chea, K. 

Phrase: "Chea,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.500: Matsukuma, D. 

Phrase: "Matsukuma,"

Phrase: "D."
Processing 00000000.tx.501: Gilchrist, H. 

Phrase: "Gilchrist,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.502: Wang, and C. 

Phrase: "Wang,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.503: Chan. 

Phrase: "Chan."
Processing 00000000.tx.504: 1998. 

Phrase: "1998."
Processing 00000000.tx.505: H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. 

Phrase: "H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "acts on cellular membranes to"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0007603:Cellular membrane [Cell Component]
   790   C3161472:Cellular Membrane [Cell Component]
   760   C0007634:Cellular [Cell]
   760   C0025255:Membranes [Tissue]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0178539:Cellular [Functional Concept]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "generate"

Phrase: "ceramide signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "apoptosis in tracheobronchial epithelial cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.506: J. 

Phrase: "J."
Processing 00000000.tx.507: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.508: 111:32093220.[Abstract/Free FullText] Haass, C., M.G. 

Phrase: "111"

Phrase: ":"

Phrase: "32093220."

Phrase: "[Abstract/Free FullText"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.509: Schlossmacher, A.Y. 

Phrase: "Schlossmacher,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.Y."
Processing 00000000.tx.510: Hung, C. 

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.511: Vigo-Pelfrey, A. 

Phrase: "Vigo-Pelfrey,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.512: Mellon, B.L. 

Phrase: "Mellon,"

Phrase: "B.L."
Processing 00000000.tx.513: Ostaszewski, I. 

Phrase: "Ostaszewski,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.514: Lieberburg, E.H. 

Phrase: "Lieberburg,"

Phrase: "E.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.515: Koo, D. 

Phrase: "Koo,"

Phrase: "D."
Processing 00000000.tx.516: Schenk, D.B. 

Phrase: "Schenk,"

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.517: Teplow, et al. 

Phrase: "Teplow,"

Phrase: "et al."
Processing 00000000.tx.518: 1992. 

Phrase: "1992."
Processing 00000000.tx.519: Amyloid beta-peptide is produced by cultured cells during normal metabolism. 

Phrase: "Amyloid beta-peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
  1000   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "is"

Phrase: "produced by cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "during normal metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.520: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.521: 359:322325.[CrossRef][Medline] Haimovitz-Friedman, A., C.C. 

Phrase: "359"

Phrase: ":"

Phrase: "322325."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Haimovitz-Friedman,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.,"

Phrase: "C.C."
Processing 00000000.tx.522: Kan, D. 

Phrase: "Kan,"

Phrase: "D."
Processing 00000000.tx.523: Ehleiter, R.S. 

Phrase: "Ehleiter,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.524: Persaud, M. 

Phrase: "Persaud,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.525: McLoughlin, Z. 

Phrase: "McLoughlin,"

Phrase: "Z."
Processing 00000000.tx.526: Fuks, and R.N. 

Phrase: "Fuks,"

Phrase: "and"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.527: Kolesnick. 

Phrase: "Kolesnick."
Processing 00000000.tx.528: 1994. 

Phrase: "1994."
Processing 00000000.tx.529: Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. 

Phrase: "Ionizing radiation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0034538:Ionising radiation [Natural Phenomenon or Process]
   861   C0034519:Radiation [Natural Phenomenon or Process]
   861   C0560559:Radiation [Quantitative Concept]
   861   C0851346:Radiation [Natural Phenomenon or Process]
   861   C1522449:Radiation [Therapeutic or Preventive Procedure]
   861   C1524020:Radiation [Therapeutic or Preventive Procedure]
   861   C1524021:Radiation [Research Activity]

Phrase: "acts on cellular membranes to"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0007603:Cellular membrane [Cell Component]
   790   C3161472:Cellular Membrane [Cell Component]
   760   C0007634:Cellular [Cell]
   760   C0025255:Membranes [Tissue]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0178539:Cellular [Functional Concept]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "generate"

Phrase: "ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.530: J. 

Phrase: "J."
Processing 00000000.tx.531: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.532: Med. 

Phrase: "Med."
Processing 00000000.tx.533: 180:525535.[Abstract] Han, X., and R.W. 

Phrase: "180"

Phrase: ":"

Phrase: "525535."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "X.,"

Phrase: "and"

Phrase: "R.W."
Processing 00000000.tx.534: Gross. 

Phrase: "Gross."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439806:Gross [Qualitative Concept]
Processing 00000000.tx.535: 1995. 

Phrase: "1995."
Processing 00000000.tx.536: Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry. 

Phrase: "Structural determination of picomole amounts of phospholipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1148554:determination [Laboratory Procedure]

Phrase: "via electrospray ionization tandem mass spectrometry."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   924   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   884   C0599748:Tandem Mass Spectrometry [Molecular Biology Research Technique]
   840   C0037813:Mass Spectrometry [Laboratory Procedure]
   840   C1516801:Electrospray Ionization [Laboratory Procedure]
   804   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   804   C0436196:Spectrometry [Laboratory Procedure]
   804   C0577559:Mass [Finding]
   804   C0596801:Ionization [Phenomenon or Process]
   804   C1306372:*Mass [Quantitative Concept]
   804   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.537: J. 

Phrase: "J."
Processing 00000000.tx.538: Am. 

Phrase: "Am."
Processing 00000000.tx.539: Soc. 

Phrase: "Soc."
Processing 00000000.tx.540: Mass Spectrom. 

Phrase: "Mass Spectrom."
Processing 00000000.tx.541: 6:12021210.[CrossRef] Han, X., R.A. 

Phrase: "6"

Phrase: ":"

Phrase: "12021210."

Phrase: "[CrossRef"

Phrase: "] Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "X.,"

Phrase: "R.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.542: Gubitosi-Klug, B.J. 

Phrase: "Gubitosi-Klug,"

Phrase: "B.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.543: Collins, and R.W. 

Phrase: "Collins,"

Phrase: "and"

Phrase: "R.W."
Processing 00000000.tx.544: Gross. 

Phrase: "Gross."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439806:Gross [Qualitative Concept]
Processing 00000000.tx.545: 1996. 

Phrase: "1996."
Processing 00000000.tx.546: Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. 

Phrase: "Alterations in individual molecular species of human platelet phospholipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1515926:Alteration [Idea or Concept]

Phrase: "during thrombin stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: ":"

Phrase: "electrospray ionization mass spectrometry-facilitated identification of the boundary conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0020792:Identification [Mental Process]
   739   C0205396:Identification [Qualitative Concept]

Phrase: "for the magnitude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449286:magnitude [Quantitative Concept]
  1000   C1704240:Magnitude [Quantitative Concept]

Phrase: "and"

Phrase: "selectivity of thrombin-induced platelet phospholipid hydrolysis."
Processing 00000000.tx.547: Biochemistry. 

Phrase: "Biochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]
Processing 00000000.tx.548: 35:58225832.[CrossRef][Medline] Han, X., D.M. 

Phrase: "35"

Phrase: ":"

Phrase: "58225832."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "X.,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.549: Holtzman, and D.W. 

Phrase: "Holtzman,"

Phrase: "and"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.550: McKeel. 

Phrase: "McKeel."
Processing 00000000.tx.551: 2001. 

Phrase: "2001."
Processing 00000000.tx.552: Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. 

Phrase: "Plasmalogen deficiency in early Alzheimer's disease subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1859141:Plasmalogen deficiency [Finding]
   774   C0011156:Disease, Deficiency [Disease or Syndrome]
   774   C0751753:Deficiency Disease [Disease or Syndrome]
   748   C0011155:Deficiency [Functional Concept]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C1623416:deficiency [Qualitative Concept]

Phrase: "and in animal models"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599779:Models, Animal [Animal]
   770   C0003062:Animal [Animal]
   770   C1515981:And [Idea or Concept]
   770   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "molecular characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "electrospray ionization mass spectrometry."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C1516801:Electrospray Ionization [Laboratory Procedure]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C0596801:Ionization [Phenomenon or Process]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.553: J. 

Phrase: "J."
Processing 00000000.tx.554: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.555: 77:11681180.[CrossRef][Medline] Hannun, Y.A. 

Phrase: "77"

Phrase: ":"

Phrase: "11681180."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hannun,"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.556: 1996. 

Phrase: "1996."
Processing 00000000.tx.557: Functions of ceramide in coordinating cellular responses to stress. 

Phrase: "Functions of ceramide"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0542341:Functions [Functional Concept]
   756 E C0031843:function [Physiologic Function]
   756 E C0700205:FUNCTION [Classification]
   756 E C1705273:Function [Intellectual Product]
   706 E C0205245:Functional [Functional Concept]
   706 E C2700217:Functional [Conceptual Entity]

Phrase: "in coordinating cellular responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "to stress."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038435:Stress [Finding]
   928 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.558: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.559: 274:18551859.[Abstract/Free FullText] Hannun, Y.A., and C. 

Phrase: "274"

Phrase: ":"

Phrase: "18551859."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hannun,"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.560: Luberto. 

Phrase: "Luberto."
Processing 00000000.tx.561: 2000. 

Phrase: "2000."
Processing 00000000.tx.562: Ceramide in the eukaryotic stress response. 

Phrase: "Ceramide in the eukaryotic stress response."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0007745:Ceramide [Biologically Active Substance,Lipid]
Processing 00000000.tx.563: Trends Cell Biol. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol."
Processing 00000000.tx.564: 10:7380.[CrossRef][Medline] Huang, S.S., F.W. 

Phrase: "10"

Phrase: ":"

Phrase: "7380."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Huang,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "F.W."
Processing 00000000.tx.565: Huang, J. 

Phrase: "Huang,"

Phrase: "J."
Processing 00000000.tx.566: Xu, S. 

Phrase: "Xu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.567: Chen, C.Y. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "C.Y."
Processing 00000000.tx.568: Hsu, and J.S. 

Phrase: "Hsu,"

Phrase: "and"

Phrase: "J.S."
Processing 00000000.tx.569: Huang. 

Phrase: "Huang."
Processing 00000000.tx.570: 1998. 

Phrase: "1998."
Processing 00000000.tx.571: Amyloid beta-peptide possesses a transforming growth factor-beta activity. 

Phrase: "Amyloid beta-peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
  1000   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "a transforming growth factor-beta activity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   888   C1149472:growth factor activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.572: J. 

Phrase: "J."
Processing 00000000.tx.573: Biol. 

Phrase: "Biol."
Processing 00000000.tx.574: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.575: 273:2764027644.[Abstract/Free FullText] Jaffrezou, J.P., T. 

Phrase: "273"

Phrase: ":"

Phrase: "2764027644."

Phrase: "[Abstract/Free FullText"

Phrase: "] Jaffrezou,"

Phrase: "J.P.,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.576: Levade, A. 

Phrase: "Levade,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.577: Bettaieb, N. 

Phrase: "Bettaieb,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.578: Andrieu, C. 

Phrase: "Andrieu,"

Phrase: "C."
Processing 00000000.tx.579: Bezombes, N. 

Phrase: "Bezombes,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.580: Maestre, S. 

Phrase: "Maestre,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.581: Vermeersch, A. 

Phrase: "Vermeersch,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.582: Rousse, and G. 

Phrase: "Rousse,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.583: Laurent. 

Phrase: "Laurent."
Processing 00000000.tx.584: 1996. 

Phrase: "1996."
Processing 00000000.tx.585: Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. 

Phrase: "Daunorubicin-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "triggering of ceramide generation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007745:Ceramide [Biologically Active Substance,Lipid]
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]
   737   C0032930:Trigger [Clinical Attribute]
   737   C1444748:Trigger [Qualitative Concept]

Phrase: "through sphingomyelin hydrolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]
Processing 00000000.tx.586: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.587: 15:24172424.[Abstract] Jan, J.T., S. 

Phrase: "15"

Phrase: ":"

Phrase: "24172424."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jan,"

Phrase: "J.T.,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.588: Chatterjee, and D.E. 

Phrase: "Chatterjee,"

Phrase: "and"

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.589: Griffin. 

Phrase: "Griffin."
Processing 00000000.tx.590: 2000. 

Phrase: "2000."
Processing 00000000.tx.591: Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. 

Phrase: "Sindbis virus entry into cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1537068:Virus Entry [Biologic Function]
   760   C1705654:Entry [Intellectual Product]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "apoptosis by activating sphingomyelinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "leading to the release of ceramide."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   753   C0007745:Ceramide [Biologically Active Substance,Lipid]
   753   C0030685:Release [Health Care Activity]
   753   C0332152:Leading [Temporal Concept]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1522538:Leading [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.592: J. 

Phrase: "J."
Processing 00000000.tx.593: Virol. 

Phrase: "Virol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]
Processing 00000000.tx.594: 74:64256432.[Abstract/Free FullText] Jarvis, W.D., R.N. 

Phrase: "74"

Phrase: ":"

Phrase: "64256432."

Phrase: "[Abstract/Free FullText"

Phrase: "] Jarvis,"

Phrase: "W."

Phrase: "D."

Phrase: ","

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.595: Kolesnick, F.A. 

Phrase: "Kolesnick,"

Phrase: "F.A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0312909:f antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.596: Fornari, R.S. 

Phrase: "Fornari,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.597: Traylor, D.A. 

Phrase: "Traylor,"

Phrase: "D."

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.598: Gewirtz, and S. 

Phrase: "Gewirtz,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.599: Grant. 

Phrase: "Grant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]
Processing 00000000.tx.600: 1994. 

Phrase: "1994."
Processing 00000000.tx.601: Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. 

Phrase: "Induction of apoptotic DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   838   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cell death by activation of the sphingomyelin pathway."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0007587:Cell Death [Cell Function]
   767   C1326120:cell activation [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0011065:Death [Organism Function]
   744   C1269647:Cell [Cell]
   744   C1306577:Death, NOS [Finding]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.602: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.603: Natl. 

Phrase: "Natl."
Processing 00000000.tx.604: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.605: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.606: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.607: 91:7377.[Abstract] Juurlink, B.H., S.K. 

Phrase: "91"

Phrase: ":"

Phrase: "7377."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Juurlink,"

Phrase: "B.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.608: Thorburne, and L. 

Phrase: "Thorburne,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.609: Hertz. 

Phrase: "Hertz."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:hertz [Quantitative Concept]
Processing 00000000.tx.610: 1998. 

Phrase: "1998."
Processing 00000000.tx.611: Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. 

Phrase: "Peroxide-scavenging deficit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0162429:Deficit, NOS [Disease or Syndrome]
   827   C2987487:Deficit [Qualitative Concept]

Phrase: "underlies"

Phrase: "oligodendrocyte susceptibility to oxidative stress."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.612: Glia. 

Phrase: "Glia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]
Processing 00000000.tx.613: 22:371378.[CrossRef][Medline] Kaneko, I., N. 

Phrase: "22"

Phrase: ":"

Phrase: "371378."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kaneko,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.614: Yamada, Y. 

Phrase: "Yamada,"

Phrase: "Y."
Processing 00000000.tx.615: Sakuraba, M. 

Phrase: "Sakuraba,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.616: Kamenosono, and S. 

Phrase: "Kamenosono,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.617: Tutumi. 

Phrase: "Tutumi."
Processing 00000000.tx.618: 1995. 

Phrase: "1995."
Processing 00000000.tx.619: Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. 

Phrase: "Suppression of mitochondrial succinate dehydrogenase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "a primary target of beta-amyloid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "its derivative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527240:Derivative [Functional Concept]

Phrase: "racemized at Ser residue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.620: J. 

Phrase: "J."
Processing 00000000.tx.621: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.622: 65:25852593.[Medline] Kawai, M., R.N. 

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "25852593."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kawai,"

Phrase: "M."

Phrase: ","

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.623: Kalaria, P. 

Phrase: "Kalaria,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.624: Cras, S.L. 

Phrase: "Cras,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.625: Siedlak, M.E. 

Phrase: "Siedlak,"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.626: Velasco, E.R. 

Phrase: "Velasco,"

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.627: Shelton, H.W. 

Phrase: "Shelton,"

Phrase: "H.W."
Processing 00000000.tx.628: Chan, B.D. 

Phrase: "Chan,"

Phrase: "B.D."
Processing 00000000.tx.629: Greenberg, and G. 

Phrase: "Greenberg,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.630: Perry. 

Phrase: "Perry."
Processing 00000000.tx.631: 1993. 

Phrase: "1993."
Processing 00000000.tx.632: Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. 

Phrase: "Degeneration of vascular muscle cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0234958:DEGENERATION MUSCLE [Disease or Syndrome]
   797   C0333467:cells degeneration [Pathologic Function]
   797   C1281300:Vascular degeneration [Disease or Syndrome]
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "in cerebral amyloid angiopathy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085220:Cerebral Amyloid Angiopathy [Disease or Syndrome]
   901   C2931784:Amyloid angiopathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0042373:Angiopathy [Disease or Syndrome]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.633: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.634: 623:142146.[CrossRef][Medline] Koh, J.Y., and D.W. 

Phrase: "623"

Phrase: ":"

Phrase: "142146."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "J.Y.,"

Phrase: "and"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.635: Choi. 

Phrase: "Choi."
Processing 00000000.tx.636: 1987. 

Phrase: "1987."
Processing 00000000.tx.637: Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. 

Phrase: "Quantitative determination of glutamate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0007585:Cell Culture [Laboratory Procedure]
   738   C0010453:Culture [Idea or Concept]
   738   C0220814:culture [Functional Concept]
   738   C0430400:Culture [Laboratory Procedure]
   738   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.638: J. 

Phrase: "J."
Processing 00000000.tx.639: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.640: Methods. 

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.641: 20:8390.[CrossRef][Medline] Kolesnick, R.N., and M. 

Phrase: "20"

Phrase: ":"

Phrase: "8390."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kolesnick,"

Phrase: "R.N.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.642: Kronke. 

Phrase: "Kronke."
Processing 00000000.tx.643: 1998. 

Phrase: "1998."
Processing 00000000.tx.644: Regulation of ceramide production and apoptosis. 

Phrase: "Regulation of ceramide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.645: Annu. 

Phrase: "Annu."
Processing 00000000.tx.646: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.647: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.648: 60:643665.[CrossRef][Medline] Kyriakis, J.M., and J. 

Phrase: "60"

Phrase: ":"

Phrase: "643665."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kyriakis,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.649: Avruch. 

Phrase: "Avruch."
Processing 00000000.tx.650: 1996. 

Phrase: "1996."
Processing 00000000.tx.651: Protein kinase cascades activated by stress and inflammatory cytokines. 

Phrase: "Protein kinase cascades"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1155502:protein kinase cascade [Molecular Function]
   793   C1707310:Cascade [Manufactured Object]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "activated by stress"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0038435:Stress [Finding]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]
   718 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "inflammatory cytokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.652: Bioessays. 

Phrase: "Bioessays."
Processing 00000000.tx.653: 18:567577.[Medline] Larocca, J.N., M. 

Phrase: "18"

Phrase: ":"

Phrase: "567577."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Larocca,"

Phrase: "J.N., M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.654: Farooq, and W.T. 

Phrase: "Farooq,"

Phrase: "and"

Phrase: "W.T."
Processing 00000000.tx.655: Norton. 

Phrase: "Norton."
Processing 00000000.tx.656: 1997. 

Phrase: "1997."
Processing 00000000.tx.657: Induction of oligodendrocyte apoptosis by C2-ceramide. 

Phrase: "Induction of oligodendrocyte apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by C2-ceramide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083632:C2-ceramide [Organic Chemical,Pharmacologic Substance]
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]
Processing 00000000.tx.658: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.659: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.660: 22:529534.[CrossRef][Medline] Levade, T., and J.P. 

Phrase: "22"

Phrase: ":"

Phrase: "529534."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Levade,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "J.P."
Processing 00000000.tx.661: Jaffrezou. 

Phrase: "Jaffrezou."
Processing 00000000.tx.662: 1999. 

Phrase: "1999."
Processing 00000000.tx.663: Signalling sphingomyelinases: which, where, how and why? 

Phrase: "Signalling sphingomyelinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "which,"

Phrase: "where,"

Phrase: "how"

Phrase: "and"

Phrase: "why?"
Processing 00000000.tx.664: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.665: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.666: Acta. 

Phrase: "Acta."
Processing 00000000.tx.667: 1438:117.[Medline] Lister, M.D., Z.S. 

Phrase: "1438"

Phrase: ":"

Phrase: "117."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lister,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Z.S."
Processing 00000000.tx.668: Ruan, and R. 

Phrase: "Ruan,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.669: Bittman. 

Phrase: "Bittman."
Processing 00000000.tx.670: 1995. 

Phrase: "1995."
Processing 00000000.tx.671: Interaction of sphingomyelinase with sphingomyelin analogs modified at the C-1 and C-3 positions of the sphingosine backbone. 

Phrase: "Interaction of sphingomyelinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "with sphingomyelin analogs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:analogs [Chemical Viewed Structurally]
   755 E C0679213:analogies [Idea or Concept]

Phrase: "modified at the C-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Modified [Functional Concept]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "C-3 positions of the sphingosine backbone."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0733755:positions [Spatial Concept]
Processing 00000000.tx.672: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.673: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.674: Acta. 

Phrase: "Acta."
Processing 00000000.tx.675: 1256:2530.[Medline] Liu, B., and Y.A. 

Phrase: "1256"

Phrase: ":"

Phrase: "2530."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.676: Hannun. 

Phrase: "Hannun."
Processing 00000000.tx.677: 1997. 

Phrase: "1997."
Processing 00000000.tx.678: Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. 

Phrase: "Inhibition of the neutral magnesium-dependent sphingomyelinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by glutathione."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.679: J. 

Phrase: "J."
Processing 00000000.tx.680: Biol. 

Phrase: "Biol."
Processing 00000000.tx.681: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.682: 272:1628116287.[Abstract/Free FullText] Liu, B., N. 

Phrase: "272"

Phrase: ":"

Phrase: "1628116287."

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.683: Andrieu-Abadie, T. 

Phrase: "Andrieu-Abadie,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.684: Levade, P. 

Phrase: "Levade,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.685: Zhang, L.M. 

Phrase: "Zhang,"

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.686: Obeid, and Y.A. 

Phrase: "Obeid,"

Phrase: "and"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.687: Hannun. 

Phrase: "Hannun."
Processing 00000000.tx.688: 1998a. 

Phrase: "1998a."
Processing 00000000.tx.689: Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. 

Phrase: "Glutathione regulation of neutral sphingomyelinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in tumor necrosis factor-alpha-induced cell death."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   877   C0431085:Tumor cell [Cell]
   877   C0597032:Tumor Cell [Cell]
   848   C0027540:necrotic cell death [Organ or Tissue Function]
   829   C0030280:Alpha cell [Cell]
   818   C0007587:Cell Death [Cell Function]
   795   C0007634:Cell [Cell]
   795   C0011065:Death [Organism Function]
   795   C1269647:Cell [Cell]
   795   C1306577:Death, NOS [Finding]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
   710   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
   710   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
   710   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.690: J. 

Phrase: "J."
Processing 00000000.tx.691: Biol. 

Phrase: "Biol."
Processing 00000000.tx.692: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.693: 273:1131311320.[Abstract/Free FullText] Liu, B., D.F. 

Phrase: "273"

Phrase: ":"

Phrase: "1131311320."

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.694: Hassler, G.K. 

Phrase: "Hassler,"

Phrase: "G.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.695: Smith, K. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.696: Weaver, and Y.A. 

Phrase: "Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "and"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.697: Hannun. 

Phrase: "Hannun."
Processing 00000000.tx.698: 1998b. 

Phrase: "1998b."
Processing 00000000.tx.699: Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain. 

Phrase: "Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of a membrane bound neutral pH optimum magnesium-dependent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "phosphatidylserine-stimulated sphingomyelinase from rat brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.700: J. 

Phrase: "J."
Processing 00000000.tx.701: Biol. 

Phrase: "Biol."
Processing 00000000.tx.702: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.703: 273:3447234479.[Abstract/Free FullText] Lowry, O.H., N.J. 

Phrase: "273"

Phrase: ":"

Phrase: "3447234479."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lowry,"

Phrase: "O.H.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0455483:o h [Finding]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439114:O NOS [Intellectual Product]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "N.J."
Processing 00000000.tx.704: Rosebrough, A.L. 

Phrase: "Rosebrough,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.L."
Processing 00000000.tx.705: Farr, and R.J. 

Phrase: "Farr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441583:Farr [Laboratory Procedure]

Phrase: "and"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.706: Randall. 

Phrase: "Randall."
Processing 00000000.tx.707: 1951. 

Phrase: "1951."
Processing 00000000.tx.708: Protein measurement with the Folin-Phenol reagents. 

Phrase: "Protein measurement with the Folin-Phenol reagents."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0202202:Protein measurement [Laboratory Procedure]
   774   C0202446:Phenol measurement [Laboratory Procedure]
   748   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.709: J. 

Phrase: "J."
Processing 00000000.tx.710: Biol. 

Phrase: "Biol."
Processing 00000000.tx.711: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.712: 193:265275.[Free FullText] Markesbery, W.R. 

Phrase: "193"

Phrase: ":"

Phrase: "265275."

Phrase: "[Free FullText"

Phrase: "] Markesbery,"

Phrase: "W.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.713: 1999. 

Phrase: "1999."
Processing 00000000.tx.714: The role of oxidative stress in Alzheimer disease. 

Phrase: "The role of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.715: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.716: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.717: 56:14491452.[Free FullText] Masters, C.L., G. 

Phrase: "56"

Phrase: ":"

Phrase: "14491452."

Phrase: "[Free FullText"

Phrase: "] Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C.L., G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.718: Multhaup, G. 

Phrase: "Multhaup,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.719: Simms, J. 

Phrase: "Simms,"

Phrase: "J."
Processing 00000000.tx.720: Pottgiesser, R.N. 

Phrase: "Pottgiesser,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.721: Martins, and K. 

Phrase: "Martins,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.722: Beyreuther. 

Phrase: "Beyreuther."
Processing 00000000.tx.723: 1985. 

Phrase: "1985."
Processing 00000000.tx.724: Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. 

Phrase: "Neuronal origin of a cerebral amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0079946:origin [Classification]
   753   C0439659:Origin [Temporal Concept]
   753   C1550512:origin [Intellectual Product]

Phrase: ":"

Phrase: "neurofibrillary tangles of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the same protein as the amyloid of plaque cores"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "blood vessels."
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.725: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.726: 4:27572763.[Abstract] Masukawa, T., T. 

Phrase: "4"

Phrase: ":"

Phrase: "27572763."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Masukawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.727: Nishimura, H. 

Phrase: "Nishimura,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.728: Kito, and H. 

Phrase: "Kito,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.729: Iwata. 

Phrase: "Iwata."
Processing 00000000.tx.730: 1983. 

Phrase: "1983."
Processing 00000000.tx.731: Influence of diethylmaleate on the formation of bis(methylmercuric)selenide and methylmercury distribution in rats. 

Phrase: "Influence of diethylmaleate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0021399:influential [Idea or Concept]

Phrase: "on the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0556985:BIS [Temporal Concept]
  1000   C2247301:BIS [Molecular Function]
  1000   C3540495:BIS [Intellectual Product]

Phrase: "methylmercuric"

Phrase: ")"

Phrase: "selenide"

Phrase: "and"

Phrase: "methylmercury distribution in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.732: J. 

Phrase: "J."
Processing 00000000.tx.733: Pharmacobiodyn. 

Phrase: "Pharmacobiodyn."
Processing 00000000.tx.734: 6:950953.[Medline] McDonald, J.W., X.Z. 

Phrase: "6"

Phrase: ":"

Phrase: "950953."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McDonald,"

Phrase: "J.W., X.Z."
Processing 00000000.tx.735: Liu, Y. 

Phrase: "Liu,"

Phrase: "Y."
Processing 00000000.tx.736: Qu, S. 

Phrase: "Qu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.737: Liu, S.K. 

Phrase: "Liu,"

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.738: Mickey, D. 

Phrase: "Mickey,"

Phrase: "D."
Processing 00000000.tx.739: Turetsky, D.I. 

Phrase: "Turetsky,"

Phrase: "D."

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.740: Gottlieb, and D.W. 

Phrase: "Gottlieb,"

Phrase: "and"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.741: Choi. 

Phrase: "Choi."
Processing 00000000.tx.742: 1999. 

Phrase: "1999."
Processing 00000000.tx.743: Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. 

Phrase: "Transplanted embryonic stem cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0596508:Embryonic Stem Cells [Cell]
   869   C0206152:transplant cell [Cell]
   861   C0038250:Stem cells [Cell]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   812   C0007634:Cells [Cell]
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "survive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: ","

Phrase: "differentiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "recovery in injured rat spinal cord."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237820:Recovery [Activity]
   753   C1555688:recovery [Idea or Concept]
   753   C2004454:Recovery [Organism Function]
Processing 00000000.tx.744: Nat. 

Phrase: "Nat."
Processing 00000000.tx.745: Med. 

Phrase: "Med."
Processing 00000000.tx.746: 5:14101412.[CrossRef][Medline] Muller, W.E., F.J. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "14101412."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Muller,"

Phrase: "W.E.,"

Phrase: "F.J."
Processing 00000000.tx.747: Romero, S. 

Phrase: "Romero,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.748: Perovic, G. 

Phrase: "Perovic,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.749: Pergande, and P. 

Phrase: "Pergande,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.750: Pialoglou. 

Phrase: "Pialoglou."
Processing 00000000.tx.751: 1997. 

Phrase: "1997."
Processing 00000000.tx.752: Protection of flupirtine on beta-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion. 

Phrase: "Protection of flupirtine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "on beta-amyloid-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: ":"

Phrase: "prevention of amyloid-induced glutathione depletion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0199176:Prevention [Therapeutic or Preventive Procedure]
   753   C1706420:PREVENTION [Research Activity]
   753   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.753: J. 

Phrase: "J."
Processing 00000000.tx.754: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.755: 68:23712377.[Medline] Okazaki, T., R.M. 

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "23712377."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Okazaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.756: Bell, and Y.A. 

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "and"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.757: Hannun. 

Phrase: "Hannun."
Processing 00000000.tx.758: 1989. 

Phrase: "1989."
Processing 00000000.tx.759: Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. 

Phrase: "Sphingomyelin turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "induced by vitamin D3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008318:Vitamin D 3 [Pharmacologic Substance,Steroid,Vitamin]
   833   C3265062:vitamin D3 [Pharmacologic Substance]
   770   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0205263:Induced [Functional Concept]

Phrase: "in HL-60 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0282549:HL-60 Cells [Cell]
   901   C1512310:HL-60 [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.760: Role in cell differentiation. 

Phrase: "Role in cell differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   812   C1511938:Differentiation [Clinical Attribute]
   812   C2945687:Differentiation [Functional Concept]
   741 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.761: J. 

Phrase: "J."
Processing 00000000.tx.762: Biol. 

Phrase: "Biol."
Processing 00000000.tx.763: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.764: 264:1907619080.[Abstract/Free FullText] Pahan, K., F.G. 

Phrase: "264"

Phrase: ":"

Phrase: "1907619080."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pahan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.765: Sheikh, M. 

Phrase: "Sheikh,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.766: Khan, A.M. 

Phrase: "Khan,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.767: Namboodiri, and I. 

Phrase: "Namboodiri,"

Phrase: "and"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.768: Singh. 

Phrase: "Singh."
Processing 00000000.tx.769: 1998. 

Phrase: "1998."
Processing 00000000.tx.770: Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. 

Phrase: "Sphingomyelinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "stimulate"

Phrase: "the expression of inducible nitric-oxide synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat primary astrocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]
Processing 00000000.tx.771: J. 

Phrase: "J."
Processing 00000000.tx.772: Biol. 

Phrase: "Biol."
Processing 00000000.tx.773: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.774: 273:25912600.[Abstract/Free FullText] Pereira, C., M.S. 

Phrase: "273"

Phrase: ":"

Phrase: "25912600."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pereira,"

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.775: Santos, and C. 

Phrase: "Santos,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.776: Oliveira. 

Phrase: "Oliveira."
Processing 00000000.tx.777: 1999. 

Phrase: "1999."
Processing 00000000.tx.778: Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants. 

Phrase: "Involvement of oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "on the impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0684336:Impairment [Pathologic Function]

Phrase: "of energy metabolism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0014272:Energy Metabolism [Physiologic Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C1442080:Energy [Quantitative Concept]

Phrase: "induced by A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003320:Antigens [Immunologic Factor]
   790   C0205263:Induced [Functional Concept]

Phrase: "A beta peptides on PC12 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "protection by antioxidants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]
Processing 00000000.tx.779: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.780: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.781: 6:209219.[CrossRef][Medline] Pinkus, R., L.M. 

Phrase: "6"

Phrase: ":"

Phrase: "209219."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pinkus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1199788:pinkus [Plant]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.782: Weiner, and V. 

Phrase: "Weiner,"

Phrase: "and"

Phrase: "V."
Processing 00000000.tx.783: Daniel. 

Phrase: "Daniel."
Processing 00000000.tx.784: 1996. 

Phrase: "1996."
Processing 00000000.tx.785: Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. 

Phrase: "Role of oxidants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "antioxidants in the induction of AP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "NF-kappaB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079904:NF-kappaB [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "glutathione S-transferase gene expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0017262:Gene Expression [Genetic Function]
   840   C1336799:Transferase Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.786: J. 

Phrase: "J."
Processing 00000000.tx.787: Biol. 

Phrase: "Biol."
Processing 00000000.tx.788: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.789: 271:1342213429.[Abstract/Free FullText] Sawai, H., and Y.A. 

Phrase: "271"

Phrase: ":"

Phrase: "1342213429."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sawai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.790: Hannun. 

Phrase: "Hannun."
Processing 00000000.tx.791: 1999. 

Phrase: "1999."
Processing 00000000.tx.792: Ceramide and sphingomyelinases in the regulation of stress responses. 

Phrase: "Ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "sphingomyelinases in the regulation of stress responses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0037903:SPHINGOMYELINASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.793: Chem Phys. 

Phrase: "Chem Phys."
Processing 00000000.tx.794: Lipids. 

Phrase: "Lipids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]
Processing 00000000.tx.795: 102:141147.[CrossRef][Medline] Schapira, A.H. 

Phrase: "102"

Phrase: ":"

Phrase: "141147."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schapira,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.796: 1996. 

Phrase: "1996."
Processing 00000000.tx.797: Oxidative stress and mitochondrial dysfunction in neurodegeneration. 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "mitochondrial dysfunction in neurodegeneration."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.798: Curr. 

Phrase: "Curr."
Processing 00000000.tx.799: Opin. 

Phrase: "Opin."
Processing 00000000.tx.800: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.801: 9:260264.[Medline] Schreck, R., P. 

Phrase: "9"

Phrase: ":"

Phrase: "260264."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schreck,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.802: Rieber, and P.A. 

Phrase: "Rieber,"

Phrase: "and"

Phrase: "P.A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C0221133:P not otherwise specified Antigen [Immunologic Factor]
   983   C0599990:p antigen [Finding]
   983   C2607880:p Antigen [Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.803: Baeuerle. 

Phrase: "Baeuerle."
Processing 00000000.tx.804: 1991. 

Phrase: "1991."
Processing 00000000.tx.805: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. 

Phrase: "Reactive oxygen intermediates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0920643:reactive oxygen intermediate [Biologically Active Substance]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "as"

Phrase: "apparently widely used messengers in the activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0169911:messengers [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0335218:messengers [Professional or Occupational Group]

Phrase: "of the NF-kappa B transcription factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040649:Transcription [Genetic Function]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   717   C0079904:NF-kappa B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C2986464:NF-kappa-B [Gene or Genome]

Phrase: "and"

Phrase: "HIV-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019704:HIV-1 [Virus]
   861   C0019682:HIV [Virus]
   861   C0019699:HIV+ [Finding]
Processing 00000000.tx.806: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.807: 10:22472258.[Abstract] Scurlock, B., and G. 

Phrase: "10"

Phrase: ":"

Phrase: "22472258."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Scurlock,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.808: Dawson. 

Phrase: "Dawson."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]
Processing 00000000.tx.809: 1999. 

Phrase: "1999."
Processing 00000000.tx.810: Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis. 

Phrase: "Differential responses of oligodendrocytes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "to tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "other pro-apoptotic agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: ":"

Phrase: "role of ceramide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.811: J. 

Phrase: "J."
Processing 00000000.tx.812: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.813: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.814: 55:514522.[CrossRef][Medline] Segui, B., N. 

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "514522."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Segui,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.815: Andrieu-Abadie, S. 

Phrase: "Andrieu-Abadie,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.816: Adam-Klages, O. 

Phrase: "Adam-Klages,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.817: Meilhac, D. 

Phrase: "Meilhac,"

Phrase: "D."
Processing 00000000.tx.818: Kreder, V. 

Phrase: "Kreder,"

Phrase: "V."
Processing 00000000.tx.819: Garcia, A.P. 

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.P."
Processing 00000000.tx.820: Bruno, J.P. 

Phrase: "Bruno,"

Phrase: "J.P."
Processing 00000000.tx.821: Jaffrezou, R. 

Phrase: "Jaffrezou,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.822: Salvayre, M. 

Phrase: "Salvayre,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.823: Kronke, and T. 

Phrase: "Kronke,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.824: Levade. 

Phrase: "Levade."
Processing 00000000.tx.825: 1999. 

Phrase: "1999."
Processing 00000000.tx.826: CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway. 

Phrase: "CD40"

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C3266896:activation of apoptosis [Cell Function]
   757   C0162638:Apoptosis Pathway [Cell Function]
           Apoptosis
Processing 00000000.tx.827: J. 

Phrase: "J."
Processing 00000000.tx.828: Biol. 

Phrase: "Biol."
Processing 00000000.tx.829: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.830: 274:3725137258.[Abstract/Free FullText] Shaikh, A.Y., J. 

Phrase: "274"

Phrase: ":"

Phrase: "3725137258."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shaikh,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.Y.,"

Phrase: "J."
Processing 00000000.tx.831: Xu, Y. 

Phrase: "Xu,"

Phrase: "Y."
Processing 00000000.tx.832: Wu, L. 

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.833: He, and C.Y. 

Phrase: "He,"

Phrase: "and"

Phrase: "C.Y."
Processing 00000000.tx.834: Hsu. 

Phrase: "Hsu."
Processing 00000000.tx.835: 1997. 

Phrase: "1997."
Processing 00000000.tx.836: Melatonin protects bovine cerebral endothelial cells from hyperoxia-induced DNA damage and death. 

Phrase: "Melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "protects"

Phrase: "bovine cerebral endothelial cells from hyperoxia-induced DNA damage"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0225336:Endothelial Cells [Cell]
   762   C0270611:cerebral damage [Injury or Poisoning]
   762   C0599732:cells damage [Cell or Molecular Dysfunction]
   742   C0007634:Cells [Cell]
   742   C0014257:Endothelial [Tissue]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.837: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.838: Lett. 

Phrase: "Lett."
Processing 00000000.tx.839: 229:193197.[CrossRef][Medline] Singh, I., K. 

Phrase: "229"

Phrase: ":"

Phrase: "193197."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Singh,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.840: Pahan, M. 

Phrase: "Pahan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.841: Khan, and A.K. 

Phrase: "Khan,"

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.842: Singh. 

Phrase: "Singh."
Processing 00000000.tx.843: 1998. 

Phrase: "1998."
Processing 00000000.tx.844: Cytokine-mediated induction of ceramide production is redox-sensitive. 

Phrase: "Cytokine-mediated induction of ceramide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "redox-sensitive."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.845: Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. 

Phrase: "Implications to proinflammatory cytokine-mediated apoptosis"

Phrase: "in demyelinating diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011303:Demyelinating Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.846: J. 

Phrase: "J."
Processing 00000000.tx.847: Biol. 

Phrase: "Biol."
Processing 00000000.tx.848: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.849: 273:2035420362.[Abstract/Free FullText] Soderberg, M., C. 

Phrase: "273"

Phrase: ":"

Phrase: "2035420362."

Phrase: "[Abstract/Free FullText"

Phrase: "] Soderberg,"

Phrase: "M."

Phrase: ","

Phrase: "C."
Processing 00000000.tx.850: Edlund, I. 

Phrase: "Edlund,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.851: Alafuzoff, K. 

Phrase: "Alafuzoff,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.852: Kristensson, and G. 

Phrase: "Kristensson,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.853: Dallner. 

Phrase: "Dallner."
Processing 00000000.tx.854: 1992. 

Phrase: "1992."
Processing 00000000.tx.855: Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. 

Phrase: "Lipid composition in different regions of the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0486616:Composition [Clinical Attribute]
   744   C1555710:composition [Idea or Concept]

Phrase: "in Alzheimer's disease/senile dementia"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C0002395:Alzheimer's Dementia [Disease or Syndrome]
           Dementia, Senile
   861   C0011268:Senile dementia [Mental or Behavioral Dysfunction]
   812   C0011265:dementia [Mental or Behavioral Dysfunction]
   812   C0392079:Senile [Finding]
   812   C0497327:Dementia [Mental or Behavioral Dysfunction]
   756 E C0231337:Old age [Finding]
   756 E C1999167:Old age [Population Group]
   712 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "of Alzheimer's type."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.856: J. 

Phrase: "J."
Processing 00000000.tx.857: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.858: 59:16461653.[Medline] Spiegel, S., and A.H. 

Phrase: "59"

Phrase: ":"

Phrase: "16461653."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spiegel,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.859: Merrill, Jr. 

Phrase: "Merrill,"

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.860: 1996. 

Phrase: "1996."
Processing 00000000.tx.861: Sphingolipid metabolism and cell growth regulation. 

Phrase: "Sphingolipid metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158438:sphingolipid metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "cell growth regulation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596286:Cell Growth Regulation [Cell Function]
   901   C1160191:growth regulation [Organism Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0007595:Cell Growth [Cell Function]
Processing 00000000.tx.862: FASEB J. 

Phrase: "FASEB J."
Processing 00000000.tx.863: 10:13881397.[Abstract/Free FullText] Sugita, M., M. 

Phrase: "10"

Phrase: ":"

Phrase: "13881397."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sugita,"

Phrase: "M."

Phrase: ","

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.864: Willians, J.T. 

Phrase: "Willians,"

Phrase: "J.T."
Processing 00000000.tx.865: Dulaney, and H.W. 

Phrase: "Dulaney,"

Phrase: "and"

Phrase: "H.W."
Processing 00000000.tx.866: Moser. 

Phrase: "Moser."
Processing 00000000.tx.867: 1975. 

Phrase: "1975."
Processing 00000000.tx.868: Ceramidase and ceramide synthesis in human kidney and cerebellum. 

Phrase: "Ceramidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0109060:Ceramidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "ceramide synthesis in human kidney"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1157399:ceramide synthesis [Molecular Function]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "cerebellum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]
Processing 00000000.tx.869: Description of a new alkaline ceramidase. 

Phrase: "Description of a new alkaline ceramidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678257:Description [Idea or Concept]
Processing 00000000.tx.870: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.871: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.872: Acta. 

Phrase: "Acta."
Processing 00000000.tx.873: 398:125131.[Medline] Szekely, J.G., and A.U. 

Phrase: "398"

Phrase: ":"

Phrase: "125131."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Szekely,"

Phrase: "J.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.U."
Processing 00000000.tx.874: Lobreau. 

Phrase: "Lobreau."
Processing 00000000.tx.875: 1987. 

Phrase: "1987."
Processing 00000000.tx.876: The effect of glutathione depletion by diamide, diethyl maleate or buthione sulfoximine on the surface structure of mouse L-cells. 

Phrase: "The effect of glutathione depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "by diamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011953:Diamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "diethyl maleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0057931:diethyl maleate [Organic Chemical]
   861   C0220874:Maleate [Organic Chemical]

Phrase: "or"

Phrase: "buthione sulfoximine on the surface structure of mouse L-cells."
Processing 00000000.tx.877: Scanning Microsc. 

Phrase: "Scanning Microsc."
Processing 00000000.tx.878: 1:273281.[Medline] Tepper, C.G., S. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "273281."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tepper,"

Phrase: "C.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.879: Jayadev, B. 

Phrase: "Jayadev,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.880: Liu, A. 

Phrase: "Liu,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.881: Bielawska, R. 

Phrase: "Bielawska,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.882: Wolff, S. 

Phrase: "Wolff,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.883: Yonehara, Y.A. 

Phrase: "Yonehara,"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.884: Hannun, and M.F. 

Phrase: "Hannun,"

Phrase: "and"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.885: Seldin. 

Phrase: "Seldin."
Processing 00000000.tx.886: 1995. 

Phrase: "1995."
Processing 00000000.tx.887: Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. 

Phrase: "Role for ceramide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "as an endogenous mediator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of Fas-induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.888: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.889: Natl. 

Phrase: "Natl."
Processing 00000000.tx.890: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.891: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.892: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.893: 92:84438447.[Abstract] Testi, R. 

Phrase: "92"

Phrase: ":"

Phrase: "84438447."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Testi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.894: 1996. 

Phrase: "1996."
Processing 00000000.tx.895: Sphingomyelin breakdown and cell fate. 

Phrase: "Sphingomyelin breakdown"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157953:sphingomyelin breakdown [Molecular Function]
   861   C0443161:break down [Qualitative Concept]
   861   C0699900:breakdown [Organism Function]
   861   C1265875:breakdown [Acquired Abnormality]

Phrase: "and"

Phrase: "cell fate."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1540661:cell fate [Cell Function]
   861   C1539479:FATE [Gene or Genome]
   789 E C1302234:Fatal [Qualitative Concept]
   789 E C1705232:Fatal [Finding]
Processing 00000000.tx.896: Trends Biochem. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.897: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.898: 21:468471.[CrossRef][Medline] Thomas, T., G. 

Phrase: "21"

Phrase: ":"

Phrase: "468471."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Thomas,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.899: Thomas, C. 

Phrase: "Thomas,"

Phrase: "C."
Processing 00000000.tx.900: McLendon, T. 

Phrase: "McLendon,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.901: Sutton, and M. 

Phrase: "Sutton,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.902: Mullan. 

Phrase: "Mullan."
Processing 00000000.tx.903: 1996. 

Phrase: "1996."
Processing 00000000.tx.904: beta-Amyloid-mediated vasoactivity and vascular endothelial damage. 

Phrase: "beta-Amyloid-mediated vasoactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   741   C1980011:Vasoactive [Qualitative Concept]

Phrase: "and"

Phrase: "vascular endothelial damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]
Processing 00000000.tx.905: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.906: 380:168171.[CrossRef][Medline] Thorburne, S.K., and B.H. 

Phrase: "380"

Phrase: ":"

Phrase: "168171."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Thorburne,"

Phrase: "S."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "B.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.907: Juurlink. 

Phrase: "Juurlink."
Processing 00000000.tx.908: 1996. 

Phrase: "1996."
Processing 00000000.tx.909: Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. 

Phrase: "Low glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "high iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0860976:high iron [Finding]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "govern"

Phrase: "the susceptibility of oligodendroglial precursors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.910: J. 

Phrase: "J."
Processing 00000000.tx.911: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.912: 67:10141022.[Medline] Tonnetti, L., M.C. 

Phrase: "67"

Phrase: ":"

Phrase: "10141022."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tonnetti,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "M."

Phrase: "C."
Processing 00000000.tx.913: Veri, E. 

Phrase: "Veri,"

Phrase: "E."
Processing 00000000.tx.914: Bonvini, and L. 

Phrase: "Bonvini,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.915: D'Adamio. 

Phrase: "D'"

Phrase: "Adamio."
Processing 00000000.tx.916: 1999. 

Phrase: "1999."
Processing 00000000.tx.917: A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinasemediated signal transduction. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A role for neutral sphingomyelinase-mediated ceramide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in T cell receptor-induced apoptosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   911   C2610891:T cell apoptosis [Cell Function]
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]
   717   C0034790:T-Cell Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "mitogen-activated protein kinasemediated signal transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037083:Signal Transduction [Cell Function]
   799   C1160185:transduction [Organism Function]
   799   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.918: J. 

Phrase: "J."
Processing 00000000.tx.919: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.920: Med. 

Phrase: "Med."
Processing 00000000.tx.921: 189:15811589.[Abstract/Free FullText] Verheij, M., R. 

Phrase: "189"

Phrase: ":"

Phrase: "15811589."

Phrase: "[Abstract/Free FullText"

Phrase: "] Verheij,"

Phrase: "M."

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.922: Bose, X.H. 

Phrase: "Bose,"

Phrase: "X.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.923: Lin, B. 

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.924: Yao, W.D. 

Phrase: "Yao,"

Phrase: "W.D."
Processing 00000000.tx.925: Jarvis, S. 

Phrase: "Jarvis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.926: Grant, M.J. 

Phrase: "Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.927: Birrer, E. 

Phrase: "Birrer,"

Phrase: "E."
Processing 00000000.tx.928: Szabo, L.I. 

Phrase: "Szabo,"

Phrase: "L.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.929: Zon, J.M. 

Phrase: "Zon,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.930: Kyriakis, et al. 

Phrase: "Kyriakis,"

Phrase: "et al."
Processing 00000000.tx.931: 1996. 

Phrase: "1996."
Processing 00000000.tx.932: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. 

Phrase: "Requirement for ceramide-initiated SAPK/JNK signalling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514873:Requirement [Functional Concept]

Phrase: "in stress-induced apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.933: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.934: 380:7579.[CrossRef][Medline] Xu, J., C.H. 

Phrase: "380"

Phrase: ":"

Phrase: "7579."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xu,"

Phrase: "J.,"

Phrase: "C.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.935: Yeh, S. 

Phrase: "Yeh,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.936: Chen, L. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.937: He, S.L. 

Phrase: "He,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.938: Sensi, L.M. 

Phrase: "Sensi,"

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.939: Canzoniero, D.W. 

Phrase: "Canzoniero,"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.940: Choi, and C.Y. 

Phrase: "Choi,"

Phrase: "and"

Phrase: "C.Y."
Processing 00000000.tx.941: Hsu. 

Phrase: "Hsu."
Processing 00000000.tx.942: 1998. 

Phrase: "1998."
Processing 00000000.tx.943: Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. 

Phrase: "Involvement of de novo ceramide biosynthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   847   C0027540:necrotic cell death [Organ or Tissue Function]
   824   C0006110:cerebral death [Pathologic Function]
   804   C0007587:Cell Death [Cell Function]
   790   C0011065:Death [Organism Function]
   790   C1306577:Death, NOS [Finding]
   713   C0431085:Tumor cell [Cell]
   713   C0597032:Tumor Cell [Cell]
Processing 00000000.tx.944: J. 

Phrase: "J."
Processing 00000000.tx.945: Biol. 

Phrase: "Biol."
Processing 00000000.tx.946: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.947: 273:1652116526.[Abstract/Free FullText] Xu, J., S. 

Phrase: "273"

Phrase: ":"

Phrase: "1652116526."

Phrase: "[Abstract/Free FullText"

Phrase: "] Xu,"

Phrase: "J.,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.948: Chen, S.H. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.949: Ahmed, H. 

Phrase: "Ahmed,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.950: Chen, G. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.951: Ku, M.P. 

Phrase: "Ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532717:ku [Quantitative Concept]
  1000   C1881335:kU [Quantitative Concept]

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.952: Goldberg, and C.Y. 

Phrase: "Goldberg,"

Phrase: "and"

Phrase: "C.Y."
Processing 00000000.tx.953: Hsu. 

Phrase: "Hsu."
Processing 00000000.tx.954: 2001. 

Phrase: "2001."
Processing 00000000.tx.955: Amyloid-beta peptides are cytotoxic to oligodendrocytes. 

Phrase: "Amyloid-beta peptides"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0078939:Amyloid beta-Peptides [Amino Acid, Peptide, or Protein]
   966 E C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "are"

Phrase: "cytotoxic to oligodendrocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   790   C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.956: J. 

Phrase: "J."
Processing 00000000.tx.957: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.958: 21:RC118.[Medline] Yaar, M., S. 

Phrase: "21"

Phrase: ":"

Phrase: "RC118."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yaar,"

Phrase: "M."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.959: Zhai, P.F. 

Phrase: "Zhai,"

Phrase: "P.F."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.960: Pilch, S.M. 

Phrase: "Pilch,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.961: Doyle, P.B. 

Phrase: "Doyle,"

Phrase: "P.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539794:P-B [Gene or Genome]
Processing 00000000.tx.962: Eisenhauer, R.E. 

Phrase: "Eisenhauer,"

Phrase: "R.E."
Processing 00000000.tx.963: Fine, and B.A. 

Phrase: "Fine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205232:Fine [Qualitative Concept]
  1000   C0687757:fine [Regulation or Law]

Phrase: "and"

Phrase: "B.A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0368721:B antigen [Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.964: Gilchrest. 

Phrase: "Gilchrest."
Processing 00000000.tx.965: 1997. 

Phrase: "1997."
Processing 00000000.tx.966: Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. 

Phrase: "Binding of beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C1149161:beta-amyloid binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to the p75 neurotrophin receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0254837:p75 Neurotrophin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0132298:Neurotrophin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1323315:neurotrophin [Molecular Function]
   827   C1332408:neurotrophin [Gene or Genome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.967: A possible mechanism for Alzheimer's disease. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A possible mechanism for Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.968: J. 

Phrase: "J."
Processing 00000000.tx.969: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.970: Invest. 

Phrase: "Invest."
Processing 00000000.tx.971: 100:23332340.[Abstract/Free FullText] Yankner, B.A., L.R. 

Phrase: "100"

Phrase: ":"

Phrase: "23332340."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yankner,"

Phrase: "B.A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0368721:B antigen [Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A.,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.972: Dawes, S. 

Phrase: "Dawes,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.973: Fisher, L. 

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.974: Villa-Komaroff, M.L. 

Phrase: "Villa-Komaroff,"

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.975: Oster-Granite, and R.L. 

Phrase: "Oster-Granite,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061864:granite [Inorganic Chemical]
   861   C0885382:granite [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.976: Neve. 

Phrase: "Neve."
Processing 00000000.tx.977: 1989. 

Phrase: "1989."
Processing 00000000.tx.978: Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. 

Phrase: "Neurotoxicity of a fragment of the amyloid precursor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.979: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.980: 245:417420.[Medline] Yoshimura, S., Y. 

Phrase: "245"

Phrase: ":"

Phrase: "417420."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yoshimura,"

Phrase: "S."

Phrase: ","

Phrase: "Y."
Processing 00000000.tx.981: Banno, S. 

Phrase: "Banno,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.982: Nakashima, K. 

Phrase: "Nakashima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.983: Takenaka, H. 

Phrase: "Takenaka,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.984: Sakai, Y. 

Phrase: "Sakai,"

Phrase: "Y."
Processing 00000000.tx.985: Nishimura, N. 

Phrase: "Nishimura,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.986: Sakai, S. 

Phrase: "Sakai,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.987: Shimizu, Y. 

Phrase: "Shimizu,"

Phrase: "Y."
Processing 00000000.tx.988: Eguchi, Y. 

Phrase: "Eguchi,"

Phrase: "Y."
Processing 00000000.tx.989: Tsujimoto, and Y. 

Phrase: "Tsujimoto,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.990: Nozawa. 

Phrase: "Nozawa."
Processing 00000000.tx.991: 1998. 

Phrase: "1998."
Processing 00000000.tx.992: Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. 

Phrase: "Ceramide formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157399:ceramide formation [Molecular Function]
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "leads to caspase-3 activation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   797   C1159825:Caspase Activation [Molecular Function]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1879547:Activation [Activity]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "during hypoxic PC12 cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007587:Cell Death [Cell Function]
   861   C0085262:PC12 Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.993: Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation. 

Phrase: "Inhibitory effects of Bcl-2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on ceramide formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157399:ceramide formation [Molecular Function]
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "caspase-3 activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.994: J. 

Phrase: "J."
Processing 00000000.tx.995: Biol. 

Phrase: "Biol."
Processing 00000000.tx.996: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.997: 273:69216927.[Abstract/Free FullText] Yoshimura, S., Y. 

Phrase: "273"

Phrase: ":"

Phrase: "69216927."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yoshimura,"

Phrase: "S."

Phrase: ","

Phrase: "Y."
Processing 00000000.tx.998: Banno, S. 

Phrase: "Banno,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.999: Nakashima, K. 

Phrase: "Nakashima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.1000: Hayashi, H. 

Phrase: "Hayashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.1001: Yamakawa, M. 

Phrase: "Yamakawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1002: Sawada, N. 

Phrase: "Sawada,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.1003: Sakai, and Y. 

Phrase: "Sakai,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.1004: Nozawa. 

Phrase: "Nozawa."
Processing 00000000.tx.1005: 1999. 

Phrase: "1999."
Processing 00000000.tx.1006: Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death. 

Phrase: "Inhibition of neutral sphingomyelinase activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "ceramide formation by glutathione"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1157399:ceramide formation [Molecular Function]
   819   C1157234:glutathione formation [Molecular Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "in hypoxic PC12 cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007587:Cell Death [Cell Function]
   861   C0085262:PC12 Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.1007: J. 

Phrase: "J."
Processing 00000000.tx.1008: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.1009: 73:675683.[CrossRef][Medline] Yu, S.P., Z.S. 

Phrase: "73"

Phrase: ":"

Phrase: "675683."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "S.P.,"

Phrase: "Z.S."
Processing 00000000.tx.1010: Farhangrazi, H.S. 

Phrase: "Farhangrazi,"

Phrase: "H.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.1011: Ying, C.H. 

Phrase: "Ying,"

Phrase: "C.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.1012: Yeh, and D.W. 

Phrase: "Yeh,"

Phrase: "and"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.1013: Choi. 

Phrase: "Choi."
Processing 00000000.tx.1014: 1998. 

Phrase: "1998."
Processing 00000000.tx.1015: Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death. 

Phrase: "Enhancement of outward potassium current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "may"

Phrase: "participate in beta-amyloid peptide-induced cortical neuronal death."
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   781   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   781   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   764   C2825879:Amyloid, Beta [Laboratory Procedure]
   762 E C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   742   C0001613:Cortical [Body Part, Organ, or Organ Component]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007776:Cortical [Body Part, Organ, or Organ Component]
   742   C0011065:Death [Organism Function]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0022655:Cortical [Body Part, Organ, or Organ Component]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0205263:Induced [Functional Concept]
   742   C0330390:Beta [Plant]
   742   C0439096:Beta [Intellectual Product]
   742   C0521390:Neuronal [Immunologic Factor]
   742   C1306577:Death, NOS [Finding]
   742   C2004068:Beta [Qualitative Concept]
   729   C2754100:neuron death [Cell Function]
Processing 00000000.tx.1016: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.1017: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.1018: 5:8188.[CrossRef][Medline] Zhang, P., B. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "8188."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.1019: Liu, G.M. 

Phrase: "Liu,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1020: Jenkins, Y.A. 

Phrase: "Jenkins,"

Phrase: "Y.A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "A."
Processing 00000000.tx.1021: Hannun, and L.M. 

Phrase: "Hannun,"

Phrase: "and"

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.1022: Obeid. 

Phrase: "Obeid."
Processing 00000000.tx.1023: 1997. 

Phrase: "1997."
Processing 00000000.tx.1024: Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. 

Phrase: "Expression of neutral sphingomyelinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "identifies"

Phrase: "a distinct pool of sphingomyelin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0337051:Pool [Geographic Area]
   760   C1509144:pool [Clinical Attribute]
   760   C2349200:Pool [Functional Concept]

Phrase: "involved in apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C1314939:Involved [Functional Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.1025: J. 

Phrase: "J."
Processing 00000000.tx.1026: Biol. 

Phrase: "Biol."
Processing 00000000.tx.1027: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.1028: 272:96099612.[Abstract/Free FullText] Zhang, S.C., B. 

Phrase: "272"

Phrase: ":"

Phrase: "96099612."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang,"

Phrase: "S."

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.1029: Ge, and I.D. 

Phrase: "Ge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538705:GE [Gene or Genome]

Phrase: "and"

Phrase: "I.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0152277:i d [Therapeutic or Preventive Procedure]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.1030: Duncan. 

Phrase: "Duncan."
Processing 00000000.tx.1031: 1999. 

Phrase: "1999."
Processing 00000000.tx.1032: Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. 

Phrase: "Adult brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "generate"

Phrase: "oligodendroglial progenitors with extensive myelination capacity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0870134:Progenitor [Family Group]
Processing 00000000.tx.1033: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.1034: Natl. 

Phrase: "Natl."
Processing 00000000.tx.1035: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.1036: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.1037: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.1038: 96:40894094.[Abstract/Free FullText]

Phrase: "96"

Phrase: ":"

Phrase: "40894094."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

